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ABSTRACT
The goals of this dissertation research were to develop an integrated
computational and experimental platform for characterizing protein isoforms and post
translational modifications (PTMs) in microbial systems by top-down FT-ICR mass
spectrometry. To accomplish this goal, we employed methodologies of microbial
growth, intact protein and protein complex extractions, followed by sample preparation
and then progressed to identification of the instrumentation needed to integrate the topdown and bottom-up proteomics methodologies used in these studies. Emphasis is placed
on the development of integrated top-down and bottom-up informatics and the challenges
faced in the integration of these two large mass spectrometry data sets and extraction of
relevant biological data. We then illustrate how top-down and bottom-up methods can be
applied to the analysis of complex protein mixtures, protein complexes, and microbial
proteomes. Through the work of this dissertation we have contributed to the advancement
of top-down proteomics by providing an experimental platform which will aid in the
analysis of intact proteins and their associated PTMs and isoforms, as well as providing a
computational method that allows for the integration of top-down and bottom-up data
sets.
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Chapter 1
Introduction to the Analysis of Intact Proteins and PTMs in Microbial Systems by
Mass Spectrometry
Some of the text presented below has been published as Nathan C. VerBerkmoes, Heather
M. Connelly, Chongle Pan, and Robert L. Hettich, Mass Spectrometric Approaches to
Characterizing Bacterial Proteomes. Expert Review in Proteomics (2004), 1, 433-445.
The large amounts of information generated in the genomics era have begun to
reveal the complexities of microbial systems. For example, complete genome sequence
reveals the blueprint for life, in that it includes all information about the genes and gene
products used by the organism for all of its life functions. This level of global genome
information about an organism now makes it possible to begin to pursue an integrated
approach to understanding how these organisms live and function by cataloging and
understanding all of the biological components, their functions, and all of their
interactions in a living system and communities of living systems [1]. A natural extension
of genomics (the study of the complete set of genes for an organism) research is the
characterization of the gene products, most of which are proteins. This latter research
area is defined as proteomics (the study of the entire suite of proteins from a genome).
Proteome analyses, whether in simple microbes, yeast, or higher organisms, present a
much greater challenge than the genomics sequencing efforts. While the genome is
relatively static, the proteome is very dynamic. The genome generally contains a set
number of copies of every gene; however, proteins in the proteome can be expressed in a
wide concentration range, varying from only a few copies per cell for regulatory proteins
to many thousands per cell for ribosomal subunits.
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Proteins are complex 3D structures, which constitute the machinery of a cell and
at any time point perform the structural, catalytic, and signaling processes critical to
cellular life. To aid in these complex processes, proteins often contain post translational
modifications (PTMs); more than three hundred of these modifications have been
identified to date [2].The term post translational modification (PTM) refers to
modifications that occur during or after translation of the polypeptide chain.These post
translational modifications are important to provide protein heterogeneity, thereby
allowing a protein to exist in multiple isoforms. Most proteins must be modified in one
or more of a number of ways with PTMs before they achieve their final functional form.
PTM categories include: (a) covalent modifications such as phosphorylation,
methylation, and glycosolation; (b) proteolytic processing e. g., the removal of signal and
or pre-peptide sequences; (c) nonenzymatic modifications including deamidation and
racemization. Some common modifications found in bacteria and therefore addressed in
this study include: N-terminal methionine truncation, acetylation, methylation,
phosphorylation, and the removal of signal sequences.
The first of these modifications is the N-terminal methionine truncation, in which
the N-terminal residue of the newly-synthesized protein is modified in bacteria to remove
the formyl group. The N-terminal methionine may also be removed by certain
methionine aminopeptidases. The truncation of the N-terminal methionine depends on the
charge and size of the amino acid side chain occupying the next position from the Nterminal methionine. The truncation event follows what is known as the “N-end rule”.
This rule states that residues bearing small uncharged side chains, such as alanine, which
are considered stable, allow docking of methionine peptidases that cleave the N-terminal
2

methionine[3]. Also, there are approximately 12 destabilizing residues, according to the
“N-end rule”, that mark the protein for degradation by ubiquitin ligase. Therefore,
biologically the truncation may relate to the half-life of the protein..
In the case of acetylation, the amino-terminal residues of some proteins are
acetylated, as well as lysines and arginines within the protein sequence. The biological
significance of amino-terminal modification varies; some proteins require acetylation for
function whereas others that are acetylated do not absolutely require the modification. It
is possible that only a subset of proteins actually requires this modification for activity or
stability, whereas the remainders are acetylated only because their termini fortuitously
correspond to consensus sequences. Proteins with serine and alanine termini are the most
frequently acetylated, and these residues, along with methionine, glycine, and threonine,
account for over 95% of the amino-terminal acetylated residues [4, 5]. Only a subset of
proteins with any of these amino-terminal residues are acetylated, however, none of them
guarantees acetylation [6]. The complexity of the termini that are acetylated is due to the
presence of multiple N-acetyltransferases (NATs), each acting on different groups of
amino-acid sequences and whose specificity is determined by two or more residues at the
amino-terminal positions [7]. Amino-terminal acetylation does not necessarily protect
proteins from degradation, as has often been supposed, nor does it play any obvious role
in protection of proteins from degradation by the 'N-end rule' pathway that determines
whether to degrade proteins according to their amino-terminal residue.
The second common class of modifications includes amino acid side chain
modifications. Common examples of these side chain modifications include methylation,
acetylation, and phosphorylation. Methylation is an example of a common PTM found
3

primarily on lysine and arginine. These two residues have very polar side chains that are
positively charged. When these residues are blocked by a methylation, the basic nature
of that site within the protein can be changed, thereby making it more or less accessible
to other protein targets. Also, when the basic nature of lysine and arginine are changed, it
may serve to alter the protein structure. Many proteins have conformations that are pH
dependent, and when altered unfold or fold in a new configuration; methylation may play
a role in this process. Finally, within this class of side chain modifications is
phosphorylation. Phosphorylation of proteins (at Ser, Thr, Tyr and His residues) is an
important regulatory mechanism. For example, phosphorylation of tyrosine residues is
an important aspect of signal transduction pathways, and bacterial cells sense and
respond to environmental signals through histidine phosphorylation [8]. The final
category is proteolytic processing, or the removal of signal and or pre-peptide sequences.
As a protein is being synthesized, decisions must be made about sending it to the correct
location in the cell, where it will be required. The information for doing this resides in the
nascent protein sequence itself. Once the protein has reached its final destination, this
information may be removed by proteolytic processing. This class of proteins all contains
an N-terminus termed a signal sequence or signal peptide. The signal peptide is usually
13-36 predominantly hydrophobic residues, flanked on the N-terminal side by one or
more positively charged amino acids such as lysine or arginine, and containing neutral
amino acids with short side-chains (such as glycine or alanine) at the cleavage site. The
signal peptide is recognized by a multi-protein complex termed the signal recognition
particle (SRP). As proteins with signal sequences are synthesized, they are bound by the
SecB protein. This prevents the protein from folding. SecB delivers the protein to the cell
4

membrane where it is secreted through a pore formed by the SecE and SecY proteins.
Secretion is driven by the SecA ATPase. After the protein has been secreted, the signal
sequence is removed by a membrane bound leader peptidase [9].
Understanding these complex PTMs is often a difficult task. However,
difficulties exist, progress has been made toward identifying PTMs across multiple
microbial species. One of the major goals of this dissertation was to develop methods for
the identification of PTMs from microbial species under multiple growth conditions
(Chapter 7). The two chosen species include Rhodopseudomonas palustris and
Escherichia coli. Rhodopseudomonas palustris belongs to the α- proteobacteria and is a
purple nonsulfur anoxygenic phototrophic bacterium found in diverse environments from
fresh water to soil. One of the unique features of R. palustris is its ability to grow and
function under many metabolic states. These states include: photoheterotrophic, where
energy is obtained from light and carbon from organic carbon sources; photoautotrophic,
where energy is from light and the main source of carbon is from carbon dioxide;
chemoheterotrophic, in this state carbon and energy are from organic compounds; and
finally chemoautotrophic, where energy is from inorganic compounds and carbon from
carbon dioxide [10, 11, 12]. These multiple growth states provide the wild type R.
palustris (strain CGA0010) with the ability to be a biofuel producer by generating
hydrogen gas as a byproduct of nitrogen fixation, as well as a greenhouse gas sink by
converting carbon dioxide into cell mass.
Since most of these metabolic states can easily be attained in laboratory settings,
R. palustris is an ideal model system for the study of diverse metabolic modes and their
control within a single organism. Recently, the genome of R. palustris has been
5

sequenced, revealing a 5.4 Mb genome with 4836 potential protein encoding regions
[13]. This sequencing and annotation effort, along with proteome profiling [121], proteinprotein interaction studies, global gene knockouts [14], and transcriptome profiling [15]
will provide a detailed systems biology characterization of this microbe.
The second microbe chosen for study was Escherichia coli. This microbe is a γproteobacteria and found commonly as a facultative anaerobe that colonizes the lower gut
of animals but also survives when released into the environment. E. coli are rod-shaped
bacteria that possess adhesive fimbriae. Escherichia coli has become a model organism
for studying many of life's essential processes, partly due to its rapid growth rate and
simple nutritional requirements. Researchers have well established information about E.
coli's genetics; and have completed many of its strains genome sequences. E. coli K-12,
was the earliest organism to be "suggested as a candidate for whole genome sequencing"
[16]. Several strains of E. coli have been sequenced and studied in detail. It has a single
circular chromosome with 4,639,221 base pairs and 4288 protein-coding genes. Of these
protein-coding genes, 38% have no attributed function. E. coli K-12's genome, has a
50.8% G+C content. Genes that code for proteins account for 87.8% of the genome,
stable RNA-encoding genes make up 0.8%, 0.7% is made of noncoding repeats, and
about 11% is for regulatory and other functions [16]. An interesting feature of E. coli
K12 is the ability to develop antibiotic resistance to streptomycin through point mutations
within the ribosomal proteins, and is the reason why this organism was used for study in
this dissertation (chapter 4).
Characterization of a bacterial proteome typically refers to the comprehensive
detection and identification of the entire suite of proteins expressed by the microbial cell.
6

The entire suite of proteins may not be expressed under one growth condition or time
point, therefore multiple growth states or time points may be examined to look at the
entire complement of proteins in an organism. One of the techniques of choice to perform
these complex characterizations of proteins from within the cell, is mass spectrometry.
Mass spectrometry provides a powerful method to measure ions of intact and fragmented
molecules in order to provide molecular mass information, as well as ion manipulation
capabilities for obtaining detailed structural information at the isomeric level, including
differentiation of isomers in many cases. Originally, mass spectrometry was known for its
use in small molecule evaluation, but advances in the 1980’s made it possible to extend
its applications to large biomolecules such as proteins, nucleic acids, and their
complexes. These key advances included the ability to ionize these large molecules
using two new techniques. The new ionization techniques of electrospray ionization
(ESI) [17] and matrix-assisted laser desorption/ionization (MALDI) [18,19] provided a
new way of forming gas-phase ions from these larger molecules. These advances enabled
mass spectrometry to become a leading technology for proteome measurements, due to
its inherent ability to identify proteins, including hypothetical species, at high mass
accuracy, resolution, and throughput, even from complex mixtures [20,21].
Currently, there are two major methods for analyzing proteins by mass
spectrometry. The top-down method involves measuring intact proteins, either with or
without MS/MS of these intact proteins. This method was first introduced with
electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry,
ESI-FTICR-MS [22, 23, 24] and expanded to ion traps with novel ion-ion reactions [25].
In the bottom-up, method, intact proteins are digested with a protease such as trypsin,
7

Glu-C or cyanogen bromide (CNBr), and the resulting peptide mixtures are analyzed by
MS or MS/MS. It should be noted that in this definition it does not matter whether the
initial separations are performed on intact proteins or peptides; rather, the experiment
type is defined by the species measured by the MS. Thus, 2D-PAGE of intact proteins
followed by in-gel digestion and MS analysis is considered a bottom-up approach. The
actual development of the bottom-up methodology cannot be traced to a single lab, but
rather evolved from multiple labs using very different techniques including gel-based[26,
27, 28, 29, 30] and solution-based separations[31, 32, 33] followed by MS or MS/MS for
protein identifications. These two general approaches can be summarized as follows:
Bottom-up proteomics: Protein mixtures (from cell lysate or protein complexes) are
proteolytically digested (usually with trypsin), and the resulting peptide mixture is
examined by mass spectrometry. The MS data are used to query a peptide database from
the specific organism to identify the protein components of the original mixture. This
method is excellent for determining protein identities, but provides very limited
information about the molecular form of the intact proteins.
Top-down proteomics: Complex protein mixtures from cell lysates or protein complexes
are examined directly by on-line or off-line MS. No digest is conducted; rather the intact
proteins are measured with MS and MS/MS [34]. This method provides fewer protein
identities, but does give detailed information about the intact molecular forms of the
proteins, including post-translational processing (small molecule additions, truncation,
mutations, and signal peptides).
Both techniques have advantages and disadvantages and will be discussed in
detail below. Bottom-up proteomics is by far the more widely used method, mainly
8

because it is much simpler to conduct and does not require high performance MS
instrumentation. The progress in the field of bottom-up proteomics has been staggering.
It has now become possible (if not routine) to measure ~1000-1500 proteins from a
microbe under a given growth condition with a high degree of confidence in a 1-3 day
period, depending on the technology used. Furthermore, if enough mass spectrometers
are assembled, this analysis can be rapidly repeated for protein identification for an
organism under a variety of different growth conditions.
Bottom-up proteomics has become almost routine to perform, although, top-down
proteomics has moved at a slower pace. This lag in development is primarily due to the
following factors: liquid-based separations of intact proteins are more difficult than
peptides, MS and MS/MS analyses of intact proteins are more difficult to conduct and
interpret than peptides, the high performance MS instruments capable of adequate
analysis of intact proteins from complex mixtures are fairly expensive and have not been
designed for routine operation in most cases, and the algorithms to analyze MS/MS of
intact proteins are not as well developed or commercially available. Even with these
experimental challenges, top-down proteomics provides a level of information that the
bottom-up technique does not, which is the intact state of the protein. Information on the
intact state of the protein is critical, since proteins function as intact molecular species,
not as a combination of simple, small peptides. Thus, a full understanding of the intact
state of proteins (PTMs, truncation, mutations, and signal peptides) is necessary.
Bottom-up MS proteomics has become very powerful over the past five years,
although, it is clear that this is an indirect protein identification technique, as the intact
protein species are never measured directly, but rather only a fraction of the proteolytic
9

peptides for any given protein are identified. This leads to some concern that subtle
aspects of the protein, such as the presence of isoforms, or post-translational
modifications, might be missed by the bottom-up approach. This need for intact protein
measurements in complex mixtures has prompted investigation into developing MS
technologies for this task. At initial thought, this may seem straightforward based on the
extensive past work on characterizing purified protein samples, in fact, this approach
turns out to be a formidable analytical challenge for proteomes due to at least three
factors. First, the protein molecules masses can range from 5–200 kDa, requiring high
performance MS technology for accurate measurements. Second, the extreme
heterogeneity of protein sequences gives rise to a substantial ionization suppression effect
when very complex mixtures of proteins are examined. Thus, the proteins with the
largest amount of surface charge will ionize most easily and will be over-represented in
the mass spectrum relative to their abundance in the sample. This factor suggests that
some type of pre-fractionation, or on-line chromatography, will most likely need to be
used for intact protein measurements. Third, the unambiguous identification of larger
proteins is difficult, due to the isotopic packet that confounds accurate mass
measurements and the inability to extensively fragment these proteins, under tandem
mass spectrometry conditions, to get complete sequence information. All three of these
factors are much easier for peptides because of their lower molecular masses and more
extensive fragmentation. However, research is underway in several laboratories and has
shown remarkable progress in overcoming these challenges for the top-down approach.
One particular factor that must be noted is that most of the developments of the top-down
approach have focused on the experimental LC and MS measurement technologies. As a
10

result, the bioinformatics component is much less developed for the top-down data
analysis.
One of the challenges in separating complex protein mixtures is keeping the
proteins intact and soluble during the preparation/fractionation process. Because MS
measurements do not require the proteins to be in their active forms, it is sometimes
desirable to denature the entire complex mixture as early in the clean-up process as
possible. While this usually inactivates cellular proteases, it also can cause undesirable
protein precipitation in the samples. For the bottom-up MS approach, it is advantageous
to denature and digest the complex protein samples as early as possible in the clean-up
process. Because only peptides are measured, protein stability is not an issue for this
method. In contrast, protein stability is critical for the top-down MS approach. To
enhance this, during the cellular lysing process, a protease inhibitor cocktail is often
added to arrest protein degradation. The protease inhibitors, which are often small
molecules, stabilize the protein samples, but can often be removed prior to MS
characterization.
The critical component for top-down proteomics by MS is measurement of the
molecular masses of the intact proteins. The five important experimental aspects of this
measurement are mass accuracy, mass resolution, dynamic range, mass range, and
detection sensitivity.
(i)

Mass resolution. The measure of how well adjacent peaks can be
differentiated in the mass spectrum. This value is typically given as the peak
full width at half maximum (FWHM).
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(ii)

Mass accuracy. The comparison of the measured mass to the calculated mass.
This value is typically given as error in either percentage or parts-per-million
(ppm).

(iii)

Mass range. The difference between the largest and smallest molecular mass
that can be measured.

(iv)

Detection limits. The smallest amount of sample that can be measured with a
signal/noise of at least 3:1.

(v)

Dynamic range. The molar difference between the least abundant component
and the most abundant component that can be detected in a single sample.

The wide molecular range of possible proteins experienced in proteomics has
researchers proposing the use of technologies such as MALDI-TOF-MS. This approach
does provide an advantage for the analysis of large protein species, but does have some
draw backs such as limited mass resolution and accuracy. For example, a protein with a
molecular mass of 50 kDa can generally only be measured using a TOF-MS to about
0.02% (~ 10 Da). While this mass measurement is far superior to what is obtainable from
gel electrophoresis, this value could still correspond to many proteins within a given
database. Therefore, a much more accurate measurement, providing a higher level of
mass accuracy, is needed to limit the number of possible proteins identifications from
employed databases. This is the driving force to employ techniques such as ESI-FTICRMS for intact protein measurements. This technology provides unprecedented
capabilities for high performance measurements, although, many experimental
parameters are difficult to employ and need further development. For example, the same
protein with a molecular mass of 50 kDa could be measured with the FTICR-MS
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technique to about 0.0005% or 5 parts-per-million (~0.25 Da). Thus, high resolution and
accurate mass measurements of intact proteins are often sufficient information to identify
many bacterial proteins, without further structural information. However, this statement
is true in many cases, confounding the identification of intact proteins are protein
truncations and post-translational modifications that alter the measured molecular masses,
making it difficult to correlate the measured protein mass with the value predicted from
the genome data. For this reason, it is best to integrate the measured molecular mass
information with either structural data obtained by tandem mass spectrometry or with
data obtained by the bottom-up MS method on the same organism [35].
High-resolution molecular mass measurements of intact proteins reveal the complex
isotopic packet resulting from the combination of naturally-occurring isotopes. This
necessitates comparing the measured and calculated isotopic distributions to verify
protein identification [36]. In practicality, the high-resolution molecular mass
measurement is used to query a protein database for a given organism. The possible
protein matches falling within the specified mass accuracy window are tabulated, and a
calculated isotopic distribution is determined for each one (for FTICR-MS
measurements, there are usually no more than 3-4 possible proteins within the 5-10 ppm
range of the measured mass). For each putative protein, the calculated isotopic
distribution and most abundant peaks are compared to the measured values for final
protein identification.
Even with the high-resolution molecular mass measurements discussed above, the
dynamic range and heterogeneity of intact proteins in these complex mixtures can
confound the MS measurements. The basic problem stems from the limited ability to
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simultaneously measure hundreds (or even thousands) of proteins in a single mixture. An
obvious solution to this dilemma is to incorporate some aspect of protein fractionation,
either off-line or on-line, with the MS measurement. This increases the sample handling
and possible contamination or sample losses, but the MS measurement requirements are
greatly relaxed. For example, off-line anion-exchange chromatography can be used to
fractionate complex protein mixtures from crude cell lysates. Each fraction, which
contains between 50-200 proteins, is more easily interrogated by mass spectrometry [35].
The most common protein fractionation approach has been to incorporate reversephase liquid chromatography on-line with the MS. This arrangement permits the proteins
to be physically separated by their hydrophobicity on the stationary phase of the column,
and then eluted, sequentially, directly into the mass spectrometer. Reverse phase
chromatography columns, employed in this research, have a stationary phase composed
of silicate which has reactive hydroxyl groups. In order to cap these hydroxyl groups and
keep them from reacting with the proteins, alkyl chains are added. The longer the alkyl
chain caps of the silicate ends, the further the proteins are from the reactive hydroxyl
groups. Generally, most peptide work employs a C18 stationary phase for the best
separations. However, this is not the case for intact proteins wherein the shorter the
carbon backbones within the stationary phase generally mean better separation of intact
proteins. This need for shorter carbon chains is due to the large size and variation of
hydrophobicities of intact proteins. Therefore, most intact protein separations employing
reverse phase chromatography use a C2 to a C4 carbon backbone. This form of
separation and measurement takes longer, (usually about 2 hours for the LC-MS
experiment), although, a much more extensive analysis of the complex protein mixture is
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possible. This approach has been demonstrated for the characterization of the chloroplast
grana proteome [37] and the yeast large ribosomal subunit [38], and resulted in not only
protein identifications but also detection of post-translational modified species. It is
feasible to employ a multi-dimensional chromatographic approach for more enhanced
protein fractionation. For example, a two-dimensional LC-MS experiment has been
conducted on Saccharomyces cerevisiae by using a version of gel electrophoresis
employing acid-labile surfactants, followed by reverse-phase LC directly into an FTICRMS [39].
There are several alternatives to on-line chromatography. One such approach
involves surface enhanced laser desorption/ionization TOF-MS approach [40]. For this
method, a variety of chemical (hydrophobic, ionic, or mixed) or biochemical (antibody,
DNA, enzyme, or receptor) surfaces are used to preferentially absorb selected protein
species. This allows the fractionation to be fairly generic or highly specific, thereby
selectively reducing the complexity of the protein sample. These surfaces can be
incorporated into protein chips, providing a high-throughput sampling methodology for
MALDI-TOF-MS, although the identification of proteins from only their low-resolution
molecular mass is difficult. Another alternative to liquid chromatography focused on
exploiting the demonstrated power of gel electrophoresis. As a modification of
conventional 2-D PAGE, mass spectrometry has been used to replace the size-based
separation component of the SDS-PAGE separation [41]. For this method, the proteins
separated according to pI are then measured by MALDI-TOF-MS, with either postsource decay dissociation of intact proteins, or peptide mass mapping experiments. Such
information can be used to construct virtual 2-D gels.
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To unambiguously verify the protein assignment by top-down MS, it is
advantageous to acquire at least some structural information for the intact proteins
[23,42]. This can be accomplished with a variety of tandem mass spectrometry
experiments, involving collisional dissociation, electron dissociation, or
photodissociation. Proteins usually fragment much less extensively than peptides, but
there is often sufficient fragment ion information to confirm or reject a possible protein
identification from the accurate mass measurement. For example, the presence of only
three or four fragment ions from a protein was found to be sufficient for a 99.8%
probability of identifying the correct protein from a database of 5,000 bacterial protein
forms [43]. This methodology can be applied for proteins both with and without
disulfide bonds [44,45]. Electron capture dissociation shows promise for the most
extensive fragmentation of intact proteins in a high-throughput manner [46,47]. Electron
capture dissociation uses low-energy electrons to neutralize the charges on the protein
producing cleavage of the amide bond to form c and z ions, and usually provides
extensive sequence coverage of proteins even up to 45 kDa in size [48]. A combination
of collisional dissociation and electron capture dissociation can be used to provide
complementary information on intact proteins in bacterial proteomes [49]. Collisional
activated dissociation (CAD) traditionally has been one of the most common
fragmentation methods for proteins in top-down mass spectrometry. CAD is capable of
producing high fragmentation efficiency with relatively simple implementation [50]. For
very large proteins (molecular masses exceeding 150 kDa), it may be advantageous to
employ partial proteolytic digestion to make large peptides (5-50 kDa), and then
characterize these species [51]. One of the more extensive techniques for top-down MS
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is a combination of capillary LC-MS with infrared multiphoton dissociation (IRMPD)
[52]. IRMPD offers a method of fragmentation where no single frequency excitation is
required and the ions of all m/z values are dissociated at the same time [53]. This method
has been demonstrated to be useful with proteins and peptides.
As stated above, the bottom-up and top-down MS approaches each have unique
capabilities and limitations. One approach to exploit the power of each technique is to
integrate them together, with the goal of more comprehensive proteome characterization.
A flow-chart describing how this integrated technique might be designed is illustrated in
Figure 1.1. Off line fast protein liquid chromatography (FPLC) is used in this integrated
method to separate the large complex mixtures of proteins mixtures for top-down analysis
due to its proven ability to reduce down the complexity of the mixture. Therefore, by
reducing the complexity of the protein mixture, this method allows for better separation
from the on-line HPLC methods used, as well as more comprehensive protein
identifications [35]. This method of off line FPLC fractionation followed by on line
HPLC does take a large amount of protein starting material this is not of great concern
due to the ability to produce more than enough material from the chosen microbe’s
cultures. Another area of concern using this strategy is the loss of protein during the off
line separation. This problem is unavoidable due to the need to have a prior separation of
the complex protein mixture before the top-down analysis.
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Figure 1.1: Integrated protein preparation and identification.
Flow chart illustrating how an integrated top-down and bottom-up MS approach can be
used to characterize a bacterial proteome.
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By providing this initial separation step with FPLC, we increase the overall ability
to analyze and identify more proteins than with no initial separation. We have found this
technique of off line fractionation followed by on line HPLC to be highly reproducible
and simple to implement for a large-scale study of multiple samples [35]. An integrated
top-down and bottom-up approach allows for a more complete characterization of protein
complexes due to the unique strength of each technique. In an integrated approach, intact
protein masses, from the top-down analysis, corresponding to a particular PTM or
isoform, are then able to be compared to the comprehensive list of proteins provided by
the bottom-up analysis. This correlation between the two methods can provide PTM
location and identity with more certainty. The comprehensiveness of this technique has
been previously demonstrated in studies of the Shewanella oneidensis [35] proteome as
well as the 70S ribosomal complex from Rhodopseudomonas palustris [54].
The major goal of this dissertation was to build a platform for the analysis of
intact proteins from complex mixtures, in order to obtain information about the natural
state of the proteins. The hope was to gain greater biological insight into the complex
systems of microbes by providing starting information about the function, and possible
cellular location of proteins from bacteria. At the start of this dissertation, top-down
proteomics was only beginning to be developed in numerous laboratories. Thus, a major
effort was needed to develop the necessary biological, analytical, and computational tools
to addresses this daunting technical challenge of analysis intact proteins. The research
presented here has helped to bring us one step closer to achieving that goal.
The following is an outline of that effort. Chapter 2 details the current ORNL
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“top-down” proteomics pipeline for microbial proteomics, which was developed
primarily through efforts of this dissertation. Chapter 3 details the fundamental work on
the FT-ICR for the evaluation of proteins and PTMs. These fundamental efforts were
needed to advance this dissertation work on proteins and PTMs. Chapter 4 illustrates our
evaluation of complex ribosomal mixtures for PTMs and isoforms from the two microbes
R. palustris and E. coli. Chapter 5 further illustrates the effectiveness of examining PTMs
in protein complexes for key regulation sites from Rhodopseudomonas palustris. Chapter
6 introduces new computational methods developed for integrated top-down and bottomup data for the identification of PTMs. Finally, Chapter 7 concludes with the application
of “top-down” proteomics for the first characterization of a microbial proteome from
multiple growth conditions. This dissertation is the culmination of years of effort to
develop a top-down proteomics platform for the characterization of intact proteins and
PTMs from microbial proteomes with differing environmental conditions.
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Chapter 2
Experimental Platform for the Analysis of Intact Proteins and PTMs in Microbial
Systems by Mass Spectrometry
Introduction
This chapter describes the experimental platform for analysis of intact proteins
and their associated post translational modifications (PTMs) from either protein
complexes or microbial cell extracts that was developed through the course of this
dissertation. While a common experimental thread of analyzing intact bacterial proteins
for PTMs and isoforms by an integrated top-down and bottom-up mass spectrometry
approach can be found in all following chapters, the exact methods vary to some degree.
This chapter breaks each part of the process down and explains variations and advantages
and disadvantages of the various methods. The ORNL integrated top-down and bottomup platform is illustrated in Figure 2.1. The major parts include cell growth, protein
extraction/sample preparation, liquid chromatography, mass spectrometry, proteome
informatics and biological information extraction. Each of these subtasks are detailed
below.
Cell Growth and Protein Preparation
For all studies presented in this dissertation bacteria were grown from stock
solutions in batch format. Generally, glycerol stock solutions of the WT strain or a
mutant strain are kept at -80oC. For the R. palustris studies in Chapters 4, 5 and 7, the
wild-type (WT) strain CGA0010 was a gift from Dr. Caroline Harwood at the University
of Washington and can be obtained from Dr. Dale Pelletier in the Life Science
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Figure 2.1: Major steps in integrated top-down and bottom-up proteomics pipeline.
Illustrated is each major step in the ORNL proteomics pipeline for the analysis of
individual protein complexes and entire proteomes.
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Division at ORNL. The Escherichia coli protein purifications that were used in the
antibiotic resistance work in Chapter 6 were supplied by Dr. Morgan Giddings at the
University of North Carolina already in the purified intact protein form.
Growth of Wild Type R. palustris
R. palustris strain CGA0010, a hydrogen-utilizing derivative of the sequenced
strain (unpublished C. S. Harwood) and referred to here as the wild-type strain, was
grown under the three conditions (chapter 7). Wild type R. palustris cells were grown
anaerobically in light or aerobically in dark on defined mineral medium at 30 °C to midlog phase (OD660nm = 0.6). Carbon sources were added to a final concentration of 10
mM succinate and 10 mM sodium bicarbonate. For the photoheterotrophic N2 fixing
cultures, ammonium sulfate was replaced by sodium sulfate in the culture medium and N2
gas was supplied in the headspace. Chemoheterotrophic cells were grown aerobically in
the dark with shaking at 200 rpm; phototrophic cells were grown anaerobically in the
light with mixing with a stir bar. All anaerobic cultures were illuminated with 40 or 60 W
incandescent light bulbs from multiple directions. 4-5 liters of cells were grown for all
three states and pooled together for each state.
Protein Extraction of Wild type R. palustris
The cell pellet from each growth state were resuspended in ammonim acetate
buffer then lysed using a French Press. Total protein yields range between 60-120 mg of
protein for each of the three growth states. Cell extract was centrifuged at 10,000 X g for
35 minutes in a Sorvall centrifuge to remove all unbroken cells. Protein extract was used
for off-line anion exchange FPLC fractionation. Anion Exchange fractionation was used
due to the pI range of most proteins is in 3-7 range. By employing anion exchange with
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buffers in the pH range of 7.5-8, most proteins will not reach their isoelectric point and
will be eluted off the column according to their pI. Illustrated in Figure 2.2 is the protein
isolation process followed by mass spectrometry. To perform off-line anion exchange
chromatography 60 mg of protein was injected onto a 5 ml HiTrap (HiTrap SP HP,
Amersham Pharmacia) ion exchange column connected to an AKTA (Amersham
Pharmacia) FPLC system. After protein injection a 30 minute ammonium acetate gradient
was run from 0.2 M to 2 M at pH 7.5. Twenty fractions from each growth state (total of
60 from 3 growth states) were determined to have sufficient protein amounts (400 µg) by
a Bradford protein assay. Each FPLC fraction obtained was then divided into two
portions. One portion was examined by 1D LC-MS-MS bottom-up mass spectrometry
and the other portion of the sample was examined using LC-FTICR-MS for top-down
mass spectrometry.
Creation of Affinity Tagged Proteins in R. palustris
The R. palustris wild type strain (CGA0010), harboring the pBBR5-DEST/42
modified Gateway expression plasmid (Invitrogen, Carlsbad, CA) with the RPA0274,
RPA0272, RPA2966 open reading frames (ORF) were generated at Oak Ridge National
Laboratory by Dr. Dale Pelletier. The ORFs were cloned into the expression plasmid
with the V5 and 6xHis affinity tags fused at the C-terminus of the protein.
R. palustris cells harboring the expression plasmid were grown anaerobically and
under nitrogen fixing conditions in PM-N2 (photosynthetic nitrogen fixing medium) or in
PM (photosynthetic medium) under non-nitrogen fixing conditions. Cells were harvested
at mid-log phase (O.D.660 ~0.8). Cell pellets were re-suspended in NTA binding buffer
(50 mM NaH2PO4 at pH 8, 300 mM NaCl, 10 mM imidazole, 5 mM ATP, and 10 mM
24

Cells in Lyses Buffer
French Press

Suspension of insoluble and soluble proteins

(10,000 g for
for 35
35 min)
min)
Centrifugation (100,000g

Crude Supernatant

Pellet

Anion exchange
FPLC fractionation

Collect fractions with at least
400ug protein

Intact Proteins evaluated for
all fractions

Trypsin Digest
of all fractions
2X mass
spectrometry
analysis

Figure 2.2: Steps in protein purification performed.
Illustrated are the steps in cell growth to protein purification employed in dissertation.
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MgCl2, 10 mM KCl, 100 µg/ml PMSF and 10 µg/ml leupeptin) and lysed with 1X
BugBuster (Novagen). Cellular debris was removed with an initial centrifugation at 4°C
using an SS-34 Sorval rotor at 12,100 × g for 30 minutes. The supernatant was
centrifuged for an additional 15 minutes at 23,700 × g. The final resulting supernatant
was then immediately used in the first stage of the affinity purification.
Affinity Purification
The presence of two tags (6X His-tag and V5 antibody tag) within the expressed
protein allowed for the use of a dual affinity purification strategy to “capture” the
complexes. Figure 2.3 illustrates the affinity purification process employed. This is a
standard protocol for large-scale isolation of protein complexes from R. palustris in our
laboratory, in which a large number of strains each bearing a plasmid encoding a
different affinity-tagged protein [55].
In the first purification step, Ni-NTA beads (Qaigen, Valencia, CA) (previously
washed in NTA Binding buffer 4X) are added to the supernatants and were incubated on
a rotator for one hour at ambient temperature. The beads were then collected by
centrifugation at 425 × g, transferred to new tubes, and washed 4X with NTA wash
buffer (50 mM NaH2PO4 at pH 8, 300 mM NaCl, 20 mM imidazole, 5 mM ATP, 10 mM
MgCl2, 10 mM KCl). Afterwards, bound proteins were eluted from the Ni-NTA beads
4X with NTA elution buffer (50 mM NaH2PO4 at pH 8, 300 mM NaCl, 500 mM
imidazole, 5 mM ATP, 10 mM MgCl2, 10 mM KCl). Combined eluents (approximately
150 µl total) were diluted with 400 µl buffer (5 mM ATP, 10 mM MgCl2, 10 mM KCl)
and immediately used for the second affinity purification step.

26

Tags (His-tag, V5-tag)

Bait Protein

1

Gently Lyse
Cells
2
3

4

Affinity
Purification
Beads

1
5

Isolate Protein complex

Mass Spectrometry
for protein ID

Bioinformatics
Figure 2.3: Steps in protein affinity purification performed.
Illustrated are the steps in affinity protein purification employed in dissertation.
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V5 beads (Sigma, St. Louis, MO) (previously washed in PBS buffer) were added to the
combined eluents from the Ni-NTA capture and incubated on a rotator for one hour at
ambient temperature. The beads were then centrifuged at 425 × g and washed 4X with
V5 wash buffer (50 mM Tris-HCl, 10 mM CaCl2 at pH 7.6, 5 mM ATP, 10 mM MgCl2,
and 10 mM KCl). Afterwards, the bound proteins were eluted three times from the V5
beads with V5 elution buffer (80% acetonitrile and 1% formic acid). The combined
eluents were analyzed by protein chip measurements to give total protein concentration of
5µg in 150µl of eluent. This affinity purification method was completed 4 times to
provide 2 purifications for Top-down mass spectrometry analysis and two purifications
for bottom-up mass spectrometry analysis of each R. palustris growth state.
Approximately 10 µg of affinity purification eluent from each growth state was digested
for bottom-up analysis with sequencing grade trypsin added at 1:20 (wt/wt) of protein to
enzyme. The digestions were run with gentle shaking at 37 °C for 12 hours. Samples
were immediately desalted with an Omics 100 µl solid phase extraction pipette tip
(Varian, Palo Alto, CA). All samples were frozen at -80°C until LC-MS/MS analysis.
FTICR-MS
Rationale for Using Fourier Transform Ion Cyclotron Resonance Mass Spectrometry
(FTICR-MS) for the Characterization of Intact Proteins and PTMs in Microbial Systems
The analysis of large bio-polymers i.e. proteins, and their associated complexes is
a current area of scientific investigation addressed in this dissertation. Fourier
Transform-Ion Cyclotron Resonance-Mass Spectrometry (FTICR-MS) is an analytical
tool that has found particular application in the area of biological mass spectrometry [56].
FTICR-MS is particularly suited to the analysis of intact proteins as well as peptides [57]
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because of its unique method of mass analysis and m/z determination. FTICR-MS
provides mass resolution (FWHM of 100,000 to 150,000) far superior to other types of
instruments and also provides high mass accuracy (1 to 10 ppm for molecules of 100 to
30,000 Da) with proper calibration [57, 58]. In addition, its ability to comprehensively
measure a wide dynamic range (up to 105) provides an exceptional tool for the analysis of
complex mixtures. FTICR-MS has mass resolving power unparalled by other mass
analyzers consequently, what appears as an unresolvable mixture with other techniques
appears as a data rich mass spectrum. This resolving power can be utilized at low mass as
well as high mass applications. However, it is important to remember, the FTICR-MS
resolving power does decrease with increasing mass to charge.
The high performance that can be achieved only by FTICR-MS was particularly
crucial for analyzing intact proteins and their modified forms. Because of multiple carbon
atoms in the molecule, the molecular region of the protein exists as a population of
numerous isotopic species. The mass of a protein is determined most accurately if
different isotopic species are resolved. Even for smaller proteins, FTICR-MS is only the
instrument that can comprehensively resolve all of these isotopic species. Resolution of
isotopic species is even more important when analyzing modified proteins. For example,
as described in Chapter 4, the GlnK proteins in R. palustris are modified with an
uridylylation. The modified forms of the protein have a mass shift of 306.2 Da and are
difficult to resolvable in other low resolution instruments, such as ion traps. Another
PTM that is sometimes difficult to resolve in lower resolution instruments is the
methylation. The mass of methylation is 14 Da, which is very close to the mass of other
common side chain losses such as water or ammonia (18 and 17 Da, respectively). Such
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mass differences of intact proteins can be probed only when isotopic species are
comprehensively resolved. In the next section, the fundamental principles of FTICR-MS
will be illustrated. A more detailed description of FTICR-MS can be found in [57, 58].
Basic Principles of FTICR
In all FTICR-MS experiments preformed ions were generated in an electrospray
source, de-solvated in a heated glass capillary, accumulated in a external hexapole,
transferred into a high vacuum region with a quadrupole lens system, and then detected in
the cylindrical analyzer cell of the mass spectrometer (Figure 2.4). Ion detection was
achieved in an ultra low vacuum region (~2 X 10-10 Torr) through the use of differential
pumping stages. Initial pumping was achieved using a mechanical pump which lowered
the pressure to the millitorr range. The next stage of pumping was achieved using a turbopump to lower the pressure to ~ 10-5 Torr. Finally, two cryopumps lowered the base
pressure to approximately 2 X 10-10 Torr. Once the ions reach the analyzer cell under the
low pressure, the process of detection takes place. Detection in a FTICR is unique when
compared to other mass spectrometers. FTICR-MS measurements rely on the cyclotron
motion of ions in a magnetic field. This cyclotron motion is due to magnetic forces that
bend the ion motion into a circle. The frequency of the ion cyclotron motion is unique to
an ion of a particular mass/ charge. On the other hand, the frequency of the ion cyclotron
motion is independent of ion velocity and proportional to magnetic field strength. Thus
ions of a given mass to charge will have the same cyclotron frequency, regardless of the
time the ion enters the cell or the velocity with which the ion enters the cell.
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Hexapole

Figure 2.4: Schematic of IonSpec FTICR-MS.
Illustrated is the IonSpec ES-FTICR-MS instrument. Ions are introduced through the
Analytica electrospray ion source and transferred through a heated glass capillary into a
mechanically-pumped region, next through a skimmer, then into a turbopumped rf-only
hexapole for accumulation and storage at 2 X 10-5 Torr. Finally, the ions are then gated
through a shutter, down a quadrupole ion guide into the Penning cell within the high
magnetic field. The penning cell is at ~10-10 Torr provided by two cryopumps. Figure is
courtesy of IonSpec (www.IonSpec.com).
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Measuring the cyclotron frequency permits ultra-high mass resolution [57, 58]. To put
this into context, the base equation of ion cyclotron frequency can be examined [57].

ω = q B/m
In this equation (ω) is the cyclotron frequency, (B) the magnetic field strength, (q) the
charge of the ion and (m) the mass of the ion examined [57]. The frequency of the ion
cyclotron is independent of ion velocity and proportional to magnetic field strength, and
is inversely proportional to the mass/charge of the ion. In our case the magnetic field of
the FTICR-MS used is 9.4T, therefore, the ion frequencies are in the radio frequency (rf)
range of 10 kHz to 3 MHz. Using the above equation, the frequency of the ion cyclotron
motion can be used to determine the mass/charge of an ion; what is ultimately measured
in FTICR-MS.
It is important to understand that the ions are confined within the analyzer cell by
an electrostatic potential and magnetic fields. The electrostatic potential is applied on two
plates positioned perpendicularly to the magnetic field in the cell. Ions trapped in a
magnetic field generally have incoherent cyclotron motion (i.e. they are moving
independent of each other). In this mode, it is impossible to detect their net motion. To
force the ions to move coherently, an electric field at the appropriate frequencies need to
be applied. Normally the radius of an ion’s orbit will be about 0.1 mm, but if an RF
frequency is sent to the cell that is equal to the cyclotron frequency of the ion, it will gain
energy from the rf field and move into a larger orbit. As a positively charged ion passes
near the first electrode (forming part of the ICR cell), it will induce electrons toward the
electrode. Then, as the ion moves away and approaches the second electrode, the
electrons migrate to the second electrode instead [57].
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While absorbing power, the ions are accelerated, and at the same time, all ions of the
same mass/charge are forced to move in a phase coherent motion forming a packet of
ions. This coherent ion cyclotron motion is called the ion cyclotron resonance (ICR). On
the other hand, if the frequencies of rf and ion cyclotron are different, the ions will not
absorb power. This time dependent migration of the electrons is converted to an image
current by placing a resistor on the wire connecting the two electrodes, and the resulting
image current is a sinusoidal signal (Figure 2.5). The signal produced is amplified and
then fed into a computer. The amplitude of the image current is proportional to the
number of ions within the ion packet. If there are only ions of a single mass/charge in the
mass analyzer cell, the image current will resemble a pure sine wave. This sine wave can
be expressed in the time domain as a function of voltage amplitude with respect to time.
By a mathematical operation called Fourier transformation, the time image current can be
converted into the frequency domain. In the frequency domain, amplitude is proportional
to the abundance of ions trapped in the analyzer cell. In other words, the mass spectrum is
a mirror image of the frequency domain. If there are ions with different mass/charge
ratios, a complex waveform representing multiple image currents from the ion packets
will be formed. In order to Fourier transform this waveform, it needs to be converted into
a series of individual waveforms, called the Fourier series. In the Fourier series, the
waveform is expressed as the sum of all the sine and cosine terms, therefore, forming the
image current for an individual ion packet [57, 58]. The image current produced by the
Fourier series is converted into the frequency domain, and the frequency domain is
further converted into a mass spectrum (Figure 2.6).
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Figure 2.5: Generation of image current within the FTICR-MS.
(Image was taken from www.IonSpec.com)
Schematic of how the image current is obtained from the ion cyclotron frequency. The
magnetic field is represented by the green (B) within the diagram.
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Figure 2.6: Generation of mass spectrum from the image current within the FTICR-MS.
(A) The image current produced from a complex protein mixture. (B) The mass spectra
obtained after a Fourier transform from the image current.
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Experimental Procedure for Mass Spectrometric Analysis of Protein and Peptides
Employed In This Study
ESI-FTICR Mass Spectrometry
All ESI-FTICR mass spectra were acquired with an IonSpec (Lake Forest, CA)
9.4-Tesla HiRes electrospray Fourier transform ion cyclotron resonance mass
spectrometer. A Harvard syringe pump (flow rate of 1.75 µL/min) was used for direct
infusion into an Analytica electrospray source (Analytica of Branford, CT). After
generation, ions were accumulated in an external hexapole and transferred into the highvacuum region with a quadrupole lens system. Detection then followed in the cylindrical
analyzer cell of the mass spectrometer. Calibration of the mass spectrometer was
accomplished externally with ubiquitin, resulting in a mass accuracy of ±3-5 ppm and
mass resolutions of 50,000-160,000 (FWHM) as previously described [59].
Capillary HPLC-FT-ICR-MS
Capillary HPLC-FTICR-MS was accomplished with a Dionex UltiMate HPLC
interfaced directly to the FTICR instrument. A C4 reverse-phase column (VYDAC
214MS5.325 C4 column 300µm id x 250mm, 300Å with 5µm particles, Grace-Vydac,
Hesperia, CA) was employed for all separations. The R. palustris FPLC purification
eluent and E. coli ribosome purifications consisting of 20-30 µg of total protein was
injected onto the column and eluted at 4 µl/min into the electrospray ion source of the
FTICR-MS. The gradient was run from 100% solvent A (95% water, 5% acetonitrile,
0.1% formic acid, 50 mM hexafluorisoproponal) to 100% solvent B (95% acetonitrile,
5% water, 0.1% formic acid, 50 mM hexafluorisoproponal.) over a 75-min. linear
gradient. Hexafluorisoproponal (HFIP) was added as a chaotrope to help proteins unfold
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and keep them from forming multimers, which gives better peak resolution. Ions were
generated with a 3700 V potential between a grounded needle and heated transfer
capillary. After generation, ions were accumulated in an external hexapole for two
seconds and transferred into the high-vacuum region with a quadrupole lens system.
Detection then followed in the cylindrical analyzer cell of the mass spectrometer.
Calibration of the mass spectrometer was accomplished externally with ubiquitin
resulting in a mass accuracy of ±3-10 ppm and resolutions of 50,000-160,000 (FWHM).
Because the mass resolution was at least 50 000 for the intact protein measurements, the
molecular masses of these proteins could be measured with isotopic resolution.
Quadrupole Ion Trap MS
The function of the quadrupole ion trap is as follows; preformed solution phase
peptide ions are sprayed through an electrospray or nanospray source on the front of the
instrument into a heated capillary. The heated capillary is generally set at 150-2500C and
functions to desolvate the ions. The ions are then directed through a tube lens and passed
through a skimmer. The skimmer acts to focus the ion beam and skim off neutrals. Next,
the ions are directed through a quadrupole and octopole, which acts as an ion beam guide
to focus the ions into the ion trap. The ion beam enters into the trap through the inlet and
is trapped through action of the three hyperbolic electrodes: the ring electrode, the
entrance and exit the endcap electrodes (Figure 2.7) [60]. Various dc and rf voltages are
applied to these electrodes which results in the formation of a potential well, in which
ions are trapped. The ring electrode RF potential produces a 3D quadrupole potential
field within the trap. This traps the ions in a stable oscillating trajectory within the trap to
produce what is known as dynamic trapping.
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Figure 2.7: Schematic of a quadrupole ion trap mass spectrometer.
The diagram shows the major components to a quadrupole ion trap mass spectrometer.
At the start of the diagram the ESI needle assembly (electrospray ionization) provides the
ions travel through the mass spectrometer and are detected by the EM (electron
multiplier). Figure Provided by Thermo (www.thermo.com).

38

An ion will be stably trapped depending upon the values for the mass and charge of the
ion, the size of the ion trap (r), the oscillating frequency of the fundamental rf (Ω), and
the amplitude of the voltage on the ring electrode ( V). The dependence of ion motion on
these parameters is described by the two dimensionless parameter qz and az, as evident in
the formula below [60]. The qz value will determine when m/z ejection takes place.
m/z eject = 4V/(0.908r2Ω2)
For detection of the ions, the potentials are altered to destabilize the ion motions resulting
in ejection of the ions through the exit endcap. The ions are usually ejected in order of
increasing m/z by a gradual change in the potentials. The "stability diagram" depicts the
region where radial and axial stability overlap (Figure 2.8). Depending upon the
amplitude of the voltage placed on the ring electrode, an ion of a given m/z will have a
(qz) value that will fall within the boundaries of the stability diagram, and the ion will be
trapped. If the q z value at that voltage falls outside of the boundaries of the stability
diagram (qz = 0.908), the ion will hit the electrodes and be lost. By sequentially
increasing the voltage on the ring electrodes, ions trajectories from low m/z to high m/z
are made unstable (Figure 2.8). This “stream” of ions generated from this sequential
ejection are focused onto the detector or electron multiplier of the instrument in order to
produce the mass spectrum. The initial mass spectrum obtained is what is known as a full
scan. The ions observed within the full scan are next selected by their m/z values for
isolation and subsequent fragmentation. This selection is accomplished by destabilizing
and ejecting all other ions with lower and higher m/z values as described above. The
process of selection is essentially gas phase purification of the ion inside the mass
spectrometer.
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Figure 2.8: Stability diagram for the quadrupole ion trap.
(Figure taken from Karen R. Jonscher and John R. Yates, III, www.ABRF.org)
Diagram showing the regions of stability within the quadrupole ion trap depicted in terms
of the operating voltages and frequencies. The important terms on the diagram are the (a)
and (qz) functions. These functions represent stability ranges within the 3D trap.
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The selected ion is then excited by increasing its orbital frequency, which causes it to
collide with the helium bath gas inside the ion trap mass spectrometer [60]. These
repeated collisions with the helium gas cause collision induced fragmentation. After
fragmentation occurs, the fragment ions are maintained within the ion trap mass
spectrometer. The same process of destabilizing and ejecting ions that occurred in the
full scan is performed for the fragment ions thereby producing what is know as an
MS/MS or MS2 spectrum. The entire MS/MS process is repeated for three to four more
times for different selected ions within the ion trap before the mass spec returns to a full
scan. The process of full scans followed by MS/MS is repeated throughout an entire
chromatographic run, creating thousands of MS/MS spectra and their associated parent
m/z measurements.
Within this dissertation, 1D-LC-MS/MS was used for all peptide analysis. This
methodology is one of the simplest and easiest to implement, and was the reason it was
chosen within this body of work. It requires only three major instruments, a low-flow
HPLC pump, an autosampler, and the electrospray quadrupole ion trap mass spectrometer
(ES-QIT-MS).
1D-LC-ES-MS/MS
All R. palustris and E. coli protein preparations from each fraction were digested
for bottom-up analysis with sequencing grade trypsin added at 1:20 (wt/wt) of protein to
enzyme. The digestions were run with gentle shaking at 37 °C for 12 hours. Samples
were immediately desalted with an Omics 100 µl solid phase extraction pipette tip
(Varian, Palo Alto, CA). All samples were frozen at -80°C until LC-MS/MS analysis.
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For all peptide samples, one-dimensional (1D) LC-MS-MS experiments were
performed with a Famos/Switchos/Ultimate HPLC System (Dionex, Sunnyvale, CA)
coupled to an LCQ-DECA XP Plus quadrupole ion trap mass spectrometer (Thermo
Finnigan, San Jose, CA) equipped with a nanospray source as previously described [61].
A 160 minute linear gradient from 100% solvent A (95% H2O/5% ACN/0.5% formic
acid) to 100% solvent B (30% H2O/ 70% ACN/0.5% formic acid) was employed. For all
1D LC-MS-MS data acquisition, the LCQ was operated in the data dependent mode with
dynamic exclusion enabled (repeat count 2), where the four most abundant peaks in every
MS scan were subjected to MS-MS analysis. Data dependent LC-MS-MS was performed
over a parent m/z range of 400-2000.
Data Analysis
All resulting top-down and bottom-up data sets were analyzed with two methods.
In the first method, the well established bottom-up algorithm SEQUEST was used to
identify MS-MS spectra with their counterparts predicted from a protein sequence
database [62]. The sequence information of the peptide cannot easily be directly
interpreted from the MS/MS spectrum due to the complexity of the fragmentation
processes. Instead, SEQUEST performs cross correlation comparisons between the
observed spectrum and computationally derived spectra from protein and nucleotide
databases. The parent mass of the peptide provides a look-up function to find candidate
peptide sequences within the potential mass window of the observed parent peptide. The
observed MS/MS spectrum is then directly compared to hundreds of potential candidate
MS/MS spectra and a best scoring candidate match is made. For all database searches, an
R. palustris proteome database was used, which contained 4,833 proteins and 36 common
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contaminants or the E. coli K-12 database plus common contaminants. Distracter
databases of other organisms, such as yeast, were used to search against for verification
of false positive rates. All resultant output files from SEQUEST were filtered by
DTASelect [61] at the 1-peptide, 2-peptides and 3-peptides level with the following
parameters: SEQUEST, DeltCN of at least 0.08 and cross correlation scores (Xcorrs) of
at least 1.8 (+1), 2.5 (+2) and 3.5 (+3), followed by Contrast [61] for comparison. The
DTASelect [61] software can take any number of LC-MS/MS analyses and sort and filter
peptide identifications to provide html and text output files of identified proteins, while
the Contrast [61] algorithm can compare across multiple outputs from DTASelect [61]
for multiple proteomics experiments. The filtering levels used for all searches are
considered to be conservative, generally giving less than 1-5% false positive rates at the 2
peptide level depending on the data sample size and the database size.
In the second method, integrated top-down and bottom-up searching was
performed with PTMSearch Plus software developed at Oak Ridge National Laboratory
(Chapter 6). Output files containing bottom-up data from PTMSearch Plus were filtered
by DTASelect [61] at the 2-peptides level with the following parameters: MASPIC [63],
scores of at least 23 (+1), 28 (+2) and 43 (+3). These scores were used to give the same
approximate 5% false positive rate as with the scores applied for SEQUEST above. The
output files containing top-down data were filtered with at least three peaks within the
isotopic package, a 3000 Da mass cutoff and a relative abundance of at least 10%. The
false positive rate (proteins identified that are not correct identifications) within the topdown searching is considerably higher than the bottom-up methods due to the presence of
PTMs. Post translational modifications increase the likelihood of a combination of PTM
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masses added to the protein equaling the measured mass being searched. The same
scenario is true for false negatives. False negatives are real proteins not identified or not
included in the output of identifications due to low scores. The searching algorithms may
miss proteins due to a mass with a combination of PTMs giving a better score than the
real identification. Another area of concern in top-down data analysis is proteins with
good signal to noise ratios and abundant isotopic packages that are not identified. This
lack of identification could be due to three reasons. The first reason is degradation and
truncation products making the mass significantly different from the predicted masses in
the database. Second, a combination of PTMs or unique PTMs leaves the protein
unidentified. Finally, missed start calls in the genome annotation process provide wrong
protein masses within the database. Due to the false positives, false negatives and no
identifications encountered with top-down searching alone an integrated top-down and
bottom-up data searching is employed. The integrated searching provides a confident list
of proteins from the bottom-up data that the top-down data can be compared against. In
the data searching employed within this dissertation a combination of bottom-up peptide
data, as well as a top-down intact mass measurement was required for a positive
identification.
The PTMSearch Plus program allows for the combined searching of both the topdown and bottom-up data sets; as well as allowing for the searching of a defined set of
PTMs (Chapter 6). In the integrated top-down and bottom-up data searches a standard
set of PTMs were searched for including: methylation, acetylation, N-terminal
methionine truncation, and disulfide bonds (restricted to top-down data). Less common
PTMs such as uridylylation were searched individually. All data outputs generated are
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manually inspected and then compared using Microsoft Access (Microsoft Corp.,
Redmond, WA).
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Chapter 3
Extension of FTICR-MS Methodology for Proteins and Peptides: Advanced Charge
State Determination and Alternative Fragmentation Approaches
Data presented below is in preparation for submission or in press
Heather M. Connelly and Robert L. Hettich. Comparison of MSAD and SORI-CAD for
Peptides and Peptide Mixtures Using Fourier Transform Ion Cyclotron Resonance Mass
Spectrometry. Journal of the American Society of Mass Spectrometry, In final
preparation (2006). All MS sample preparation, experiments and data analysis were
performed by Heather M. Connelly.
David L. Tabb, Manesh B. Shah, Michael Brad Strader, Heather M. Connelly, Robert L.
Hettich, Gregory B. Hurst. Determination of Peptide and Protein Ion Charge State by
Fourier Transformation of Isotope-Resolved Mass Spectra. Journal of the American
Society of Mass Spectrometry, Accepted, In Press (2006). All FTICR-MS sample
preparation and experiments were performed by Heather M. Connelly.
Introduction
In the process of this dissertation work, a need for fundamental advancements in
the analysis of proteins and peptides was essential. Two areas of particular interest were
better methods for determination of charge states for large proteins and advanced protein
fragmentation methods with FTICR-MS. Both of these areas were examined to improve
the overall experimental platform for identifying intact proteins and their associated
PTMs.
The first area of development was the robust determination of charge states for
large proteins. Generally, the determination of the charge state for an ion with FTICRMS is straight forward if the spectrum is sufficiently resolved to distinguish peaks in the
isotope packet for the ion. FTICR mass spectrometry provides very high resolution and
accuracy because of the accuracy with which it is possible to measure the frequency of
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ion cyclotron motion in the Penning trap [64]. This resolving power enables acquisition
of mass spectra of electrosprayed intact protein ions with resolved isotopologues. Due to
the unparalleled mass resolution and accuracy of the FTICR-MS, this is usually not a
problem for proteins under electrospray conditions in which the analyte concentration
and ion detection parameters can be optimized. A more challenging scenario is presented
for situations in which these carefully controlled conditions are not possible, such as LCFTICR-MS measurements. In this case, the signal quality is compromised and the direct
measurement and resolution of charge states from intact proteins is much more difficult.
Due to the difficulties encountered with ion trap measurements and charge state
determination, Dr. David Tabb (ORNL post doctoral research associate with the OBMS
group) developed an automated method for determining charge states from highresolution zoom scans within the linear ion trap. Further, we decided this method could
be applied to LC-FTICR-MS measurements and charge state determination, in order to
perform an automated method for determining charge states from high-resolution mass
spectra. Fourier transforms of isotope packets from high-resolution mass spectra are
compared to Fourier transforms of modeled isotopic peak packets for a range of charge
states. The charge state for the experimental ion packet is determined by the model
isotope packet that yields the best match in the comparison of the Fourier transforms.
The second area targeted for FTICR-MS development was the evaluation of
proteins and peptide fragmentation methods within the FTICR-MS. A number of tandem
mass spectrometry methods are employed to dissociate peptides and proteins using a
FTICR-MS instrument; these include collision activated dissociation (CAD), surface
induced dissociation (SID), electron capture dissociation (ECD), and multiphoton
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infrared photodissociation (IRMPD). Traditionally MS/MS on a FTICR-MS has been
accomplished with sustained off-resonance irradiation collisionally activated dissociation
(SORI-CAD). This method makes use of the off-resonance excitation of the parent ions
being investigated [65]. SORI-CAD is capable of producing high fragmentation
efficiency with relatively simple implementation [65]. However, the need for manual
individual parent ion selection, the low duty cycles required, and the delay for pump
down after the introduction of pulsed collision gas make SORI-CAD difficult to use on
complex mixtures. In contrast, electron capture dissociation uses low-energy electrons to
neutralize the charges on the protein, producing cleavage of the amide bond to form c and
z ions [66]. Surface induced dissociation (SID) allows for large amounts of energy to be
deposited into a molecule in a very short amount of time [67]. Also, SID does not have
the problematic introduction of collision gas, as with SORI-CAD, and has been
implemented successfully to a FT-ICR for the study of biological molecules by Laskin et
al. [67]. This method, although successful, can create the problem of charge
neutralization and requires specialized equipment and implementation that may not be
readily available in most instances. IRMPD offers a method of fragmentation where no
single frequency excitation is required and the ions of all m/z values are dissociated at the
same time [68]. This method has been demonstrated useful with biomolecules [68].
However, IRMPD is not always universally available, making another method capable of
dissociation of all m/z values at the same time desirable.
Recently, new techniques for dissociation have been employed using the rf-only
multipole within the external source of an ESI FT-ICR-MS including: multipole storage
assisted dissociation (MSAD) [69, 70], “ion thrashing”[71], and photon-induced
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dissociation known as external IRMPD [72]. Previously, it was demonstrated that
electrospray generated ions can be externally accumulated in an rf-only multipole prior to
mass analysis by a FT-ICR [73]. Multipole storage assisted dissociation (MSAD) was
first observed when ions were accumulated in the rf-only multipole for an extended
period of time [74]. During a MSAD experiment there is not any apparent contact with
the rods of the hexapole that could generate a surface induced dissociation. Space
charging in the hexapole seems to push the ions out radially allowing them to obtain rf
from the rods generating ions with higher kinetic energy [72,75, 76, 77]. The excited ions
generated are then able to be fragmented with the background gas molecules in the
hexapole (air at ~10-5 torr), making it a form of CAD [78]. MSAD allows for ion
activation and dissociation simultaneously with ion accumulation and no collision gas is
introduced into the analyzer cell, so no pump down period is needed creating a more
efficient method [78]. Like IRMPD, the MSAD method provides an effective way to
accomplish dissociation on all m/z values at once, but does not provide a way to perform
targeted fragmentation. Also, this method is quite accessible unlike IRMPD since most
FT-ICR instruments are equipped with a linear ion trap at the interface of the electrospray
ionization source to the FTICR cell.
The level of fragmentation observed using MSAD is a function of hexapole
accumulation time, dc off set voltage applied, and concentration of sample being used
[75]. The dc offset voltage controls the depth of the electrostatic axial well [77,79]. The
larger the dc offset voltage that is applied, the greater the capacity of the ion reservoir
within the hexapole which allows for more space charging and dissociation by MSAD
[79]. Extended ion accumulation times provide a larger population of ions with in the
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multipole facilitating in the space charging and ion oscillation at higher amplitudes [80].
Also important is the total sample concentration; varying sample concentration can
require the need for different accumulation times to induce dissociation in MSAD
experiments.
This method has been used to successfully generate fragment ions in intact
proteins, although, little has been reported on the efficacy of using MSAD on peptides. A
study by Haselmann et al. compared the effects of SORI-CAD, MSAD, and ECD on a
single peptide and found fragment peaks more abundant with MSAD, when compared to
SORI-CAD [81]. However, the Haselmann et al. study gave good preliminary results, an
exhaustive MSAD and SORI-CAD comparison of peptides and peptide mixtures was not
performed until this study. In this work, we report on the efficacy of using MSAD
instead of SORI-CAD on single peptide solutions, simple peptide mixtures and peptide
solutions from tryptic digest of intact proteins to provide in-depth data on fragmentation
patterns, ion series generated, and spectral complexity.
Methods and Materials
LC-FTICR-MS of Intact Proteins for Charge State Determination
Five proteins (ubiquitin, chicken lysozyme C, bovine ribonuclease A, bovine
carbonic anhydrase II, and bovine beta lactoglobulin-B) were dissolved in HPLC grade
water to give a final concentration of 1 mg/mL of each protein, and diluted as required
for the analysis. All capillary HPLCFTICR experiments were performed with an Ultimate
HPLC (LC Packings) coupled to an IonSpec 9.4 T FTICR-MS (Lake Forest, CA) mass
spectrometer equipped with an Analytica electrospray source. A Vydac 214MS5.325
(Grace-Vydac, Hesperia, CA) C4 reverse phase column (300 m i.d. X 250 mm, 300 Å
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with 5 m particles) was directly connected to the Analytica electrospray source with 100
micron i.d. fused silica tubing. Injections of 30 µg of total protein were made onto a 100
µl loop. The flow rate was 4 µL/min, with a 75 min gradient going from high water (95%
water, 5% acetonitrile, 0.5% formic acid) to high organic (95% acetonitrile, 5% water,
0.5% formic acid). All mass spectra were acquired with a 2 s hexapole ion accumulation
time; 2 scans were signal averaged, 1024 K data points were acquired, and 2 zero fills
were performed. The Hann window was used for apodization. Mass resolving powers of
35,000 to 120,000 FWHM were achieved. Mass calibration was performed externally
using an ubiquitin protein standard, providing approximately 10–50 millidalton accuracy.
Mass spectra were viewed via the Omega 8 instrument control software provided by
IonSpec. The most abundant isotopic mass (MAIM) for each protein was computed [82],
and a spreadsheet calculated the m/z ratio corresponding to each charge state. To
compute the MAIM values the most abundant isotopic mass within the isotopic package
was compared to a calculated most abundant mass within the isotopic package. To obtain
the calculated MAIM, the sequence of the protein was input in to the PAWS [84]
software to obtain the number of each molecular atom present for the sequence. Once the
molecular atoms were obtained, they were input into the Exact Mass Calculator, provided
as part of the IonSpec software package, in order to determine the calculated most
abundant isotopic mass within the isotopic package. Three mass spectra from the LCFTICR-MS data, containing charge state packets for the five proteins, were chosen for
charge state analysis. The FTDocViewer “Isotope Clusters” feature displayed the isotopic
packets from each spectrum along with the assigned charge state(s). A beta-version of
IonSpec’s PeakHunter algorithm (version 0.0.24) was then used to assess charges for the
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same spectra. Scripts were developed for examination of the data in external software.
The mass spectra from the IonSpec instrument are extracted to an MS1 file [83] by
“MakeMS1”, a Visual Basic Script for FTDocViewer in the Omega8 instrument control
software. The isotopic packets for proteins ranging in charge from z = 5 to 30 are
modeled, and FFTs of these charge models are stored. The observed mass spectra are
read into memory by the “Tact” algorithm, C ++ software created at ORNL for analysis
of FTICR data from intact proteins. The software identifies the set of nonoverlapping one
m/z-wide windows containing the highest intensity within each mass spectrum. The FFT
of each one m/z-wide window is computed, and the charge model FFT that best matches
the FFT of the observed spectrum (in terms of normalized dot product score) is stored as
the charge state for that packet.
Methods for MSAD Fragmentation
Eight synthetic peptides along with angiotensin I, angiotensin II, Neurotensin,
Bradykinin, Des-Arg Bradykinin, Thr-Bradykinin, and Meth-Enkephalin were used as
purchased from Sigma-Aldrich (St. Louis, MO) without further purification. Each of the
peptides and protein solutions were prepared in 50/50 Acetonitrile/water: 0.1 % Acetic
Acid to a total concentration of 10 µM. Acetonitrile and HPLC grade water were
purchased from Burdick and Jackson (Muskegon, MI). Acetic acid (99.9 %) was from
Sigma-Aldrich (St. Louis, MO).
Mixtures of Angiotensin I, Meth-Enkephalin, synthetic peptides 3, 4, 6, and 7
were made using 10µM concentration solutions at a ratio of 1:1 and also peptide was
mixed at a 1:100 ratio to the other 5 peptides. Bovine Serum Albumin (Sigma-Aldrich,
St. Louis, MO) and Horse Apomyoglobin (Sigma-Aldrich, St. Louis, MO) were
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denatured with 6M Guanidine and 5 mM DTT at 60OC for 1 hour and then diluted in 50
mM Tris (pH 7.5)/ 5 mM CaCl2 to obtain a final Guanidine concentration of 1 M.
Sequencing grade trypsin (Promega, Madison WI) was added at a concentration of 1:50
and allowed to digest for 16 hours. Trypsin was then added a second time at a
concentration of 1:50 and digested for another 6 hours, followed by a final reduction step
with 10mM DTT for 1 hour. Samples were immediately desalted with a C18 Sep-Pak
(Waters, Milford MA) and concentrated by centrifugal evaporator (Savant Instruments,
Holbrook, NY). Samples were diluted in 50:50:0.1 ACN:H2O:HOAc to a total
concentration of 10 µM.
ES-FT-ICR mass spectra were all acquired with an IonSpec (Lake Forest, CA)
9.4-Tesla (Cryomagnetics Inc., Oak Ridge, TN) HiRes electrospray Fourier transform ion
cyclotron resonance mass spectrometer. A Harvard syringe pump set at a flow rate of
1.75 µL/min was coupled to an Analytica electrospray source (Analytica of Branford,
CT). After generation, ions were accumulated in an external hexapole and transferred
into the high-vacuum region with a quadrupole lens system. Detection then followed in
the cylindrical analyzer cell of the mass spectrometer. Calibration of the mass
spectrometer was accomplished externally with ubiquitin resulting in a mass accuracy of
±3 ppm and resolutions of 50,000-160,000 (FWHM) for peptides.
To perform ion collisional dissociation an ion of interest was isolated from a
peptide within the analyzer cell of the mass spectrometer and then accelerated into a
nitrogen target gas under sustained off-resonance irradiation collision-activated
dissociation (SORI-CAD). An rf pulse set at ~ 1KHz lower in frequency applied for 2
seconds at an amplitude range of 2-5 volts was used for the ion excitation in SORI-CAD
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experiments. During the ion excitation step a pulsed valve was used to admit the nitrogen
collision gas into the high vacuum region to a maximum pressure of about 5 X 10-6 Torr.
Prior to ion detection the base pressure was returned to 6X10-10 Torr.
Under normal mass spectrum conditions the dc voltage in the rf-only hexapole,
located at the interface of the electrospray source and the FT-ICR cell, is at -3.5v with an
ion accumulation time of one to two seconds. These experimental parameters generate
multiply charged molecular ions with virtually no fragmentation. When performing a
MSAD experiment these conditions are altered to facilitate dissociation within the
hexapole. The dc offset voltage is decreased to -7 to -11 volts and accumulation time is
increased to 4-5 seconds creating extensive fragmentation of the ions within the rf-only
hexapole. After dissociation and injection into the ICR cell, ion detection followed.
Since no parent ion isolation, activation, or pump down delays from collision gas
addition were needed, overall scan functions for MSAD experiments generally took 2 to
6 s per transient acquired. Each spectrum obtained was comprised of 2 co-added
transients acquired at 1024K data points. Deconvolution of product ion spectra to a zero
charge state was accomplished with the IonSpec deconvolution software.
All peptide samples were tested at a number of different offset voltages and
accumulation times. It was found that a 5 second accumulation and -11 V offset voltage
were the optimal conditions to produce MSAD fragmentation in all samples, therefore, all
MSAD data presented have these conditions. Also important is the total sample
concentration; this is why all peptide samples were kept at 10uM for both the SORI-CAD
and MSAD experiments thus preventing the need for different accumulation times to
induce dissociation in MSAD experiments [70]. Due to the extensive fragmentation
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observed in a MSAD experiment, a high resolution instrument, such as an FT-ICR, is
needed to resolve these complex spectra.
Data analysis was accomplished with the ProteinInfo function of the PROWL
website provided by the Rockefeller institute [84]. PROWL is a protein analysis website
that enables users to perform mass calculations, mass spectrometry fragmentation, and
insilico digest of proteins. These functions within the PROWL website allow for the
comparison of experimental data to calculated data for the protein. Both CAD and MSAD
fragments, generated in the mass spectra, were analyzed under the mass spectrometry
fragmentation function to assign fragmentation patterns. Manual inspection was used to
verify all PROWL results and to search for additional identification of internal fragments
from the loss of water, which is due to PROWL only assigning ammonia loss. For the
simple peptide mixture, the MSAD spectrum of the mixture was compared to the
individual MSAD spectrum for each component in order to identify which fragment ions
were generated from each individual peptide component present in the mixture. These
matching MSAD fragments could then be assigned identifications using PROWL.
Fragment ions identified from BSA and Apomyoglobin with PROWL were only reported
to two decimal places by the program. To obtain a more accurate mass to compare to the
FT-ICR MSAD fragments for tryptic digest of both BSA and Apomyoglobin, the PAWS
[84] program was used to determine the atom composition, of MSAD fragment ions.
Following the determination of atom composition the IonSpec exact mass calculator was
used to calculate the exact mass of the fragment ion that could be compared to the mass
of the MSAD fragment ion observed in the spectrum.
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Results for Charge State Determination of Intact Proteins
Charge Measurement for Intact Protein Isotope Clusters in FTICR Spectra
The resolution of FTICR mass spectrometry makes it possible to apply the
developed charge state determination technique to small sections of normally-acquired
mass spectra. The Tact software, developed at ORNL by Dr. David Tabb, for intact
protein identification from FTICR data was adapted to find isotopic packets in collections
of mass spectra and perform charge state assignments by FT. The FFTs of these packets
were compared to FFTs of modeled isotopic packets in order to determine charges by
moving across the experimental isotopic package while comparing how well the
overlapping experimental isotopic peaks match. Because most proteins adopt multiple
charge states under electrospray conditions, multiple isotopic packets of known charge
are available to test charge state detection algorithms. Three mass spectra from a liquid
chromatographic separation interfaced via electrospray with the FTICR were examined;
mass spectrum 10 included charge packets for ribonuclease A, mass spectrum 23 showed
the presence of ubiquitin and lysozyme, and mass spectrum 42 gave evidence for beta
lactoglobulin and carbonic anhydrase. Table 3.1 compares the performance of IonSpec’s
“FTDocViewer” and “PeakHunter” software to that of Tact for charge state inference.
Each charge determination reported from Tact is the top-scoring match.
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Table 3.1: Automated protein charge state assignments from FTICR data
Charge MAIM m/z
7
8
9
10
11
12

1956.04
1711.66
1521.59
1369.53
1245.12
1141.44

5
6
7
8
9
10
11
12

1713.92
1428.44
1224.52
1071.58
952.62
857.46
779.60
714.72

9

1590.87

11
12
13
14
15
16
17

1662.67
1524.20
1407.03
1306.60
1219.56
1143.40
1076.20

21
22
23
24
25
26
27
28
29
30

1383.08
1320.26
1262.90
1210.32
1161.95
1117.30
1075.95
1037.56
1001.82
968.46

Charge State Assignment*
Intensity
FTDoc Z
PeakHunter Z
Tact Z
Ribonuclease A, Mass Spectrum 10
0.05
No Call
No Call
5
11.35
10, 8
10,4,4
9
21.14
10, 9
1, 2, 9
11
7.15
10
10
10
5.80
11, 1
11
11
0.83
3, 12
12
12
Ubiquitin, Mass Spectrum 23
0.06
2, 4
No Call
5
4.80
6
6
6
26.74
7
7
7
19.30
8
8
8
15.98
9
9
9
5.53
10
10
10
2.67
11
11
11
0.49
12
12
12
Lysozyme, Mass Spectrum 23
1.16
9, 2
9, 4
9
Beta Lactoglobulin, Mass Spectrum 42
0.09
8
No Call
18
0.10
8, 6, 2
12, 3, 3
6
0.40
2, 13
14
13
3.61
2, 14
1, 14
14
2.31
1, 14, 15
15, 2
15
0.09
2
16
16
0.14
No Call
29, 7
27
Carbonic Anhydrase, Mass Spectrum 42
0.08
4
3
30
0.11
5
4
22
0.38
No Call
8, 8
23
0.30
1
12, 12
8
0.17
1
10, 5
25
0.16
2, 4
26
26
0.14
No Call
29, 7
27
0.07
No Call
No Call
28
0.10
No Call
29
29
0.07
No Call
No Call
30

*Correct charge assignments are shown in bold font.
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Tact Score
0.46
0.58
0.49
0.75
0.87
0.91
0.76
0.86
0.83
0.84
0.97
0.97
0.92
0.89
0.76
0.47
0.37
0.49
0.50
0.59
0.65
0.34
0.31
0.31
0.26
0.29
0.48
0.38
0.34
0.54
0.63
0.40

While Table 3.1 also lists the Tact score for each top-ranking assignment, it is important
to emphasize that these scores are not used in an absolute sense, but rather for ranking
matches for each isotope packet. That is, there is no absolute threshold score above which
a charge state assignment is accepted. Instead, the reported charge state assignment is
simply that with the highest Tact score. While Tact reported only one charge assignment
for each peak packet, FTDocViewer and PeakHunter can report multiple charge
assignments for each set of isotopic peaks, giving them a better chance of randomly
hitting the correct charge, but reducing their specificity.
The isotopic packets in scan 10 for ribonuclease A were intense, but also
contained additional isotopic packets near the most intense packets, suggesting that other
forms of the protein were also present. Perhaps, because of these additional packets, the
two most intense packets, corresponding to the z = 8 and z = 9 charge states of the
protein, resulted in multiple charge state calls by FTDocViewer and PeakHunter and an
incorrect charge assignment by Tact. For less intense isotope packets corresponding to
higher charge states, Tact and PeakHunter yielded correct results, while FTDoc returned
multiple possible charges for the z = 11 and 12 states. Scan 23 included isotopic packets
for ubiquitin and lysozyme. Ubiquitin’s packets for z = 7 through 9 were the most
intense, and they were more than an order of magnitude more intense than lysozyme’s
sole isotopic packet at z = 9. All of these packets were assigned the correct charge by all
three algorithms. The z = 5 charge state for ubiquitin, however, was called correctly by
only the Tact algorithm. This isotopic packet was the least intense to be assigned a
correct charge in this collection of mass spectra. Scan 42 comprised a much greater
challenge. β- lactoglobulin and carbonic anhydrase both contributed isotopic packets, but
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β-lactoglobulin’s z = 14 charge state was approximately 10-fold more intense than the
most intense carbonic anhydrase isotopic packet. FTDocViewer and PeakHunter both
yielded multiple charge state calls for many isotopic packets. In several cases, the packets
for carbonic anhydrase were not assigned charges by these algorithms, presumably
because these low-intensity peaks were not easily centroided. Tact, however, was able to
assign four consecutive correct charge states for β-lactoglobulin. For carbonic anhydrase,
only Tact was able to achieve any consistency, assigning eight of the 10 charge states
correctly. Scan 42 demonstrates that FFT is particularly powerful for inferring charge
states from noisy signals of low intensity. Overall, Tact performed comparably to FTDocViewer and PeakHunter in determining charge states from ion packets of moderate
intensity and signal-to noise ratio, while providing an improvement for low abundance,
noisy isotope packets. It is important to keep in mind that, in the context of this LC-MS
experiment, the proteins were available during only a limited time for MS data
acquisition during elution of a peak in a liquid chromatography separation. As such, the
optimal performance factors for high-resolution mass measurement must be
compromised somewhat to accommodate the shorter time frame for ion detection (i.e.,
few scans and fewer data points for the transient signal). The exquisite resolution possible
for FTICR instruments, along with FTDocViewer and PeakHunter processing algorithms,
enables accurate determination of charge states for proteins up to at least 60 kDa under
direct infusion conditions, where protein concentrations and ion accumulation and
detection parameters can be optimized. Accurate charge state determination is a critical
component for computational programs such as THRASH [85], which seek to combine
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this information with isotopic abundance in order to permit comparisons between
measured and predicted mass spectra for molecular identifications.
Results for the Comparison of MSAD and SORI-CAD for Peptides and Peptide
Mixtures
SORI-CAD and MSAD for Single Peptides
A range of peptides were examined with MSAD in this study in order to
determine the general utility of the technique, and to make a general comparison with
SORI-CAD. It has been previously demonstrated that proteins have similar fragmentation
patterns in both low energy MSAD experiments and in SORI-CAD [69, 77]. However, in
this study, high energy MSAD (based on experimental observation) was used to take
advantage of the unique property of MSAD, which is the ability to put high amounts of
collisional energy into the peptide. This high energy MSAD was performed by simply
elongating the accumulation time to 4-5 seconds from 2 seconds and adjusting the
magnitude of the dc offset to -11V from -7V for all peptides. These high energy MSAD
experimental parameters were compared with standard SORI-CAD conditions. SORICAD experiments were accomplished with a rf pulse, set at ~ 1KHz lower in frequency
than normal mass spectra acusition, applied for 2 seconds at an amplitude range of 2.84.0 volts to ensure complete dissociation of the peptide.
In this study, we have conducted MSAD and SORI-CAD experiments with
peptides that exhibit a wide range of diversity in their amino acid sequence, molecular
weight and post translational modifications (Table 3.2). The MSAD spectrum and SORICAD spectrum are shown for both synthetic peptide 1 and Bradykinin (Figure 3.1).
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Table 3.2 Name, sequence and molecular weight of all peptides used.

synthetic 1
synthetic 2
synthetic 3
synthetic 4
synthetic 6
synthetic 7
synthetic 8
Angiotensin 1
Angiotensin 2
Bradykinin
Thr-Bradykinin
Des-Arg Bradykinin
Meth-Enkephalin
Neurotensin

Sequence
Acetyl-RAYIFAVR-OH
AQTERKSGKRQTER
GKAKVTGRWK
VHLTPVEK
MEMKKVLNS
FLEEI
YIGSR
NRVYIHFPHL
NRVYIHPF
RPPGFSPFR
RPPGFTPFR
PPGFSPFR
YGGFM
ELYEDKPRRPYI
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MW
1036.6
1673.9
1129.7
922.1
1079.3
649.7
594.7
1296.5
1046.2
1060.2
1074.2
904
573.7
1672.9

Figure 3.1: B and Y ion labeled MSAD and SORI-CAD spectrum for Bradykinin and
Synthetic peptide 1. The loss of water labeled with (*) and the loss of ammonia labeled
with (o). (A) MSAD spectrum of Bradykinin (B) SORI-CAD spectrum of Bradykinin (C)
MSAD spectrum of Synthetic 1 (D) SORI-CAD spectrum of Synthetic 1.
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In the Bradykinin MSAD spectrum (Figure 3.1A) the loss of water and ammonia occurs
with the prominent b or y ion. In the case of the y7 ion within the MSAD spectrum
(Figure 3.1A) the loss of water is most likely from the serine side chain contained in the
sequence of the fragment ion. In contrast to the MSAD spectrum, the SORI-CAD
spectrum (Figure 3.1B) for Bradykinin has the same prominent b8, b9, y7, and y6 ions
without the loss of water and ammonia. To simulate fragmentation of peptides with post
translational modifications, synthetic peptide 1 was chosen because it has an acetyl group
on the N-terminal. In the MSAD spectrum of synthetic peptide 1, the acetyl group is
maintained only on the b7 ion and not on any other b ions or the y-ion series (Figure
3.1C). In comparison, the SORI-CAD spectrum has the acetyl group maintained on the
fragment ion b8 (Figure 3.1D). Both the MSAD fragment ions for synthetic peptide 1
contain the acetyl group on one ion; the SORI-CAD spectrum also has the acetyl group
on the prominent b ion within the spectrum.
Both SORI-CAD and MSAD experiments provided identifiable peptide
fragmentation patterns when searched using the PROWL website [84]. Comparisons of
identifiable fragments from both methods reveal a more extensive fragmentation pattern
in the MSAD spectra, with 10 out of 15 peptides showing more identifiable fragment ions
than seen with SORI-CAD (Figure 3.2).
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SORI-CAD vs. MSAD
16

14

SORI-CAD
MSAD

Identified fragment ions

12

10

8

6

4

2

0
syn1

syn2

syn3

syn4

syn6

syn7

syn8

angio1

angio2

Brady

Thr-Brady Des-Arg
Brady

MethEnkep

Neur

Peptides

Figure 3.2: Comparison of MSAD and SORI-CAD fragment ion identifications for all
14 peptides.
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MSAD experiments produce more fragment ions than SORI-CAD, although, the
fragment ions that are produced in SORI-CAD are more easily identified and give a
spectrum where almost all fragment ions are b and y ions, without the internal fragments
and loss of water and ammonia. Table 3.3 shows the most abundant MSAD and SORICAD fragment ions for each peptide. On average, there are 2 to 4 fragment ions observed
in the SORI-CAD spectrum; in comparison, there are 4 to 10 fragment ions in the MSAD
spectra (Table 3.3). When comparing the MSAD and SORI-CAD fragment ions, the
predominant fragment ions in the spectra of both methods are often the same. This can be
seen in the comparison of MSAD and SORI-CAD spectra for synthetic peptide 4 where
both methods have a prominent b8 and b7 ions (Table 3.3). The differences in the amount
of abundant fragment ions in the case of synthetic peptide 4 is the b8 and b7 fragment ions
in the MSAD spectrum are also accompanied by fragment ions with a loss of water,
ammonia, or both. Another difference in the number of abundant fragment ions observed
between MSAD and SORI-CAD spectra are the amount of internal fragments. This is
demonstrated in synthetic peptide 6, where some of the same predominant b and y ions
within the MSAD spectrum have five additional internal fragment ions (Table 3.3).
MSAD experiments allow for the dissociation of all parent ions within the rf-only
hexapole without pre-selection or isolation of parent ions, as required with SORI-CAD
experiments. This simultaneous dissociation of parent ions gives a (b and y) series of
ions although, this series has numerous internal fragment ions with water and ammonia
loss. The internal fragment ions observed are possibly occurring from the layering
sequential fragmentation, where a y-ion is formed followed by another fragmentation
event that fragments the y-ion, giving a b-ion creating an internal fragment that has both a
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Table 3.3: Most abundant fragment ions from MSAD and SORI-CAD
SORI-CAD

MSAD

Peptide
synthetic 1

mass
1019.5735
976.5340

ID
b8+acetyl
b8

mass
976.5490
881.4810
863.4708
839.4692
767.4292
763.3966
692.3616
604.3691

synthetic 2

1656.9046
1499.8229
1352.7613
1245.0000
300.6062

b14
b13
b12
y10
b3

787.4061
700.3772
642.3486
625.3229

y13b8, y12b9
y7b13
y*12b8, y12b*8
y*12b*8

synthetic 3

874.5290
745.4103
646.3574

y7
y6
y5

1130.6771
797.4930
797.4831
745.4221
728.4116
613.3707

y10
b8
b8
y6
y*6,
y8b8, y*5b10

synthetic 4

904.5306
775.4280
572.3182
471.2693

b8
b7
y5
y4

922.5342
904.5360
886.5207
775.4272
757.4186
740.3910
685.4032
667.3974
649.3903

y8
b8
bo8
b7
bo7
b*o7
y6
y*6
y*o6

synthetic 6

859.4900
819.4605
745.4040
688.4163

b7
Y7
b6
y6

1060.5515
973.5278
859.4911
714.4148
583.3723
542.3089
697.4080
679.3906
649.3341

b9
b8
b7
y7b8
y7b*7, y*7b7
y5b9, y*5
yo7b8
yo7bo8
y5

synthetic 7

631.3324
518.2440

b5
b4

631.3158
649.3341

b5
y5

synthetic 8

576.3034

b5

595.3240

y5

Angiotensin 1

1295.7120
1027.5310
930.5140
512.2739

y10
b8
b7
y4

1277.6543
1181.6592
1027.5335
895.4815
783.4191
765.4006

b10
y9
b8
y8b9
b6
bo6
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ID
b8
b7+acetyl
b*7
y7
y6
b6
b5
y5

Table 3.3: Continued
SORI-CAD

MSAD

Peptide
Angiotensin 2

mass
1027.5313
931.5180

ID
b8
y7

mass
1045.5322
1027.5125
784.4000
765.3886
669.3738

Bradykinin

1042.5724
904.4668
886.4446
806.4059

b9
y8
b8
y7

886.4480
869.4369
806.4099
789.3976
709.3550
992.3518

b8
bo8
y7
y*7
y6
yo6

Thr-Bradykinin

918.4921
554.2995

y8
b5

1074.5695
899.4847
820.4328
802.4019
803.4057
723.3864
705.3649

y9
b8
y7
yo7
y*7
y6
Yo6

Des-Arg Bradykinin

886.4558
729.3487
709.3772

b8
b7
y6

806.3939
789.3827
709.3678
652.3238
634.3130

y7
y*7
y6
y5
yo5

Meth-Enkephalin

555.2069
424.1742

b5
b4

585.1631
573.2314

y6b8, y*7b7, y7b*7
y5

Neurotensin

660.3990

y5

633.8616
556.9702

y11b7
y*6b11, y6b*11
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ID
y8
b8
b6
b *6
y7b6

y and b end. This effect could be due to the ions multiple pass in the z-direction in the
hexapole as proposed by Pan et al. [77]. It has also been demonstrated that the proportion
of fragment ions increase with pressure [86]. The effect of pressure and space charging in
the rf-only hexapole will lead to a smaller mean free path for the ion and higher
oscillation amplitudes creating more kinetic energy and therefore leading to the creation
of more internal fragment ions [86]. Unlike MSAD, SORI-CAD takes place in the ICR
cell where there is an order of magnitude difference in pressure from the hexapole
creating ions with a larger mean free path that experience less space charging thereby
leading to lower oscillation amplitudes and no observed internal fragment ions. Due to
the nature of MSAD, where it has been suggested that the lowest energy process is
selected for dissociation [75], the loss of ammonia and water is often seen as compared to
SORI-CAD where there is rarely a loss of water or ammonia. The loss of water in a
MSAD experiment is mainly coming from the side chain of the amino acids, such as
threonine and serine (since it is a low energy requirement dissociation) [87], while the
loss of ammonia is primarily coming from the the N-terminal. SORI-CAD also gives b
and y ions, but there are rarely water and ammonia loss and also no internal fragment
ions present.
MSAD for Simple Mixtures
Even though MSAD can not isolate a parent ion for fragmentation, a combination
of peptides, from the single peptide standards, was used to provide individual peptide
identifications, as well as examine sensitivity and dynamic range for the mixtures. Six
individual peptide standards (synthetic 3,4,6,7, angiotensin1, meth-enkephalin) were
chosen and mixed at a 1:1:1:1:1:1 concentration for all six peptides in order to form a
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simple peptide mixture. A mass spectrum was obtained for the mixture followed by a
MSAD spectrum (Figure 3.3). These two spectra were compared to see if any parent ions
remained and to examine the extent of fragmentation for the individual peptides within
the mixture. Each parent peptide within the mass spectrum (Figure 3.3A) was assigned a
color label which was used to label corresponding fragment ions within the MSAD
spectra (Figure 3.3B). As indicated by the dashed lines, some of the parent peptides did
remain in the MSAD spectrum for angiotensin1, synthetic 3 and synthetic 4 (Figure 3.3).
The major fragment ions in the mixture MSAD spectrum were generally the same
fragment ions found in the MSAD spectrum for the individual peptide. This can
especially be seen for angiotensin 1 where all of the abundant fragment ions produced in
the mixture MSAD spectrum are the same as those found in the MSAD spectrum of
angiotensin 1 (Table 3.3, Figure 3.3B). However, Meth-Enkephalin did not produce any
major fragment ions within the MSAD spectrum, as seen when fragmented as a single
peptide, but this could be due to the small size of this peptide (MW=573.7). The similar
MSAD fragmentation patterns for individual peptides, as well as in the mixture, make it
possible to verify the presence of a peptide in a mixture. Furthermore, the identity of the
parent protein could be determined based on the peptide fragmentation and sequence
information provided by MSAD.
Peptide mixtures were also prepared with varying concentrations for each of the
individual peptides in order to examine sensitivity and dynamic range. The mixtures
contained all six peptides, as before (synthetic 3,4,6,7, angiotensin-1, meth-enkephalin),
but one peptide was at a 1:100 concentration to the other 5 peptides. This 1:100 mixture
ratio was repeated for each of the six peptides.
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Figure 3.3: Dissociation data for 1:1 peptide mixture. A) FT-ICR spectrum of peptide
mixture with each peptide mass peak labeled a different color. B) MSAD spectrum of
peptide mixture with fragment ions labeled in the color corresponding to parent peptides.
Dashed lines show the remaining parent masses in the spectrum.
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Each parent peptide was assigned the same color label as in the 1:1:1:1:1:1:1 mixture,
which was then used to label corresponding fragment ions within the MSAD spectra
(Figure 3.4). Generally, the peptide that was at a lower concentration within the mixture
produced MSAD fragments within the spectrum. This can be seen for the peptide
mixture with angiotensin-1 at a lower concentration to the other five peptides (Figure
3.4). The major MSAD fragment ions are labeled within the spectrum to show that
fragment ions from all six peptides are present (Figure 3.4). Only the most abundant
fragment ions are labeled within the MSAD spectrum, although, the lower abundant
fragment ions also provided identifications (Figure 3.4). For synthetic peptides 4 and 3,
the parent ion remains within the spectrum (labeled with a (*) in the corresponding
color). This identification of low abundance fragment ions demonstrates the good
sensitivity and dynamic range of the MSAD method on peptide mixtures of varying
concentration. The success rate of MSAD for providing fragment ions for all peptides in
the mixture is 100%. To test the success rate of smaller peptides at lower concentrations
meth-enkephalin was mixed at a lower concentration (1:100) to the other five peptides
(data not shown). Again, there were identifiable fragment ions from all six peptides
within the mixture. The fragment ions from meth-enkephalin were at a lower abundance
within the spectrum, but still provide an identifiable isotopic packet when the peaks are
expanded. In this study, the sensitivity and dynamic range afforded by MSAD is
comparable to other methods of dissociation that do not require pre-isolation of parent
ions.
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Figure 3.4: MSAD spectrum for six peptide mixture containing synthetic 3,4,6,7,
angiotensin-1, and meth-enkephalin with angiotensin-1 at a 1:100 concentration to the
other five peptides. The major fragment ions are color labeled, according to which parent
peptide they were generated from, within the MSAD spectrum. Remaining parent
peptides within the MSAD spectrum are labeled with a (*) and corresponding color.
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MSAD forTryptic Digest of Apomyoglobin and BSA
Previously, only limited research has been conducted on MSAD of single peptides
with no information being provided for more complex mixtures, especially tryptic
digests. In general, most bottom-up proteomics work requires tryptic digest of intact
proteins followed by some form of MS/MS analysis. MSAD allows for a MS/MS
experiment on tryptic digest without pre-selection of parent ions, making it a useful
sequencing tool that has a lower duty cycle with a smaller time scale than methods such
as SORI-CAD. In this study, we have conducted MSAD experiments on tryptic digest of
two large proteins, BSA and Apomyoglobin, to test the utility of MSAD for more
complex peptide mixtures.
To examine the efficacy of MSAD on tryptic digests, a mass spectrum was
obtained for the tryptic digest of apomyoglobin, followed by a MSAD spectrum (Figure
3.5a-b). The MSAD spectrum for the tryptic digest of Apomyoglobin shows 22 unfragmented parent tryptic peptides (Figure 3.5b). There are 22 un-fragmented parent
tryptic peptides remaining in the spectra, but most of these are lower in abundance. The
five most abundant remaining parent ions within the apomyoglobin tryptic digest MSAD
spectrum are labeled (*), revealing a wealth of abundant identifiable MSAD fragment
ions (Figure 3.5b). Also, the MSAD spectrum of apomyoglobin contains a large number
of internal fragment ions, as well as fragment ions that have a loss of water or ammonia,
as seen in the single peptide and simple mixtures MSAD spectra (Table 3.4). This can be
seen for identified apomyoglobin tryptic peptide 17-VEADIAGHGQEVLIR-31,
spanning amino acids 17 through 31, which has all internal fragment ions with loss of
water or ammonia (Table 3.4).
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Figure 3.5: BSA and Apomyoglobin Tryptic digest MSAD spectrum. A) Apomyoglobin
tryptic digest FT-ICR spectrum. B) Apomyoglobin tryptic digest MSAD spectrum with
surviving parent masses labeled with (*). C) BSA tryptic digest FT-ICR spectrum. D)
BSA tryptic digest MSAD spectrum with surviving parent masses labeled with (*).
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Table 3.4: Apomyoglobin tryptic digest MSAD fragmentation data
MSAD
fragment
MSAD fragment ion (calculated)
ion
(measured)
Mass
Mass
ID
Sequence

Sequence of Tryptic Peptide
32-LFTGHPETLEK-42

618.3272
540.2588

618.32246
540.25706

y5
y10b6

ETLEK
FTGHP

32-LFTGHPETLEKFDKFKHLK-50

540.2588
760.4654
602.3585
618.3272
585.335

540.25706
760.40338
602.31899
618.26494
585.29244

y18b6
Y*9b*16
y*12b12
y*16b*9
y*12b*12

FTGHP
KFDKFK
TLEKF
GHPETL
TLEKF

32-LFTGHPETLEKFDKFKHLKTEAEMK-56

618.3272
585.335
602.3585
737.4197

618.26494
585.29244
602.31899
737.431

y*22b*9
y*18b*12
y*18b12
y10b21

GHPETL
TLEKF
TLEKF
KHLKTE

32-LFTGHPETLEKFDKFK-47

618.3272
540.2588
585.335
760.4654

618.28875
540.25706
585.29244
760.40338

y*13b9
y18b6
y*9b*12
y*6b*16

GHPETL
FTGHP
TLEKF
KFDKFK

1-GLSDGEWQQVLNVWGKVEADIAGHGQEVLIR-31

540.2588
687.3822
660.3053
706.4031
679.4
588.2961

540.23057
687.31021
660.26293
706.35643
679.33028
588.2418

y*14b23
y*9b*29
y*14b*24
y*23b*14
y*17b*21
y*13b*25

EADIAG
GHGQEVL
EADIAGH
QVLNVW
GKVEADI
ADIAGHG

119-HPGDFGADAQGAMTK-133

626.2714

626.20983

y*14b*8 PGDFGAD

103-YLEFISDAIIHVLHSKHPGDFGADAQGAMTK-133

626.2714
588.2961
719.4053
613.3476

626.20983
588.2418
719.37281
613.3561

y*14b*24
y*17b*20
y*26b12
y27b10

PGDFGAD
ADIAGHG
SDAIIHV
ISDAII

97-HKIPIKYLEFISDAIIHVLHSKHPGDFGADAQGAMTK-133 588.2961
719.4053
579.3518
630.3732

588.2418
719.37281
579.303
630.35029

y*17b*26
y*26b18
y*27b*16
y*33b9

SKHPGD
SDAIIHV
ISDAII
IKYLE

97-HKIPIKYLEFISDAIIHVLHSK-118

719.4053
613.3476
579.3518
630.3732

719.37281
613.3561
579.303
630.35029

y*11b18
y12b16
y*12b*16
y*18b9

SDAIIHV
ISDAII
ISDAII
IKYLE

103-YLEFISDAIIHVLHSK-118

719.4053
613.3476
579.3518

719.40786
613.3561
579.303

y6
HVLHSK
y12b10 ISDAII
y*12b*10 ISDAII

17-VEADIAGHGQEVLIR-31

687.3822
660.3053
588.2961

687.31021
660.26293
588.2418

y*9b*13 GHGQEVL
y*14b*8 EADIAGH
y*13b*9 ADIAGHG
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Table 3.4: Continued
MSAD
fragment ion
(measured)
Mass
706.4031
585.335

Mass
ID
Sequence
706.35643 y*8b*14 QVLNVW
585.31491 y5b16
NVWGK

78-KKGHHEAELKPLAQSHATK-96

660.3053
803.4717
708.3645
692.365
617.3262
537.3076

660.32178
803.40518
708.36806
692.33676
617.30474
537.25605

y18b7
y*8b*19
y15b10
y*8b16
y*9b16
y*14b*10

KGHHEA
LAQSHATK
HEAELK
LAQSHAT
PLAQSH
EAELK

79-KGHHEAELKPLAQSHATK-96

803.4717
708.3645
692.365
617.3262
537.3076

803.40518
708.36806
692.33676
617.30474
537.25605

y*8b*18
y15b9
y*8b17
y*9b15
y*14b*9

LAQSHATK
HEAELK
LAQSHAT
PLAQSH
EAELK

Sequence of Tryptic Peptide
1-GLSDGEWQQVLNVWGK-16
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MSAD fragment ion (calculated)

There are also many identified apomyoglogin peptides in the mixture that have missed
enzymatic cleavages. This phenomenon is evident when examining the identified
sequences of the fragment ions. For example, the first four peptides in Table 3.4 all start
at amino acid number 32 but end at varying lengths from amino acid number 42 to 56
(Table 3.4). These missed cleavages create a series of fragment ions that have the same
mass and sequence for the different tryptic peptides. However, there are repeating
fragments within the MSAD spectrum due to missed enzymatic cleavages, the fragment
ions obtained allow for the identification of these missed cleavage locations within the
amino acid sequence of the peptide and protein. Therefore, the extensive fragmentation
provided by MSAD gives the ability to identify peptides with missed enzymatic
cleavages.
In order to examine efficacy of using MSAD on a tryptic digests of a large
protein, tryptic digests of BSA were used in this study. For comparison, a mass spectrum
was obtained for the tryptic digest of BSA followed by a MSAD spectrum (Figure 3.5cd). Similar to apomyoglobin, the MSAD spectrum of the BSA tryptic digest reveals 20
un-fragmented parent tryptic peptides within the spectrum (Figure 3.5d). Of these 20 unfragmented parent peptides, only six (labeled with a (*)) are abundant within the MSAD
spectrum (Figure 3.5d). Again, similar to apomyoglobin, the MSAD spectrum of BSA
tryptic digest contains a large number of internal fragment ions with the loss of water
and/or ammonia (Table 3.5). The fragment ions obtained by MSAD for BSA are more
distinct, with less repeating fragment ions, than apomyoglobin. However, there are still
identified missed enzymatic cleavages for BSA as well as identified non-tryptic peptides.
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Table 3.5: BSA tryptic digest MSAD fragmentation data

Sequence of Tryptic Peptide

MSAD
fragment ion
(measured)
Mass

MSAD fragment ion (calculated)
Mass
ID
Sequence

224-LSQKFPK-230

588.3166

588.31457

y6b6

SQKFP

143-YLYEIAR-149

616.3291

616.30949

y*5b7

YEIAR

580-LVVSTQTALA-589

616.3291

616.33062

y9b7

VVSTQT

506-AFDEKLFTFHADICTLPDTEK-526

616.3291
616.3291
751.3986

616.29825
616.29825
751.3986

y*20b6
y*19b7
y*7b*21

FDEKL
DEKLF
TLPDTEK

511-LFTFHADICTLPDTEKQIK-529

751.3986
716.365

751.3986
716.3675

y*10b*16 TLPDTEK
b6
LFTFHA

268-YICNQDTISSKLK-281

711.4109

711.35649

y*8b*13

DTISSKL

384-HLVDEPQNLIKQNCDQFEK-402

711.4109
810.4057

711.41535
810.39976

y12b13
y8b10

NLIKQN
DEPQNLI

231-AEFVEVTKLVTDTKVHKECCHGDLLE
CADDTADLAKYICDNQDTISSKLKECCDK-286

711.4109
887.5088

711.35649
887.52021

y*13b*50 DTISSKL
y12b52
TISSKLKE

384-HLVDEPQNLIK-394

810.4057

810.39976

y8b10

DEPQNLI

329-DAFLGSFLYEYSR-341

810.4057

810.40378

y10b10

LGSFLYE

551-TVMENFVAFVDK-562

660.3739

660.37209

y6b12

VAFVDK

27-GLVLIAFSQYLQQCPFDEHVK-47

660.3739

660.37209

y18b9

LIAFSQ

342-RHPEYAVSVLLR-353

663.3358

663.27785

y*11b*7

HPEYAV

83-VASLRETYGDMADCCEKQE
PERNECFLSHKDDSPDLPK-120

663.3358
751.3986
716.365

663.3466
751.3986
716.36192

y35b8
y*22b22
y14b30

LRETY
KQEPER
CFLSHK

83- VASLRETYGDMADCCEKQEPERNECFLSHKD
DSPDLPKLKPDPNTLCDEFKADEKKFWGK-142

663.3358
751.3986
716.365
887.5088
647.4093

663.3466
751.3986
716.36192
887.47795
647.37684

y57b8
y*44b22
y36b30
y*7b60
y*27b39

LRETY
KQEPER
CFLSHK
EKKFWGK
PDLPKL

292-SHCIAEVEKDAIPENLPPLTADFAEDK
DVCK-322

751.3986
716.365

751.3986
716.36192

y*28b*10 IAEVEKD
y14b24
PLTADFA

246-VHKECCHGDLLECADDRADLAK-267

655.3993

655.38913

y6b22

RADLAK

121-LKPDPNTLCDEFKADEKKFWGK-142

887.5088

887.47795

y*7b22

EKKFWGK
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For example, peptide 224-LSQKFPK-230 has a missed cleavage, but the most abundant
fragment ion y6b6 was able to provide an identification of the peptide as well as the
verification of a missed cleavage site (Table 3.5). Also identified was the non-tryptic
BSA peptide 580-LVVSTQTALA-589 from the predominant fragment ion y9b7 (Table
3.5). The ability to identify missed cleavages and non-tryptic peptides provides another
argument for the viability of MSAD with complex peptide mixtures.
Identification of MSAD fragments from BSA and Apomyoglobin were made
using the PROWL website mass spectrometry fragmentation function. Fragment ion
identification in PROWL is output with two decimal places. In order to obtain a more
accurate mass match for each PROWL identified MSAD fragment ion, the fragment ion
mass was calculated to four decimal places in order to match back to the mass of the
MSAD fragment from the spectrum. Identification of MSAD fragments from BSA and
Apomyoglobin using PROWL and calculated masses show several possible tryptic
fragments corresponding to each identifiable MSAD fragment in the spectra (Tables 3.4
& 3.5). However, this is in part a consequence of multiple tryptic peptides that are
capable of producing fragment ions with the same sequence. There is also a preference
toward certain fragment ions within the MSAD spectrum. Each tryptic peptide gives a
preferential MSAD fragment ion that can have different combinations of water and
ammonia loss (Table 3.4 & 3.5).
The use of MSAD, as a replacement for more commonly applied fragmentation
methods such as SORI-CAD with a FT-ICR is a feasible option for simple peptide
solutions, tryptic digest and simple mixtures. MSAD provides a fragmentation method
that can fragment all peptides in the sample, in one step, eliminating the isolation step
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needed for SORI-CAD, which provides a more operationally simple and time saving
method. This is especially important if sample limitation is of concern. On preliminary
inspection, the MSAD method provides a more extensive identifiable fragmentation
pattern than SORI-CAD. However, the MSAD method does lead to more internal
fragment ions making identification more complicated. The MSAD method works well
on simple peptides, but when applied to complex tryptic digest the lack of fragmentation
of major parent ions and the number of internal fragment ions produced does present a
rather complex spectrum, but this is not of enough significance not to provide
identification of the peptide or protein. A large number of MSAD fragments from tryptic
peptides were identified. MSAD on simple mixtures gives a rather rich spectrum of
identifiable fragment ions when the peptides are at equal concentrations. The sensitivity
of MSAD could provide some problems, but for complex mixtures being examined by
FT-ICR-MS where rapid dissociation of parents ions is needed MSAD provides a very
useful alternative to SORI-CAD.
Conclusions
Through these two studies, better methods for protein charge state determination
under liquid chromatography conditions and fragmentation of proteins and peptides
within the FTICR-MS were examined. By applying new methods, such as the TACT
program and MSAD fragmentation, fundamental advancements in these areas were made.
The TACT program allowed for the determination of large proteins charge states under
liquid chromatography time frames better than previously applied software. Also shown
in this study, was that complex mixtures being examined by FT-ICR-MS, where rapid

80

dissociation of parent ions is needed, MSAD provides a very useful alternative to SORICAD.
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Chapter 4
Application of the Integrated Top-Down Bottom-Up Methodology for the
Characterization of Ribosomal Protein Mixtures for PTMs and Isoforms
Data presented below is in final preparation for submission or published as the following
Heather M. Connelly, Eric Hamlett, David Robinette, Kevin Ramkissoon, HsunCheng Hsu, Ming Yu, Robert L. Hettich, and Morgan C. Giddings.
Characterization and Comparison of Ribosomal Protein Heterogeneity and
Isoforms in Wild-Type and Variant Strains of E. coli. Nature Biotechnology, In
final preparation (2006). All FTICR top-down and LCQ Bottom-up sample
preparation, experiments and data analysis were performed by Heather M.
Connelly.
Strader, M.B.; VerBerkmoes, N.C.; Tabb, D.L.; Connelly, H.M.; Barton, J.W.; Bruce,
B.D.; Pelletier, D.A.; Davison, B.H.; Hettich, R.L.; Larimer, F.W.; and G.B. Hurst.
Characterization of the 70S Ribosome from Rhodopseudomonas palustris using an
Integrated “Top-Down” and “Bottom-Up” Mass Spectrometric Approach. Journal of
Proteome Research, 2004; 3, 965-978. All bottom-up MS, sample preparation,
experiments and data analysis on Rhodopseudomonas ribosomal complex were
performed as a joint effort between Nathan C. VerBerkmoes, Brad Strader,and David
Tabb, All top-down experiments and data analysis was performed by Heather M.
Connelly with assistance from Robert L. Hettich.
Introduction
Integrating “top-down” and “bottom-up” MS-based proteomic strategies provides
a powerful tool to examine complex protein mixtures, such as proteins in multicomponent complexes, or even complete proteomes. The first of these methods is intact
protein, or top-down mass spectrometry, which can be used to provide intact protein
identification, as well as insight into protein modification states. This powerful method
can provide information on the natural state of intact proteins, including details about
post-translational modifications (PTM’s), truncations, mutations, signal peptides, and
isoforms, due to the ability to measure the molecular mass of a protein very accurately
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and detect any covalent modifications that alter the mass of a protein. The top-down mass
spectrometry approach for proteins was first introduced with electrospray-Fourier
transform ion cyclotron resonance mass spectrometry (ESI-FTICR-MS) [22, 23, 24]. The
dynamic range, sensitivity, and mass accuracy offered by high performance FT-ICR-MS
affords not only unambiguous protein identification in many cases, but also detailed
information about protein modifications. Eventough, top-down methodologies provide a
powerful analytical approach, some limitations do exist; on-line chromatography of intact
proteins is often difficult due to the wide range of protein sizes and hydrophobicities.
Furthermore, data are often difficult to analyze and interpret due to limited bioinformatics
tools.
The more common peptide or “bottom-up” mass spectrometric approach involves
enzymatic digestion of intact proteins with a protease such as trypsin, Glu-C or cyanogen
bromide in order to generate a peptide mixture. This peptide mixture is then analyzed by
MS/MS methods to generate peptide fragmentation spectra that are compared back to a
database with searching algorithms. This “bottom-up” proteomics approach is able to
quickly and efficiently provide a comprehensive list of proteins present in a large multiprotein complex. Bottom-up methods provide a comprehensive list of proteins, although,
vital information about post translational modifications may be missed if the peptides
containing the particular modification escape detection. Furthermore, identifying
peptides that come from a complex protein mixture does not provide information on the
presence of different isoforms that may exist for a particular protein.
An integrated top-down and bottom-up approach allows for a more
comprehensive characterization of protein complexes due to the unique strength of each
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technique. In an integrated approach, intact protein masses from the top-down analysis
corresponding to a particular PTM or isoform can be compared to the comprehensive list
of proteins provided by the bottom-up analysis. This correlation between the two
methods can provide PTM location and identity with more certainty. The
comprehensiveness of this technique has been previously demonstrated in a study of the
Shewanella oneidensis proteome [35].
Since this technology was to be ultimately used for whole proteomes under
multiple growth states (Chapter 7), we started with the 70S Ribosome from
Rhodopseudomonas palustris and progressed our technique into the examination of
ribosomal proteins from multiple strains of antibiotic resistant E. coli. The ribosome has
been a model protein complex for the development of MS-based proteomics techniques;
due to the ease of purification, the limited complexity and the presence of numerous posttranslational modifications [88]. The ribosome is the universal macromolecular machine
involved in translating the genetic code into proteins. Bacterial ribosomes are composed
of a small subunit (30S) containing about 20 proteins and a single rRNA (16S), and a
large subunit (50S) consisting of over 30 proteins and two rRNAs (23S and 5S). The
bacterial ribosomal proteins have been shown to be well conserved across different
species, and this includes their PTMs.
In our first study, the ribosomal proteins from R. plaustris were examined for
positive identification of the protein, as well as identification of associated PTMs. For
this study, the bottom-up approach was expanded to the use of 1D and 2D LC-MS/MS
methodologies for the analysis of the enzymatically digested protein complex. This was
necessary due to the increased complexity of the protein complex. The top-down
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methodology was performed with the high resolution and high mass accuracy FT-ICR
instrument. For these experiments, we performed LC-ES-FT-ICR for intact protein
measurements. Using this integrated approach, we were able to identify a complement of
ribosomal proteins and their associated PTMs.
In the second study, we employ an integrated top-down and bottom-up approach
to characterize the ribosomal proteins from wild type K12 and two streptomycin resistant
strains of E. coli. Using this method, a complement of ribosomal proteins with unique
PTM series, isoforms, and point mutations were identified from all three strains. With
this integrated top-down and bottom-up approach, we were able to provide a more
comprehensive examination of the role of ribosomal proteins in antibiotic resistance than
if an individual method had been employed.
Results Characterization of the R. palustris 70S Ribosome
Top-down and Bottom-up Characterization of the R. palustris 70S Ribosome
The 70S ribosome from R. palustris was characterized with the integrated topdown and bottom-up technique. Integration of results was achieved by using protein
identifications from the analysis of top-down data to refine analysis of bottom-up data,
and vice versa, in an iterative manner to increase the number of characterizations of
ribosomal proteins obtained. For example, identification of a methylated protein by the
top-down approach could provide motivation to examine more closely the bottom-up
results for the presence of a methylated peptide from that protein. The combined topdown bottom-up MS analysis identified a total of 53 of the predicted 54 ribosomal
proteins [Table 4.1]. The data indicated the presence of 21 proteins for the small subunit
and 33 for the large subunit (S20 and L26 are identical). No orthologue of E. coli S22
85

was identified for R. palustris ribosomes. We also identified isoforms for L7/L12 from
the large subunit. These isoforms included one form with 3 methylations and a second
form with an acetylation. Within this work, each of the R. palustris ribosomal proteins
(RRP) is named after the corresponding ribosomal protein in E. coli. The L7/L12
isoforms were therefore named RRP-L7/L12A and RRP-L7/L12B.
Intact proteins from three separate aerobically grown ribosome samples were
examined by LC-FT-ICR-MS, and the resulting data were pooled. From this top-down
analysis, we identified 42 intact R. palustris ribosomal proteins. The four largest
ribosomal proteins (RRP-S2 at 36 kDa, RRP-S1 at 62.8 kDa, RRP-L2 at 31.6 kDa, and
RRP-S3 at 26.3 kDa) were not observed. Even though the FT-ICR-MS has sufficient
mass range to observe these species, prior experience with intact proteins suggests that
larger species, such as these, are difficult to elute from the C4 reverse-phase column
under the experimental conditions employed for the top-down liquid chromatography. It
is likely that the increased hydrophobicity of these larger proteins results in irreversible
binding on the reverse-phase column, making these proteins difficult, if not impossible,
to elute from the column.

86

Table 4.1. Ribosomal protein identification by top-down ESI-FTICR-MS [54]
Protein
L1
L3
L5
L6
L7/L12
L9
L10
L11
L14
L15
L17
L18
L19
L21
L22
L23
L24
L24
L29
L30
L31
L32
L33
L35
L36
S4
S5
S7
S8
S8
S10
S11
S12
S13
S14
S15
S16
S17
S18
S19
S20
S21
a

Calc.
Massa

Modification
loss of Met
plus Methyl
plus 2 Methyl
loss of Met
loss of Met + 3 Methyl
none
loss of Met
loss of Met+Acet+ 9 Methyl
none
none
plus 3 Methyl
loss of Met
none
loss of Met
loss of Met
none
loss of Met
loss of Met + Methyl
loss of Met
loss of Met
none
loss of Met
loss of Met + Methyl
loss of Met
none
loss of Met + Methyl
loss of Met
loss of Met
loss of Met
loss of Met+Acet+4 Methyl
none
loss of Met + Methyl
none
loss of Met
loss of Met
loss of Met
loss of Met
loss of Met
plus 6 Methyl
loss of Met
loss of Met
none

23877.832
25622.463
21064.992
19272.408
12754.07
21178.022
19067.739
15507.107
13488.498
16836.243
15716.353
12904.93
14296.764
13358.081
13826.007
10907.949
10998.226
11012.241
7849.213
7092.967
8566.315
6860.73
6248.504
7415.278
5063.971
23441.536
20522.086
17556.27
14477.6316
14575.704
11667.363
13760.215
13874.799
14313.985
11331.399
10010.563
12017.595
9553.253
9178.219
10087.371
9577.324
10062.669

MAIM (most abundant isotopic mass)
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Meas. Mass
23877.449
25622.159
21064.576
19272.674
12754.089
21178.268
19067.617
15507.246
13488.645
16836.259
15716.056
12905.157
14296.899
13358.533
13825.6447
10908.021
10998.231
11012.146
7849.239
7092.988
8566.334
6860.636
6248.45
7415.278
5063.952
23441.69
20522.411
17556.629
14477.683
14575.619
11667.404
13760.314
13875.167
14313.596
11331.9
10010.562
12017.575
9553.316
9177.834
10087.379
9577.387
10062.722

Mass error
(ppm)
16.0
11.9
19.7
-13.8
-1.5
-11.6
6.4
-9.0
-10.9
-1.0
18.9
-17.6
-9.4
-33.8
26.2
-6.6
-0.5
8.6
-3.3
-3.0
-2.2
13.7
8.6
0.0
3.8
-6.6
-15.8
-20.4
-3.6
5.8
-3.5
-7.2
-26.5
27.2
-44.2
0.1
1.7
-6.6
41.9
-0.8
-6.6
-5.3

In total, 42 proteins were tentatively identified, with the majority (25) at better
than 10 ppm mass accuracy, and only 3 differing by >30 ppm from the calculated value.
Of these 42, ten correspond directly to the predicted gene products, 21 are processed by
only methionine truncation, and the remaining 11 appear to be modified by further
acetylation and/or methylation. Three proteins, RRP-L24, RRP-L7/L12 and RRP-S8,
were found to be present in two different forms. The most highly modified species
identified was RRP-L11, which is methionine-truncated, and contains multiple
methylations and/or acetylations. About ten additional species were measured from the
ribosome sample, but could not be identified. It is likely that these species correspond to
the other ribosomal proteins, but are altered substantially (possibly by combinations of
other PTMs, oxidation, and more extensive truncation) such that they are beyond the
scope of our simple “look-up table” (excel table with all combinations of searched for
PTMs) or they could be common contaminants identified in the bottom-up analysis as
well. Using this integrated approach for the R. palustris ribosomal proteins we were able
to provide a comprehensive analysis of PTMs and isoforms that was previously unknown
for this organism.
Results for E. coli Ribosomal Proteins From All Three Strains
General Analysis of E. coli Ribosomal Proteins from All Three Strains
Proteins from three strains of K12 E. coli were examined with a combined topdown and bottom-up strategy. The three strains included a K12 wild type strain (WT), a
K12 streptomycin resistant strain (SmR), and a K12 streptomycin resistant compensated
strain where cell growth was allowed to return to a normal state (SmRC). To obtain the
accurate mass values for the top-down measurements, the most abundant isotope
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measurement method (MAIM) was used as previously described [89]. In this method the
MAIM value are obtained for the top-down measured masses and then compared to the
calculated MAIM values for each ribosomal protein. Bottom-up identifications are also
made for each ribosomal protein with the number of unique peptides identified and
protein sequence coverage recorded. To investigate the fidelity of the top-down database
searching, two distracter database searches were performed with the bacterium
Rhodopseudomonas palustris and yeast Saccharomyces cerevisiae ribosomal protein
databases plus the entire E. coli database to see how many proteins are identified using
the measured E. coli protein masses. When using the R. palustris ribosomal database, five
E. coli ribosomal measured masses are identified within 1.0 Da from the R. palustris
database; these include L31, S17, S10, L36, and L28. L31 was identified with to have a
N-terminal methionine truncation for E. coli that was not identified in R. palustris search.
For the searches against the yeast database, only three yeast proteins were identified
within 1 Da using the measured E. coli masses, including the 60S L28, 60S L44, and 40S
S21 proteins. The yeast 60S L44 protein has homology to the E. coli L12 protein which
could provide a match within the yeast database.
In the WT strain measurement, a total of 52 of the 57 ribosomal proteins were
identified by the bottom-up approach and 43 of the 57 were identified by top-down
analysis [Table 4.2]. The bottom-up analysis of the WT strain indicated the presence of
20 out of a total 22 proteins from the small subunit (denoted S1-S22), with S12 and S22
not being seen, and 30 of the possible 36 proteins from the large subunit (denoted L1L36), with L26, L31, and L34-L36 not being identified [Table 4.2].
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Table 4.2: Combined top-down and bottom-up data for the WT strain.
Subunit
S1
S2
S3
S4
S5
S6
S7
S8
S9
S10
S11
S12
S13
S14
S15
S16
S17
S18
S19
S20
S21
S22
L1
L2
L3
L4
L5
L6
L7
L9
L10
L11
L12
L13
L14
L15
L16
L17
L18
L19
L20
L21
L22
L23
L24
L25
L26
L27
L28
L29
L30
L31
L32
L33

Avrg Sequence Mass

Measured Mass

PTM

PPM

25852.07850
23337.93550
17514.26790

25852.80623 DEM
23337.98857 DEM
17514.22458 DEM, ACE

19887.93140
13995.39720
14725.03120
11735.60360
13727.78420
13651.88700

DEM
13995.439 DEM
DEM
11735.4623
DEM, MET
13652.15343 DEM, BMT

11449.31400
10137.58300
9190.56590
9573.27380

11448.96907 DEM
DEM
9190.601945
9573.259505 DEM

-3.921956536
1.493219592

10299.11000
9553.21800
8368.77370

10298.42837 DEM
9553.368212 DEM
8368.72685 DEM

66.18348576
-15.72370692
5.598191764

24598.48930
28729.30750
22257.57560

24598.41311 DEM
28728.46272 DEM
22257.41732 MET

3.097547946
29.40499001
7.111421425

20170.42370
18772.61160
12206.06290

20170.53916 DEM
DEM
12206.05081 DEM, ACE

17580.43760
14870.47030
12206.06290
16918.57380
13541.06560
14980.44430

17579.97320 DEM
14870.38882 DEM, 9-MET
12206.05081 DEM, ACE
16918.02986
13540.54586
14980.42223

14364.62170
12769.64490
13002.05480
13365.77070
11565.05541

14364.05432
12769.87237
13001.53381 DEM
DEM
11564.3661

39.49877775
-17.81365118
40.06982035

11199.13960
11185.02740
10693.46300

11185.06116 DEM
10693.44982

-3.017873698
1.23280924

8993.038869
8874.791879
7273.217968
6410.67098
7871.263986
6314.680172
6254.571417

27.89090626
58.4453912
33.89471414
-9.106773977
-20.74500203
82.139614
-23.76190494

8993.28970
8875.31060
7273.46450
6410.61260
7871.10070
6315.19890
6254.42280

DEM
DEM
DEM
DEM
DEM, MET

DEM = N-terminal methionine truncation
ACE = acetylation
MET = Methylation
BMT = beta- methylthiolation and a K to T point mutation
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-28.14992226
-2.27402291
2.473640363

-2.986624774
12.04053961

BU Seq Cov Unique Peptides
53.9
24
54.8
9
44.2
13
37.9
9
62.3
12
34.4
3
45.8
13
27.7
3
13.8
2
47.6
6
39.5
3

-19.51598339
30.12687048

-5.724074106
0.990737153
26.41566783
5.479315607
0.990737153
32.15052323
38.38242981
1.472987019

59.60239496

53.4
12.9
7.9
30.5
9.5
29.3
12
12.6
14.1

10
1
2
3
1
2
3
1
1

59
34.4
33.5
28.4
57.5
49.9
64.5
51
31.5
26.1
64.5
34.5
21.1
34.7
32.4
26.8
19.7
36.5
28
44.7
42.7
27
52.9
60.6

16
9
8
4
12
10
10
9
5
6
10
4
3
5
4
5
2
4
6
5
7
3
8
8

25.9
12.8
46
33.9

2
1
3
2

26.3
27.3

1
1

In the top-down analysis 10 of the small subunit proteins were not identified
including S1, S2, S6, S7, S9, S11, S13, S15, S18, and S22; while 11 proteins from the
large subunit were not found including L4, L9, L6, L16, L20, L22, L23, L26, and L34L36 [Table 4.2]. Ribosomal proteins from the WT strain, not found by bottom-up and
top-down, include S22, L26, and L34-L36.
From the SmR strain analyses 44 of the 57 ribosomal proteins were identified by
the bottom-up method while 41 were identified using the top-down approach [Table 4.3].
The data from the SmR strain shows the S13 and S22 proteins from the small subunit as
well as the of L26, L27, L30-L32, and L34-L36 proteins from the large subunit were not
detected by bottom-up analysis [Table 4.3]. In the SmR strain the S17, S22, L26, L31,
and L34-L36 were not found by bottom-up and top-down measurements.
Within the SmRC strain of streptomycin resistant E. coli 49 of the 57 ribosomal
proteins were identified by bottom-up methods and 43 by the top-down method [Table
4.4]. From the small subunit ribosomal proteins of the SmRC strain the S22 protein was
not observed by bottom-up analysis; while the large subunit proteins L26, and L34-L36
were not observed [Table 4.4]. The top-down analysis shows the S1, S2, S6, S13, S18,
and S22 proteins from the small subunit not detected and the L4, L9, L22, L26, L31, and
L34-L36 proteins from the large subunit not detected [Table 4.4]. Top-down and bottomup measurements did not identify the S22, L26, and L34-L36 ribosomal proteins from the
SmRC strain.
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Table 4.3: Combined top-down and bottom-up data for the SmR strain.
Subunit
S1
S2
S3
S4
S5
S6
S7
S8
S9
S10
S11
S12
S13
S14
S15
S16
S17
S18
S19
S20
S21
S22
L1
L2
L3
L4
L5
L6
L7
L9
L10
L11
L12
L13
L14
L15
L16
L17
L18
L19
L20
L21
L22
L23
L24
L25
L26
L27
L28
L29
L30
L31
L32
L33
L34
L35
L36

Avrg Sequence Mass

Measured Mass

PTM

PPM

25852.07850
23337.93550
17514.26790

25852.1039 DEM
23337.94815 DEM
17514.30762 DEM, ACE

-0.982551558
-0.542035948
-2.267808179

19887.93140
13995.39720
14725.03120
11735.60360
13727.78420
13651.88700

19887.97468
13995.30806
14724.9854
11735.49733
13727.72578
13624.85

-2.176194151
6.369594141
3.110349946
9.055350165
4.255603027

11449.31400
10137.58300
9190.56590
9573.27380

10137.89412 DEM
9190.203623
9572.489042 DEM

-30.68966242
39.41835616
81.97383846

10299.11000
9553.21800
8368.77370

10299.02371 DEM
9552.866332 DEM
8368.720287 DEM

8.378393861
36.81147023
6.382416578

24598.48930
28729.30750
22257.57560

24598.32132 DEM

6.828752691

22257.60407 MET

-1.279249839

20170.42370
18772.61160
12206.06290

20170.28273
18772.58227
12206.52929
12220.1022

6.988797166
1.562169432
-38.20937216

17580.43760
14870.47030
12206.06290
16918.57380
13541.06560
14980.44430

17580.72068 DEM
14870.58317 DEM, 9-MET
12206.52929 DEM, ACE
16917.8734
13541.00182
14980.63423

-16.10215891
-7.590210513
-38.20937216
41.39840676
4.709969059
-12.6781954

12770.35352
13002.40935 DEM
13365.48241 DEM

-55.49285086
-27.2689206
21.56905176

12226.03966
11199.07846
11185.04528 DEM
10693.45309

22.56935033
5.459347966
-1.598207976
0.927108459

8993.445437 DEM

-17.31702249

14364.62170
12769.64490
13002.05480
13365.77070
11565.05541
12226.31560
11199.13960
11185.02740
10693.46300

DEM
DEM
DEM
DEM, MET
DEM, BMT, K-T

DEM
DEM
DEM, ACE
DEM, ACE, MET

8993.28970
8875.31060
7273.46450
6410.61260
7871.10070
6315.19890
6254.42280

7272.763565
6410.312477 DEM
7871.051347
6314.651869 DEM
6254.318399 DEM, MET

4364.35210

4364.816693

96.36879372
46.81658661
6.27015228
86.62134141
16.69234769

-106.4517686

DEM = N-terminal methionine truncation
ACE = acetylation
MET = Methylation
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BU Seq Cov
46.3
54.8
42.1
40.3
62.9
42.7
46.4
21.5
20
13.6
40.3
21.8
53.4
12.9
33.7
13.4

Unique Peptides
25
14
13
12
14
4
15
2
5
1
6
1
10
1
1
1

13.3
20.7
24.1

1
3
4

59
37.4
33.5
28.4
57.5
40.7
64.5

20
12
10
7
14
11
9

36.2
31.5
19.7
64.5
35.9
28.5
34.7
32.4
26.8
19.7
36.5
16.1
44.7
51.8
15
44.2
25.5

9
9
3
9
5
4
8
6
5
2
4
4
3
9
1
8
2

12.8
22.2

1
1

27.3

1

Table 4.4: Combined top-down and bottom-up data for the SmRC strain.
Subunit
S1
S2
S3
S4
S5
S6
S7
S8
S9
S10
S11
S12
S13
S14
S15
S16
S17
S18
S19
S20
S21
S21
S22
L1
L2
L3
L4
L5
L6
L7
L9
L10
L11
L12
L13
L14
L15
L16
L17
L18
L19
L20
L21
L22
L23
L24
L25
L26
L27
L28
L29
L30
L31
L32
L33
L34
L35
L36

Avrg Sequence Mass

Measured Mass

PTM

PPM

25852.07850
23337.93550
17514.26790

25852.02755 DEM
23337.41086 DEM
17514.31651 DEM, ACE

1.970905357
22.48026609
-2.775565629

19887.93140
13995.39720
14725.03120
11735.60360
13727.78420
13651.88700

19887.90318
13995.38833
14724.25623
11735.62495
13727.65999
13624.78221

1.418850429
0.633851249
52.62949799
-1.818824214
9.048364848

11449.31400
10137.58300
9190.56590
9573.27380

11449.16009 DEM
10137.58642 DEM
9190.203623
9573.121732 DEM

13.44263945
-0.336865306
39.41835616
15.88463917

10299.11000
9553.21800
8368.77370
8466.96200

10298.68954
9553.340992
8368.84807
8466.674

40.8251781
-12.87440525
-8.886606648
34.01456154

24598.48930
28729.30750
22257.57560

24598.81402 DEM
29729.05438 DEM
22257.65787 MET

-13.20072936
-34798.85058
-3.696044955

20170.42370
18772.61160
12206.06290
12220.08980

20170.46279
18773.16783
12206.84246
12220.34692

DEM
DEM
DEM, ACE
DEM, MET, ACE

-1.937936485
-29.62960146
-63.86686734
-21.04051641

17580.43760
14870.47030
12206.06290
16918.57380
13541.06560
14980.44430

DEM
DEM, 9-MET
DEM, ACE

25.046248
-10.18017567
-63.86686734
4.564037188
10.03207606
8.639329876

14364.62170
12769.64490
13002.05480
13365.77070
11565.05541

17579.99728
14870.62168
12206.84246
16918.49658
13540.92976
14980.31488
15365.83597
14365.25629
12770.35352
13002.20087
13365.53097
11564.49163

11199.13960
11185.02740
10693.46300

11199.11761
11185.03471 DEM
10693.34952

1.963632992
-0.653641671
10.61199725

8993.28970
8875.31060
7273.46450
6410.61260
7871.10070
6315.19890
6254.42280

8993.271975 DEM
8875.421703 DEM
7273.491698
6410.667045 DEM

1.970913936
-12.51820979
-3.739345947
-8.492948084

6314.651869 DEM
6254.446543 DEM, MET

86.62134141
-3.796193631

DEM
DEM
DEM
DEM
DEM, MET
DEM, BMT, K-T

DEM
DEM
DEM
7 MET

2 ACE

DEM
DEM

DEM = N-terminal methionine truncation
ACE = acetylation
MET = Methylation
BMT = beta- methylthiolation and a K to T point mutation
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-44.17721631
-55.49285086
-11.23453194
17.93618979
48.74857753

BU Seq Cov
52.8
45.6
42.1
32.00
57.5
34.4
46.4
34.6
20
34
39.3
21.8
53.4
12.9
6.7
30.5
9.5
29.3
29.3
12.6
14.1

59
34.4
33.5
28.4
52.5
40.1
64.5
52.3
31.5
31.7
64.5
34.5
28.5
34.7
32.4
26.8
19.7
36.5
22.9
44.7
41.8
27
52.9
52.1
16.5
12.8
46
33.9
21.4
26.3
27.3

Figure 4.1 presents an example of data from the top-down approach. Shown in
Figure 4.1 is the first 15 minutes of the total ion chromatogram of the SmRC strain where
all elution of the purified ribosomal sample from the reverse phase separation occurred,
along with a deconvoluted mass spectrum corresponding to the chromatographic peak at
2.38 minutes with the isotopic pattern for the component at nominal mass 11184 Da
shown. The measured isotopic packet of this species is consistent with the calculated
isotopic packet (MAIM) of intact ribosomal protein L24. The measured isotopically
resolved peak at 11,184.383 Da was within 8 part per million of the calculated MAIM
value of 11,184.286 Da for this protein. For comparison, searching the entire E. coli
proteome database for measured mass 11,184.383 Da (L24) reveals only one protein
within 9.0 Da, and when searching the entire database including a maximum of 5 PTMs
and a 2 Da mass window five proteins are found. These proteins, even with
modifications, are well within the separable mass range for the FT-ICR-MS.
The bottom-up MS measurements often provide a more extensive list of proteins than the
top-down, and indicate the presence of some other components that are consistent across
the ribosomal purification process for each of the three strains. The most abundant of
these proteins, observed in all three strains, include bacterioferrin observed at 39-63%
sequence coverage and 6-8 unique peptides, GroEL with 23-42% sequence coverage and
9-16 unique peptides, and a Co-A linked acetaldehyde dehydrogenase with 35-39%
sequence coverage and 25-27 unique peptides.
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Figure 4.1: 15 minutes of the total ion chromatogram for the SmRC strain. Showing
where all elution of the purified ribosomal sample from the reverse phase separation
occurred, along with a deconvoluted mass spectrum corresponding to the
chromatographic peak at 2.38 minutes with the isotopic pattern for the component at
nominal mass 11184 Da shown. The measured isotopically resolved peak at 11,184.383
Da was within 8 part per million of the calculated isotopically averaged value of
11,184.286 Da for the L24 protein. Methionine truncation within the figure is labeled as
MET.
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Post Translational Modifications of Antibiotic Resistant E. coli Ribosomal Proteins
The integrated top-down and bottom-up approach allows for the identification of
PTMs, their location, as well as isoforms of ribosomal proteins. Included in the topdown PTM searches were N-terminal modifications of methionine truncation,
methylation, acetylation, and β-methylthiolation. In addition, the bottom-up analysis
contained β-methylthiolation of aspartic acid, single acetylations, and mono-, di-, and
trimethylated lysines and arginines. All of these modification types have been previously
identified in ribosomal proteins from E. coli [90, 89, 91, 92, 93]. Phosphorylation is
common in eukaryotic ribosomal proteins, although, this has yet to be definitively
identified in prokaryotic ribosomal proteins, and was therefore excluded from the subset
of modifications searched for [94].
N-terminal Methionine Truncations
N-terminal methionine truncation was the most prevalent PTM identified by topdown analysis. Of the 57 ribosomal proteins, 31 ribosomal proteins from all three strains
(WT, SmR, SmRC) were identified to have an N-terminal methionine truncation by topdown analysis in this study [Table 4.2-4.4]. The top-down approach identified an Nterminal methionine truncation if the measured intact mass for a ribosomal protein
matched that obtained by subtracting the mass of a methionine residue (131.0405 Da)
from the mass calculated from the DNA-derived amino acid sequence. The results of this
searching agreed perfectly with previous identified E. coli ribosomal proteins with Nterminal methionine truncations [90].
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β-methylthiolation
The novel β-methylthiolation PTM is known to occur at the D88 residue of the
S12 E. coli ribosomal protein [93]. In the top-down analysis of the WT strain, a MAIM
molecular mass of 13651.527 was observed corresponding to the S12 ribosomal protein
with a β-methylthiolation and an N-terminal methionine truncation with a calculated
MAIM mass of 13651.469. These top-down measured and calculated MAIM values for
S12 are within a -4.2 ppm mass accuracy. The S12 protein was identified in the bottomup analysis, although the peptide containing the D88 β-methylthiolation was not
observed. Even though the bottom-up search did not yield any positive peptide matches
the mass accuracies provided by the top-down measurement still provides strong
evidence. The SmR and SmRC strains also contain this modification along with a point
mutation and will be discussed later.
Acetylation
A number of ribosomal proteins from the three streptomycin resistant strains of E.
coli were identified by top-down and bottom-up methods to have an acetylation,
including L7, S5, L15, and L16. The L7 protein in E. coli is known to have an N-terminal
methionine truncation and acetylation of the serine at first position [90, 89]. This
modification state was found for L7 in all three strains (WT, SmR, SmRC) of antibiotic
resistant E.coli in the top-down analysis. The measured MAIM value for the modified L7
protein was 12205.520 and the calculated MAIM value was 12205.502 providing a mass
accuracy of -1.5 ppm. The bottom-up analysis did not find the N-terminal peptide for this
protein therefore missing the acetylation at the serine.
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Both bottom-up and top-down measurements provide conformation of the Nterminal truncation and acetylation of the S5 protein in all three strains. The bottom-up
analysis shows the N-terminal peptide acetylated at the alanine for all three WT, SmR,
and SmRC strains. Further more, the top-down analysis confirms this with a high mass
accuracy of 12 ppm.
Methylation
The S21 protein only in the SmRC strain was found in top-down analysis with 2
isoforms present (Figure 4.2). The first isoform present is S21 with a N-terminal
methionine truncation, the second observed isoform within the same mass spectrum is the
S21 protein with a N-terminal methionine truncation plus 7 methylations. For the S21
isoform with 7 methylations, the measured MAIM value of 8465.699 was obtained, and
when compared to the calculated MAIM value of 8465.806 Da, a ppm of 16 is obtained.
However, only two peptides, with low protein sequence coverage, were obtained for S21
in the bottom-up analysis and these two peptides did not contain a methylation. This
could be due to peptides with Methylations being lost from this small protein when the
trypsin digestion was performed.
Also identified by top-down and bottom-up analysis were the L11, S11, L3, and
L33 ribosomal proteins with methylations. The only observed isoform of the L11 protein
was found in the SmRC and WT strains with an N-terminal methionine truncation and 9
methylations.
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Figure 4.2: The S21 protein in the SmRC strain was found with top-down analysis to
have 2 isoforms present. The first isoform present is S21 with a N-terminal methionine
truncation, the second observed isoform within the same mass spectra is the S21 protein
with a N-terminal methionine truncation plus 7 methylations.
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The S11, L3 and L33 proteins were all identified with a single methylation. This data is
consistent with previous studies of E. coli ribosomal proteins [90].
Point Mutations
The S12 protein was identified only in the SmR and SmRC strain with a Nterminal methionine truncation, β-methythiolation, as well as a lysine 42 to a threonine
point mutation (Figure 4.3). The top-down analysis shows the S12 protein with a
retention time of 1.58 minutes and a measured MAIM value of 13624.45 providing a ppm
of -1.9 when compared to the calculated MAIM value of 13624.42 (Figure 4.3).
Searching of the bottom-up data found the S12 protein with the point mutation. Peptide
36-VYTTTPTKPNSALR-49 was found with the threonine in position 42 instead of the
lysine (Figure 4.3). The y-ion series is labeled in Figure 4.3 for peptide 36VYTTTPTKPNSALR-49 with the y8 ion highlighted corresponding to the threonine.
Discussion of Antibiotic Resistant E. coli Results
Two strains of streptomycin resistant E. coli (SmR and SmRC) ribosomal proteins
were analyzed and compared to the wild type K12 E. coli strain in order to see any
differential post translational modifications or amino acid substitutions present that may
confer streptomycin resistance in E. coli. The wild type strain (WT) was used as a
baseline to ensure growth, purification, and analysis was consistent for the SmR and
SmRC strains. Also the WT strain was used to provide a baseline modification state that
the SmR and SmRC strains could be compared to and see how far antibiotic strains vary
from the parent strain. In the bottom-up analysis of the WT strain, five ribosomal proteins
were not observed including L34, L35, L36, L26 and S22.
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S12 – methionine + B-methythiolation with Lysine 42 to Threonine point mutation
13624.4

Retention time 1.58

Figure 4.3: Total ion chromatrogram ans MS/MS spectrum for S12. The total ion
chromatogram is shown for the SmRC sample with the S12 protein, at retention time 1.58
min, expanded out containing a N-terminal methionine truncation, β-methythiolation, as
well as a lysine 42 to a threonine point mutation. The y-ion series is labeled for peptide
36-VYTTTPTKPNSALR-49 with the y8 ion highlighted corresponding to the threonine
point mutation.
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The L34, L36 and S22 proteins have a high percentage of basic residues providing a large
number of trypsin cleavage sites. The L34 protein has 16 lysines and arginines with its
46 amino acid sequence, followed by L36 with 12 and S22 with 11. Due to these
sequences being so rich in trypsin cleavage sites, many of the resulting peptides fall
below the lower m/z limit for isolation and fragmentation within the mass spectrometer.
In the top-down analysis, three of the larger proteins S1, S2, and L4 were not observed.
The FT-ICR-MS has sufficient mass range to analyze these proteins, but prior experience
with intact protein chromatography indicates that larger species such as these three
proteins are difficult to elute off an on-line C4 reverse phase column, under the top-down
experimental conditions employed. Low abundance and different hydrophobicities may
prevent proteins from being observed due to irreversible binding to the reverse phase
column, and lower than detectable concentrations.
When the total number of proteins observed in both the SmR and SmRC strains
are compared, a higher number of ribosomal proteins are observed for the SmRC strain.
A total of 41 ribosomal proteins were observed in the top-down analysis for the SmR
strain as compared to 43 for the SmRC strain. Also, five more ribosomal proteins were
able to be identified for the SmRC strain in the bottom-up analysis. These observed
differences in the two strains could be due to the compensation that was allowed to occur
for the SmRC strain. The acquired resistance to streptomycin by E.coli has an associated
fitness cost resulting in slowed growth. The compensated derivative strain (SmRC) was
obtained by evolving an isolate of the original streptomycin resistant strain (SmR)
through repeated serial passage, in the laboratory, until it had “compensated” for the
reduced fitness and recovered a wild type comparable growth rate. This “compensation”
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process in the SmRC strain may allow for higher protein expression providing, a greater
number of identifiable proteins. This compensation within the SmRC strain is thought to
come from intra- or extra-genic mutations and differential post translational
modifications that stabilize the resistance phenotype in the population. However, a
process of differentially post translationally modifying ribosomal proteins to compensate
fitness is thought to occur, what these modifications are have been difficult to obtain by
traditional molecular techniques. Using top-down mass spectrometry, differentially
expressed modifications could be examined for the SmR and SmRC strains. An example
of these differential post translational modifications is the S21 and L16 ribosomal
proteins. The S21 ribosomal protein is present in the SmRC strain with 7 methylations
and a N-terminal methionine truncation (Figure 4.2), whereas in the SmR strain S21 only
contains the N-terminal methionine truncation and no identified methylations. The L16
ribosomal protein was also identified with a differential post translation modification
within the SmRC strain and not in the SmR strain. The L16 protein was identified with
two acetylations in the SmRC strain, which were not identified in the SmR strain. The
use of top-down mass spectrometry provided, for the first time, a way of examining
differential post translational modifications in “compensated” streptomycin resistant
strains of E. coli.
Streptomycin resistance within E. coli is thought to occur from point mutations
within the ribosomal proteins. One such previously identified point mutation is the lysine
42 to threonine in ribosomal protein S12. The S12 protein is known as the “hinge”
protein in the ribosomal complex, and plays an important role in the structural
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conformation [95]. Therefore, it is understandable why this protein would be an
important target for antibiotic resistance.
The integrated top-down and bottom-up method identified the S12 protein with a
N-terminal methionine truncation, β-methythioaltion, as well as a lysine 42 to a threonine
point mutation in the SmR and SmRC strains. The identification of the S12 ribosomal
protein with the lysine to threonine point mutation only within the SmR and SmRC
strains, and not the WT strain, provides further conformation toward its role in
streptomycin resistance.
Conclusions
Employing the integrated top-down and bottom-up approach, first allowed for a
comprehensive evaluation of ribosomal proteins from R. palustris and second of
antibiotic resistant strains of E. coli. The analysis of component proteins of the 70S
ribosome from R. palustris enhanced several aspects of the analysis. The intact protein
measurements include the aggregate contribution of all modifications to the protein,
allowing for the discrimination of isoforms with different molecular masses, while the
peptide data provided the location of the modification in many instances.
Not only was this method useful in the analysis of R. palustris ribosomes; the use
of integrated top-down and bottom-up mass spectrometry approaches provided insight
into the role of ribosomal proteins in streptomycin resistance in E. coli. The
identification of differential modifications may provide starting points for future
biological analysis of antibiotic resistance within bacterial species.
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Chapter 5
Evaluation of PTMs and Isoforms in Protein Complexes from
Rhodopseudomonas palustris for Key Regulation Sites
All of the data presented below is accepted for publication Heather M. Connelly, Dale A.
Pelletier, Tse-Yuan Lu, Patricia K. Lankford, and Robert L. Hettich. Characterization of
pII Family (GlnK1, GlnK2, GlnB) Protein Uridylylation in Response to Nitrogen
Availability for Rhodopseudomonas palustris. Analytical Biochemistry, Accepted, In
Press (2006). All MS sample preparation, experiments and data analysis were performed
by Heather M. Connelly.
Introduction
The analysis of protein complexes, and their associated PTMs, that play a key role
in regulation was an important aspect in the development of this dissertation work. This
analysis allowed for the improved identification of PTMs and protein complexes that was
need for future work in the analysis of multiple growth states from R. palustris (Chapter
7).
The movement of ammonium across biological membranes is a process that is
conserved throughout all domains of life from bacteria to man [96]. In bacteria, the pII
family generally plays a pivotal role in nitrogen metabolism regulation due to its ability
to sense internal cellular ammonium concentrations [96,97,98]. This protein family is
able to sense and transduce an ammonium signal, via protein-protein interactions, to a
variety of enzymes involved in nitrogen metabolism [99,100,101]. The pII proteins GlnK
and GlnB in Escherichia coli are trimers that functions as small signal transduction
proteins and are able to sense the status of cellular nitrogen within prokaryotic cells
[102]. The crystal structure of GlnK in E. coli has a compact barrel structure around 50Å
in diameter and 30Å high, with an unstructured T-loop protruding from the upper surface
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[96,103]. Residue tyrosine-51 at the apex of the T-loop is uridylylated in nitrogen starved
cells, with the process being reversed when nitrogen is sufficient [96].
The general nitrogen regulation system (ntr), which has been most extensively
studied in E. coli, controls the transcriptional activity of a number of genes involved in
nitrogen regulation and assimilation, such as glnA (encoding glutamine synthetase) and
nifA (encoding the transcriptional activator for the other nif genes) [104,105]. In E. coli,
there are two levels of regulation involving the uridylylation of both the GlnB and GlnK
proteins. The first level within the cascade is the uridylylation (under low ammonium
conditions) and de-uridylylation (under high ammonium conditions) of the GlnK protein
in direct response to the intracellular nitrogen concentration, which in turn regulates the
AmtB ammonium transporter’s movement of ammonium across the cell membrane
[96,106,107]. This regulation of AmtB occurs when the cellular nitrogen status reaches a
certain level, and de-uridylylation of GlnK allows for the direct binding of AmtB and
sequestration to inhibit further ammonium transport [96,108,109]. The second level in
the cascade is the uridylylation of the GlnB pII functional protein, which is thought to
play a role in regulating enzymatic activity of glutamine synthetase (GlnA), which
catalyzes the conversion of glutamate to glutamine, by controlling the level of
adenylylation on tyrosine-397. Adenylytransferase (AT) is the enzyme that adenylylates
and deadenylylates GlnA. Regulation as to which reaction the adenylytransferase
catalyzes is determined by either unmodified GlnB (which stimulates adenylylation of
glutamine synthetase) or uridylylated GlnB (which stimulates deadenylylation of
glutamine synthetase) [110,111,112] (Figure 5.1).
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Figure 5.1: Proposed model for glutamine synthetase (GS) regulation in R. palustris
based on known models in E. coli. Two metabolic states were interrogated in this study.
The growth state shown on the left is anaerobic, grown in the light without oxygen
(photoheterotrophic) with no ammonium present (nitrogen fixing conditions). The
growth state shown on the right is photoheterotrophic growth with ammonium sulfate
present in the growth media (non-nitrogen fixing). The tagged GlnK and GlnB proteins
are suspected to be uridylylated on Tyr-51 under nitrogen-fixing conditions which in turn
activates the adenylytransferase (AT) to deadenylylate glutamine synthetase (GS), Under
non-nitrogen fixing growth the lack of uridylylation on Tyr-51 leads to the inactive form
of GS . Figure adapted from Larimer et al. Nature Biotechnology, 2004.
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In the purple non-sulfur anoxygenic phototrophic bacterium Rhodopseudomonas
palustris, the GlnK proteins also are expected to function as a primary regulator point in
ammonium sensing and thus regulation of the glutamine synthetase pathway. However,
R. palustris has unique metabolic versatility in its modes of energy generation and carbon
metabolism, and unlike E. coli, it is able to thrive under severe nitrogen limiting
conditions by fixing atmospheric nitrogen. As such, it is possible that R. palustris may
utilize a nitrogen-ammonium regulation system that varies from other commonly studied
bacteria such as E. coli [13, 11]. In R. palustris there are three encoded forms of pII
proteins; GlnK1 (RPA0272), GlnK2 (RPA0274), and GlnB (RPA2966). Also unique in R.
palustris is the encoding of two AmtB transporters within the same operon as GlnK1 and
GlnK2, with each transporter corresponding to one of the two GlnK proteins (Figure 5.2).
Based on information from other bacteria, it is likely that uridylylation of these proteins
is a key aspect of controlling the glutamine synthetase pathway. Figure 5.1 outlines a
proposed pathway in which GlnK2 is the uridylylation target protein that is sensitive to
the availability of nitrogen, and the uridylylation of GlnB activates glutamine synthetase.
Traditionally, nitrogen-ammonium regulation has been evaluated with
immunoblotting and native gel analysis for a number of organisms, such as Escherichia
coli, Gluconacetobacter diazotrophicus, Rhodospirillum rubrum, and Rhodobacter
capsulatus [96, 97, 110, 111,113]. In this methodology, a series of plasmids are created
to evaluate the effects of removing or altering a gene, or series of genes, to look at protein
expression and modification levels. Once the protein or proteins are isolated, there are
two common approaches employed, including Western blotting using antibodies or native
gels to look at the migration differences of modified or unmodified proteins of interest.
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Figure 5.2: Artemis view and sequence alignment for GlnK1, GlnK2, and GlnB. (2A)
The Artemis view showing R.palustris genome, with the bold box highlighting the
GlnK1, GlnK2 as well as both AmtB transporters located within the same operon.
(2B)The sequence alignment and homology comparison of the R. palustris (labeled Rp)
GlnB, GlnK1, GlnK2 proteins, along with the E. coli (labeled Ec) GlnK protein as a
comparison are shown.
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While these methodologies are informative, they are also very labor intensive and
sometimes difficult to reproducibly perform. Therefore, using these methods in tandem
with mass spectrometry is able to provide a comprehensive technique for the examination
of protein modifications quickly and accurately in most cases.
Mass spectrometry is a rapidly emerging tool for protein identification and
characterization. Intact protein or top-down mass spectrometry can be used to
characterize the GlnK and GlnB proteins, as well as their modification state, to ascertain
the level of regulation in the glutamine synthetase pathway of R. palustris. This powerful
method can provide information on the natural state of intact proteins, including details
about post-translational modifications (PTM’s), truncations, mutations, signal peptides,
and isoforms, due to top-down mass spectrometry’s ability to measure the molecular
weight of a protein very accurately and detect any covalent modifications that alter the
mass of a protein [114]. This information is often difficult to obtain by the more
common peptide or “bottom-up” mass spectrometry methods, where intact proteins are
digested with a protease such as trypsin or Glu-C and the resulting peptide mixtures are
analyzed by MS or MS/MS methods. The top-down mass spectrometry approach was
first introduced with electrospray-Fourier transform ion cyclotron resonance mass
spectrometry (ESI-FTICR-MS) [22, 23, 24]. The dynamic range, sensitivity, and mass
accuracy offered by high performance FTICR-MS afford not only unambiguous protein
identification in many cases, but also detailed information about protein modifications.
In this report, we will focus on the investigation of the GlnK and GlnB proteins
modification state for R. palustris as a function of nitrogen availability to the growing
bacterial cultures, and ultimately glutamine synthetase activation or inactivation. This
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will be achieved by isolating affinity-tagged GlnK2, GlnK1, and GlnB complexes under
nitrogen-fixing and non-nitrogen fixing growth conditions. Using this method in
conjunction with an integrated high resolution top-down and bottom-up mass
spectrometry approach should reveal detailed information about the presence and
isoforms of GlnK and GlnB proteins. In particular, uridylylation of GlnK is suspected to
be a key regulatory aspect of nitrogen availability, while the uridylylation of GlnB is
thought to play a key role in the regulatory aspect of glutamine synthetase. Both of these
modifications states of GlnK and GlnB should be identifiable in the different growth
samples. The experimental section can be found in Chapter 2.
Results
Characterization of GlnK1, GlnK2, and GlnB Under Non- Nitrogen Fixing Conditions
GlnK2
Affinity purifications of the GlnK2 protein complex from R. palustris under nonnitrogen fixing growth conditions were performed in order to examine the baseline
modification state of the complex and associated proteins. A Western blot was obtained
for the GlnK2 protein complex after affinity purification using antibodies to the 6X histag present within the GlnK2 protein. This immunoblot shows only the GlnK2 protein
band at approximately 13 kDa present on the gel (Figure 5.3). Lane one of the
immunoblot is the whole cell extract, followed by lane three which contains protein
extract obtained after the nickel purification step and finally lane five contains the final
V5 antibody purification extract from the affinity purification (Figure 5.3).
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Figure 5.3: Western Blot of GlnK2 complex at approximately 13 kDa. Lane one of the
immunoblot is the whole cell extract, followed by lane three which contains protein
extract obtained after the nickel purification step and finally lane five contains the final
V5 antibody purification extract from the affinity purification. Lanes two and four
contain the bypass wash elute.
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Lanes two and four are bypass wash steps that are tested as a control to ensure no protein
loss is occurring in the wash steps. The Western analysis provides another way of
visualizing and confirming the protein tagging procedures and affinity purifications for
the GlnK2 protein.
Under these growth conditions, the affinity purification procedure for tagged
GlnK2 yielded abundant proteins corresponding to the unmodified GlnK1 and
unmodified, tagged GlnK2, as determined by top-down ESI-FTICR-MS measurements
(Figure 4A). The m/z values for both the unmodified GlnK1 and tagged GlnK2 are
present within the FTICR mass spectra, with GlnK1 having a higher intensity than the
tagged GlnK2. GlnK1 is seen with a charge state package ranging from +12 to +15 with
the two most abundant m/z values of 883.9309 and 951.8519, while the tagged GlnK2
charge state package ranges from +17 to +20 with the two most abundant m/z values
being 859.9071 and 907.6828, providing a distinguishing charge state series for both
proteins. The measured and theoretical molecular mass values of unmodified GlnK1
(measured 12,360.824 Da, calculated 12,360.776 Da, 4 ppm mass error) and unmodified
tagged GlnK2 (measured 16,318.980 Da, calculated 16,318.859 Da, 7 ppm mass error)
agree very well, and demonstrate the power of this high-resolution mass spectrometric
technique. To demonstrate the ability and considerations of high-resolution top-down
mass spectrometry for directly identifying R. palustris proteins, the entire R. palustris
proteome database was queried with the measured molecular mass of 12,360.824 Da.
The closest match, as illustrated above, was the unmodified GlnK1 protein; the only other
protein within a window of 5 Da was the RPA4690 hypothetical protein at 12, 360.828
Da. Since the focus of this work is to examine modified proteins, this search then was
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expanded to include a range of common post-translational modifications. In particular,
this measured molecular mass of 12,360.824 Da was searched against the entire R.
palustris proteome database, this time including methionine truncation, as well as any
possible combination of 0-5 methylations, acetylations, oxidations, and disulfide bonds.
This search yielded only six possible proteins within a 2 Da window. Obviously, the
availability of peptide or MS/MS data for intact proteins would greatly help limit the
search space.
The experimental determination of only unmodified GlnK1 and GlnK2 is
consistent with the expectation that under non-nitrogen fixing growth conditions, the high
ammonium levels within the cell leads to an inactive form of AmtB, and thus there is no
need to modify the GlnK2, since it is only expressed endogenously at a very low level
[102]. The forced over-expression of this tagged GlnK2 under non-nitrogen fixing
conditions explains why this affinity purification yields only the tagged version of this
protein.
The same sample used to generate Figure 5.4 was examined by the bottom-up MS
technique, in which proteolytic digestion was used to generate peptides for LC-MS/MS
interrogation. The bottom-up experimental results confirmed the top-down data. Under
these non-nitrogen fixing conditions, the peptide MS results verified the presence of
unmodified GlnK1 at 89.3% sequence coverage with 16 unique peptides and unmodified,
tagged GlnK2 at 94.6% sequence coverage with 25 unique peptides. The bottom-up MS
measurements often are more extensive than the top-down, and indicate the presence of
some other minor components in this sample.
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GlnK1
GlnK2 + Tag

Figure 5.4: ESI-FTICR mass spectrum of GlnK2 affinity purification from R. palustris
grown under non-nitrogen fixing conditions. Only unmodified GlnK1 and unmodified
tagged (tag refers to 6X His-tag and V5 antibody tag) GlnK2 proteins are present in the
growth state.
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A possible DNA-binding protein Hu-alpha (RPA 2953) and the GlnB regulatory protein
were each observed with 2-peptide hits and sequence coverage’s of about 30%. The low
abundance of the GlnB protein not observed in the LC-MS/MS experiments could be due
to the weak affinity of GlnB associated with GlnK2 in the affinity purification. A few
other species were detected with single peptide hits, but were not considered to be
significant enough for confident identification.
GlnK1
Also performed, were affinity purifications of the tagged GlnK1 protein complex
from R. palustris under non-nitrogen fixing growth conditions, in order to examine the
baseline modification state of the complex and associated proteins. As determined by topdown ESI-FTICR measurements for the GlnK1 affinity purifications, two forms of
GlnK1 were identified [Figure 5.5]. These two isoforms of GlnK1 correspond to the
tagged and untagged forms of GlnK1. Both of these proteins were identified with a 5-10
ppm mass accuracy. It is important to remember that the 6X His tag and V5 antibody tag
used for affinity purifications are inserted within the plasmid DNA. Therefore, the
untagged version of the protein is coming from the bacterial chromosomal DNA. The
experimental determination of only unmodified GlnK1 in both the tagged and un-tagged
versions is consistent with the expectation that under non-nitrogen fixing growth
conditions, the high ammonium levels within the cell leads to an inactive form of the
AmtB transporter, and thus there is no need to modify the GlnK1, since there is no need
for the cell to transport ammonium.
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GlnK1

GlnK1+ Tag

Figure 5.5: ESI-FTICR mass spectrum of GlnK1 affinity purification from R. palustris
grown under non-nitrogen fixing conditions. The tagged and un-tagged versions of the
protein are present.
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The expression of GlnK1 under non-nitrogen fixing growth conditions will yield both
tagged and untagged versions of this protein due to GlnK1 existing as a multimeric form,
which interacts with both GlnK2 and GlnB [102]. Within the non-nitrogen fixing growth
state, GlnK2 is expected to be expressed at a significantly lower level in the cell as
compared to GlnK1. This observation is supported by bottom-up data, where GlnK1 is
present at 35.7% and 7 unique peptides, while GlnK2 has only one unique peptide and
21.4% sequence coverage.
GlnB
Affinity purifications of the GlnB protein complex from R. palustris under nonnitrogen fixing growth conditions were also performed. Using top-down ESI-FTICR-MS
to examine the GlnB affinity purifications reveals two isoforms of GlnB present within
the non-nitrogen fixing growth state [Figure 5.6]. The two isoforms of GlnB identified
correspond to the tagged and untagged versions of GlnB. The experimental determination
of only unmodified GlnB is consistent with the expectation that under non-nitrogen fixing
growth conditions, the high ammonium levels within the cell leads to an inactive form of
glutamine synthetase, and thus there is no need to modify the GlnB. Again it is not
surprising to see the un-tagged version of GlnB since it is coming from the chromosomal
DNA of R. palustris. Bottom-up data indicates that GlnB is present at 30% sequence
coverage and 4 unique peptides.
The top-down data shown in Figures 5.4-5.6, along with the bottom-up
information, indicate that the expression of the tagged, GlnK1, GlnK2, and GlnB proteins
and subsequent affinity purification procedures are effective in enriching the targeted
sample for mass spectrometric characterization.
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GlnB

GlnB + Tag

Figure 5.6: ESI-FTICR mass spectrum of GlnB affinity purification from R. palustris
grown under non-nitrogen fixing conditions. The tagged and un-tagged versions of the
protein are present.
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Thus, this approach can be used for in-vivo studies of GlnK1, GlnK2, and GlnB
modifications as a function of growth state. The observation of GlnK1 in the affinity
purification of the tagged GlnK2 verifies the robustness of this method. The absence of
significant quantities of other proteins (i.e. non-specific binding) also attests to the
potential of this affinity method.
Characterization of GlnK1, GlnK2, and GlnB Under Nitrogen Fixing Conditions
GlnK2
Affinity purifications of GlnK2 from R. palustris grown under nitrogen fixing
conditions revealed the presence of four isoforms of expressed GlnK2, as shown in
Figure 5.7. As expected, the unmodified tagged version of GlnK2 is present; however, it
also is accompanied by the uridylylated version of the tagged protein, as well as the
untagged GlnK2 and the uridylylated untagged version of this protein. While the
presence of untagged GlnK2 initially may be surprising, it is important to remember that
GlnK2 is thought to exist in a trimeric form, which interacts with both GlnK1 and GlnB
[97]. Thus, the expression of GlnK2 under these growth conditions will yield both
tagged and untagged versions of this protein. The affinity purification targets the tagged
GlnK2, which will bring-down the other components of the protein complex. Once
again, the high mass accuracy of 3-5 ppm afforded by the ESI-FTICR-MS provides the
ability to confirm the molecular masses of all four isoforms by comparing them with the
calculated masses.
In the direct infusion ESI-FTICR-MS experiments of the GlnK2 affinity
purification shown in Figure 5.7, GlnK1 was not observed, even though it was detected
under non-nitrogen fixing conditions (Figure 5.4).
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GlnK2 + Uridylylation +Tag

GlnK2 + Uridylylation

GlnK2

GlnK2 +Tag

Figure 5.7: ESI-FTICR mass spectrum of GlnK2 affinity purification from R. palustris
grown under nitrogen fixing conditions. Four different isoforms of the GlnK2 protein are
present within the growth state, including the tagged and untagged isoforms of the protein
as well as the modified and unmodified isoforms.
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This absence of GlnK1 in Figure 5.7 most likely is due to the overwhelming
amount of uridylylated untagged GlnK2 at similar molecular mass. This ionization
suppression effect in direct infusion ESI-MS experiments is not uncommon, and is one of
the major reasons for performing LC-MS measurements (i.e. to provide spatial separation
of proteins prior to measurement).
In order to evaluate whether ionization suppression was a factor in GlnK1
detection, samples of GlnK2 affinity purifications from the nitrogen fixing and nonnitrogen fixing growth conditions (confirmed to contain GlnK1) were mixed at a 1:1
ratio. Even though GlnK1 was observed in Figure 5.4, in this set of experiments from the
mixed sample, GlnK1 was not observed, therefore supporting the ionization suppression
postulation. To alleviate this problem, an online liquid chromatography ESI-FTICR-MS
experiment was performed to search for GlnK1 in the associated affinity purification
complex of the nitrogen fixing sample. This LC-FTICR-MS experiment allowed for
partial chromatographic separation of the GlnK2 (all isoforms) from GlnK1, and
provided evidence that GlnK1 was present in this sample (Figure 5.8). Even though the
chromatographic separation of GlnK1 was incomplete from GlnK2, there was distinct
evidence for unmodified GlnK1, as well as all four isoforms of GlnK2 in this sample.
The GlnB protein was not observed in the LC-FTICR-MS or ESI-FTICR-MS
experiments; this could be due to the low abundance or weak affinity of GlnB associated
with GlnK2 in the affinity purification. The first peak eluting in the chromatogram is
ubiquitin, added as an internal standard.
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Figure 5.8: LC-FTICR-MS total ion chromatogram of GlnK2 affinity isolation showing
the GlnK1 protein as well as all four forms of the GlnK2 protein. The first peak in the
chromatogram (tr = 4.5min) is ubiquitin which was used as an internal standard for the
chromatography.

123

Bottom-up MS characterization of this nitrogen-fixing sample confirmed the
overwhelming presence of GlnK2 (100% sequence coverage with 20 unique peptides)
and GlnK1 (92.9% sequence coverage with 15 unique peptides). As before, the bottomup MS measurements indicated the presence of some other minor components in this
sample. The same DNA-binding protein Hu-alpha (RPA 2953) and the GlnB regulatory
protein were each detected at a fairly low level. A few other species, primarily ribosomal
proteins, were detected with single peptide hits, but were not considered to be definitive
enough for identification. Bottom-up analysis also confirmed the presence of two unique
uridylylated peptides from the GlnK2 complex under nitrogen fixing growth conditions.
Each of these two peptides contains tyrosine- 51, which was suspected to be the
uridylylation site in GlnK2. Peptides 48-GAEY*AVSFLPK-58 and 48GAEY*AVSFLPKIK-60 were present with high DBDigger scores, of 58.9 for a +2 and
34.0 for a +1, and abundant ion intensities. The MS/MS spectrum of peptide 48GAEYAVSFLPK-58 is shown in Figure 5.9, with the b and y fragmentation ion series
labeled within the mass spectrum. This MS/MS spectrum shows unambiguously that the
tyrosine residue within the peptide contains the uridylylation, which adds a mass shift of
306.02 Da. Inspection of all the other peptides failed to reveal a tyrosine uridylylation at
any other position. Also present in the MS/MS were GlnK2 peptides containing tyrosine51 that were not modified with the uridylylation. These finding are consistent with the
observation of the unmodified form of GlnK2 in the top-down mass spectra. There were
no uridylylated peptides found for GlnK1 within the GlnK2 affinity purification,
verifying the top-down data that this protein is unmodified.
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Figure 5.9: MS/MS spectrum of uridylylated peptide 48-GAEY*AVSFLPK-58. The
spectrum has the b and y ions labeled showing the uridylylation on tyrosine 51 (y8 and b4
ions).
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Even though the bottom-up MS measurements verified the presence of both
uridylylated Y-51 and non-uridylylated Y-51 peptides for GlnK2, this technique did not
provide further details about which of the four isoforms was present or whether all were
present. Top-down analysis of the GlnK2 modification state proved to be the most
valuable and efficient way of confirming the presence of the multiple isoforms.
By combining the top-down and bottom-up mass spectrometry approaches, it was
possible to determine not only the unique site of uridylylation in GlnK2, but also the
range of isoforms present under nitrogen-fixing growth conditions.
In both the LC-FTICR-MS and ESI-FTICR-MS experiments of the GlnK2 affinity
purification, GlnK2 under nitrogen fixing growth conditions was observed to be
uridylylated in this affinity purification. Therefore, GlnK2 seems to play a key role in the
regulation of nitrogen availability in R. palustris and activation of the AmtB ammonium
transporter. This mechanism of AmtB regulation is different from other well
characterized systems such as E. coli where the primary regulation site is GlnK1. Also R.
palustris differs from other bacterial species in that it encodes three pII proteins
providing additional regulation sites for the bacteria within the glutamine synthetase
pathway.
GlnK1
Affinity purifications of GlnK1 from R. palustris, grown under nitrogen fixing
conditions, revealed the presence of two isoforms for both GlnK1 and GlnK2, as shown
in Figure 5.10. As expected, the unmodified tagged version of GlnK1 is present;
however, it also is accompanied by the uridylylated version of the tagged protein, as well
as the unmodified GlnK2 and the uridylylated untagged version of this protein.
126

GlnK2 + Uridylylation

GlnK1 + Tag +Uridylylation

GlnK2

GlnK1 + Tag

Figure 5.10: ESI-FTICR mass spectrum of GlnK1 affinity purification from R. palustris
grown under nitrogen fixing conditions. The unmodified and modified tagged (tag refers
to 6X His-tag and V5 antibody tag) GlnK1 isoforms are present in the growth state as
well as the unmodified and modified isoforms of GlnK2.
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The presence of untagged and modified GlnK2 again is due to the multimeric form of the
complex [102]. Thus, the expression of GlnK1 under these growth conditions will yield
both tagged and untagged versions of this protein. The affinity purification targets the
tagged GlnK1, which will bring down the other components of the multimer. This
mixture of GlnK1 and GlnK2 isoforms from this affinity purification may indicate that
under nitrogen fixing conditions GlnK2 plays a more primary role in the regulation of
AmtB. This is also supported by the lower abundance of GlnK1 in the GlnK2 affinity
purification under nitrogen fixing conditions. Once again, the high mass accuracy
afforded by the ESI-FTICR-MS provides the ability to confirm the molecular masses of
all the GlnK1 and GlnK2 isoforms by comparing them with the calculated masses.
Bottom-up data further confirms the top-down data with GlnK1 present at 73.2%
sequence coverage and 14 unique peptides. The GlnK2 protein is present at 92.0%
sequence coverage and 19 unique peptides within the same affinity purification. Bottomup analysis also confirmed the presence of two unique uridylylated peptides (48GAEY*IVNFLPK-58 and 41-GHTEIYRGAEY*IVNFLPK-58) for GlnK1 as well as
the unique uridylylated peptide 48-GAEY*AVSFLPK-58 from GlnK2.
GlnB
Affinity purifications of GlnB from R. palustris, grown under nitrogen fixing
conditions, revealed the presence of four isoforms of expressed GlnB, as shown in Figure
5.11. This affinity purification yields the unmodified tagged version of GlnB which is
also accompanied by the uridylylated version of the tagged protein, as well as the
untagged GlnB and the uridylylated untagged version of this protein.

128

GlnB + Tag + Uridylylation

GlnB + Uridylylation

GlnB + Tag

GlnB

Figure 5.11: ESI-FTICR mass spectrum of GlnB affinity purification from R. palustris
grown under nitrogen fixing conditions. Four different isoforms of GlnB proteins are
present in the growth state, including the tagged and untagged isoforms of the protein as
well as the modified and unmodified isoforms.
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It is again important to remember that GlnB exist in a trimeric form, therefore yielding all
four isoforms of the GlnB protein. Bottom-up MS data identifies GlnB at 50.7%
sequence coverage and 11 unique peptides. In the ESI-FTICR-MS experiments of the
GlnB affinity purification, only GlnB under nitrogen fixing growth conditions was
observed to be uridylylated. Therefore, GlnB may be a key regulation site of glutamine
synthetase in R. palustris. This mechanism of glutamine synthetase regulation is similar
to other well characterized systems such as E. coli where the primary regulation site is
GlnB.
Wild Type R. palustris GlnK1, GlnK2, and GlnB Analysis
In order to examine if the plasmid constructs that forced over-expression of
GlnK1, GlnK2, and GlnB would alter the normal state of the proteins, wild type R.
palustris cells were analyzed for the presence and modification state of the GlnK1,
GlnK2, and GlnB proteins. Wild type cells were grown under both photoheterotrophic
conditions as well as nitrogen fixing conditions, the cells were lysed and total protein was
extracted, FPLC anion exchange fractionation performed, and the resulting fractions were
analyzed by LC-FTICR-MS and LC-MS/MS. GlnK1and GlnB proteins were detected in
the cells grown under photoheterotrophic conditions, both in the unmodified forms.
GlnK2 was not observed under these conditions. For this growth condition, the most
abundant protein was GlnB, which may be indicative of endogenous expression under
non-nitrogen fixing conditions. The absence of GlnK2 expression and modification is
consistent with the growth state of the cells, which is anaerobic non-nitrogen fixing. The
bottom-up experimental results for the non-nitrogen fixing growth conditions revealed
GlnK1 at 38.4% sequence coverage and 3 unique peptides, and GlnB at 51.8% sequence
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coverage and 7 unique peptides. No peptides were observed for GlnK2, in accord with
the top-down MS results.
Under nitrogen fixing growth conditions, the GlnK2 and GlnB proteins were
identified in both the unmodified and modified states. The GlnK1 protein was not
observed under nitrogen fixing conditions. This observation is consistent with the
observations in the affinity purifications of higher GlnK2 expression under nitrogen
fixing conditions. These results provide evidence that plasmid constructs did not alter the
natural state of the complex.
Conclusions
The pII proteins, GlnK1, GlnK2, and GlnB, all appear to play an essential role in
ammonium and nitrogen regulation for R. palustris. Affinity purifications, in conjunction
with top-down mass spectrometry, permitted the isolation and characterization of the
functional state and isoforms for these proteins as a function of nitrogen availability.
Under non-nitrogen fixing conditions, all of these pII proteins are unmodified. Under
endogenous growth conditions, GlnB and GlnK1 are abundant, whereas GlnK2 was not
observed. Under nitrogen fixing conditions, all of these pII proteins are uridylylated, all
on the Tyr-51 positions. Thus, pII protein uridylylation appears to be tightly coordinated
with nitrogen availability. The presence of tagged and untagged protein isoforms also
provided evidence for the multimeric conformations of these species, thereby supporting
results obtained from E. coli that these proteins exist in trimers.
From this work, we conclude the GlnK2 is predominantly expressed and
uridylylated in R. palustris under nitrogen limited conditions, presumably to regulate the
AmtB transporter. Unmodified GlnK1 is abundant in non-nitrogen fixing conditions, but
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also is uridylylated under nitrogen-fixing conditions. As expected, GlnB is expressed as
an unmodified protein under non-nitrogen fixing conditions, while it also is uridylylated
under nitrogen-fixing conditions, likely regulating glutamine synthetase. By comparing
endogenous growth vs. affinity labeling conditions, we determined that the plasmid
construction did not alter the normal state of the proteins, suggesting that this
experimental protocol can be used to probe the natural modification conditions of such
proteins.
In this study, top-down mass spectrometry using FTICR-MS was found to be an
invaluable tool for determining the post translational modifications on the pII family
proteins, GlnK1, GlnK2, and GlnB, in Rhodopseudomonas palustris. By using a
combined technique of protein affinity purifications and mass spectrometry it was
determined, for the first time, that GlnK2, GlnK1 and GlnB proteins possess an
uridylylation under nitrogen fixing growth conditions in R. palustris. This information
allowed for a previously un-afforded glimpse into the modifications and isoforms of the
proteins that regulate the AmtB transporter and glutamine synthetase in R. palustris.
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Chapter 6
Computational Searching Algorithms Developed for Integrated Top-down and
Bottom-up Data for the Identification of PTMs
All of the data presented below is in preparation for submission Heather M. Connelly,
Robert L. Hettich, Chandrasegaran Narasimhan, Gary J. VanBerkel, Vilmos Kertesz.
Integrated Top-down and Bottom-up Protein and PTM searching: “PTMSearch Plus”
Analytical Chemistry (2006) All MS sample preparation, experiments, biological
knowledge behind programming, and final data analysis were performed by Heather M.
Connelly. Programming was performed by Vilmos Kertesz, post doc in OBMS group.
Introduction
One of the largest challenges in developing a top-down proteomics platform was
the development of a functional proteome informatics capability. At the start of this
dissertation, the ProSight [115] and PROCLAME [116] algorithms had been available for
the analysis of intact protein and their MS/MS spectra against protein databases as well as
PTM prediction. But no major effort had been made to integrate top-down analysis with
traditional enzymatic bottom-up analysis for protein identification and PTM analysis.
Integrating “top-down” and “bottom-up” MS-based proteomic strategies provides
a powerful tool to examine complex protein mixtures, such as proteins in multicomponent complexes or even complete proteomes. An integrated top-down and bottomup approach allows for a more comprehensive characterization of protein complexes due
to the unique strength of each technique. In an integrated approach, intact protein masses
from the top-down analysis corresponding to a particular PTM or isoform are able to be
compared to the comprehensive list of proteins provided by the bottom-up analysis. This
correlation between the two methods can provide PTM location and identity with more
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certainty. The comprehensiveness of this technique has been previously demonstrated in
studies of the Shewanella oneidensis proteome as well as the 70S ribosomal complex
from Rhodopseudomonas palustris [54, 35].
Current software searching tools can provide very good identifications from topdown protein data, as well as make predictions of possible PTMs on a protein. Examples
of these tools are ProSight PTM [115] and PROCLAME [116]. ProSight PTM [115]
combines a number of search engines and browser environments into a web application
that allows the user to analyze top-down data from proteins in the >10kDa size range.
This program uses intact protein masses and fragmentation masses from the intact
proteins to provide protein and PTM identifications. This method works well, although,
it requires the use of top-down dissociation methods such as infrared multiphoton
dissociation (IRMPD) and electron capture dissociation (ECD) that are not available to
all labs and may not be as comprehensive for complex mixtures as bottom-up methods
employing an enzymatic digestion. The PROCLAME algorithm uses intact protein mass
measurements to determine sets of putative protein cleavage and modification events to
account for the measured protein masses observed [116]. PROCLAME provide a good
prediction algorithm but is unable to incorporate mass spectrometry (MS/MS) data within
the process.
Our ORNL developed algorithm PTMSearch Plus is the first software providing a
comprehensive search method that allows for the integration of top-down protein
identification with the bottom-up peptide data to identify proteins and their associated
PTMs [Figure 6.1]. The software is built around multiple instrumentation platforms and
data inputs. These multiple instrumentation and data platforms include bottom-up ion
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Figure 6.1: Screen shot of PTMSearch Plus main data input screen.
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trap data, as well as top-down high resolution data such as FT-ICR data. The software
can perform independent top-down or bottom-up searches, as well as these two parts of
the program being able to interact. By combining these two search capabilities, the results
from the top-down search can limit the number of the proteins that are used to generate
the database used for the bottom-up search (search time decrease) and in return, the
results of the bottom-up search can be used as a confirmation for the proteins with
associated PTMs found in the top-down search. This integration reduces the search time
dramatically, allowing the user to search for more PTMs on proteins and peptides during
a reasonable time frame. The power of this integrated search method is demonstrated
using data from analysis of a protein standard mixture and a complex Rhodopseudomonas
palustris ribosomal protein mixture.
Methods and Software
System Requirements.
PTMSearch Plus was developed using Delphi 3 computer language (Borland
Software Corp., Scotts Valley, CA) under Microsoft© Windows XP Home Edition
(Microsoft Corp., Redmond, WA) operation system and can be run in any 32-bit
Windows environment with at least 256 MB RAM. Currently, the program is free to use
for any government or educational institute.
Methodology.
PTMSearch Plus currently supports seven search options allowing the user to
perform:
•

a standalone “top-down” search

•

a standalone internal “bottom-up” search
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•

MASPIC [117], “bottom-up” search

•

an integrated “top-down” and “top-down predicted” internal “bottom-up” search
with PTM/peptide limitation

•

an integrated “top-down” and “top-down predicted” MASPIC “bottom-up” search
with PTM/peptide limitation

•

an integrated “top-down” and “top-down predicted” external “bottom-up” search
(e.g. accomplished by DBDigger [118] or Sequest, etc.)

•

integration of “top-down” search results with already-made DTASelect [61]
“bottom-up” search result files

These search options are discussed in details below.
Defining a PTM.
PTMSearch Plus allows for the user to define any number and kind of PTMs
without any restrictions. When a PTM is defined, the following parameters must/can be
specified: (a) a 3-letter unique ID that is used to identify the PTM; (b) maximum number
of the specific PTM that a protein can have; (c) average mass of the PTM (used in topdown search); (d) exact mass of the PTM (used in bottom-up search); (e) if the PTM is
used in the bottom-up search (e.g. disulfide bond formation is not used in bottom-up
search); (f) "offset": if the specific PTM should be used when calculating the precursor
ion's mass but should be removed when calculating the mass of the fragment ions (e.g. it
allows the user to search for labile PTMs such as phosphorylation that is removed from
tyrosine, histidine, and serine in the ion trap prior/during fragmentation); (g) location of
amino acid that is modified (C-, N-terminal or any location on the peptide); (h) number of
amino acids that can have the specific PTM; (i) amino acids that can have the specific
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PTM; (j) maximum number of the PTM that the amino acids can have (e.g. in the case of
methylation; it can be 3 for arginine and lysine, or set to less) and (k) if the C- or Nterminal amino acid can have the PTM independent from the type of the amino acid (e.g.
acetylation can occur on the N-terminal amino acid beside every arginine and lysine
residues). The user may define and save many PTMs into a dataset and is still able to
select a sub-group of PTMs that are used in the actual search.
Standalone “Top-Down” Search
Prior to performing a standalone “top-down” search (Figure 6.2), the user has to
generate a peak list for each spectra from the raw experimental data. A Visual Basic
script was written that extracts out all the average mass peaks (calculated by the IonSpec
software) from across a selected region of the ion chromatogram, and saves them to a file
with DCP extension (deconvoluted peaks). From the DCP files that have been generated,
the user is able to select the DCP files to be searched through. The user is able to
accomplish searching using the same searching conditions on an unlimited number of
DCP files in one software run without user intervention by selecting a directory
containing the DCP files of interest. Also needed, prior to starting the top-down search,
is a specified FASTA protein database; giving the user the ability to search against any
annotated organism, combination of organisms or subset of proteins. The user also has
the ability to limit the top-down search to the deconvoluted peaks which meet certain
criteria: (a) the m/z of a deconvoluted peak must be larger than the preset threshold value
(3000 Da by default); (b) minimum number of isotopic peaks deriving a deconvoluted
peak (3 by default);
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Figure 6.2: Flow chart of the top-down searching method within PTMSearch Plus.
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(c) FFT size and (d) apodization settings used to generate the spectra resulting in the
deconvoluted peak must be selected in the program. Also, the user has the ability to
specify the conditions for a match to the deconvoluted peak found in a top-down
spectrum: (a) maximum difference between the m/z of a deconvoluted peak and that of
the calculated m/z of the PTM protein, and (b) maximum number of PTMs on the protein.
Standalone "Bottom-Up" Search
Built into the PTMSearch Plus program is a simple internal bottom-up searching
algorithm that is based on the presence and intensity of b- and y-ions in the spectrum.
The scoring mechanism is not discussed here in more detail as it was implemented only
to demonstrate the power of the integrated top-down and bottom-up searches, such as
how limiting the number of peptides to search against in a bottom-up run can drastically
reduce search time. PTMSearch plus is designed to allow for the user to use a scoring
algorithm of their choice at any time. To demonstrate the ability to implement different
scoring algorithms, we implemented the MASPIC scoring algorithm [117] within the
software. When using either the internal or the MASPIC standalone bottom-up search,
the user must (a) define the number of missed tryptic cleavages; (b) maximum number of
PTM a peptide can have (see below); (c) minimum and (d) maximum mass of the tryptic
peptide; (e) minimum number of amino acid residue a peptide must have (to exclude
short peptides from the search that are normally not unique for a protein); (f) the
maximum difference between the peptide and the precursor ion's mass to search the
corresponding MS/MS spectra against the b and y fragment ions of the peptide, and (g)
the maximum difference between the m/z of a peak in the MS/MS spectrum and that of
the b and y ions of the peptide to be used in the scoring.
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Integrated "Top-Down" and "Bottom-Up" Search
Figure 6.3 shows the simplest approach to integrate "top-down" and "bottom-up"
searching algorithms in general. In this case, "top-down" and "bottom-up" data are
searched independently and the results are compared. This approach is considered to be a
complete search, as all proteins (and their possible PTMs) are checked against the two
different datasets. Figure 6.4 shows a different approach, that is implemented in
PTMSearch Plus to integrate "top-down" and internal or MASPIC "bottom-up" search
algorithms. First, a "top-down" search is accomplished, followed by assigning all
combination of possible PTMs found to that particular protein. E.g. if protein 1 was
found with three different PTMs in the "top-down" search: 2 methylations; 4
methylations and a β-methythiolation; then all possible combinations of these PTMs are
assigned to protein 1. The assigned PTM represents the most complex set of PTMs that a
single peptide of the given protein can have. At this point the user has two options: I.)
creating peptide sequences exclusively from the proteins found in the "top-down" search
using their individually assigned PTMs, or II.) creating peptide sequences from the
proteins found in the "top-down" search using their individually assigned PTMs as well
as from proteins not found in the "top-down" search using their intact (non-modified)
sequence. Each method may drastically decrease the number of peptide sequences used
in the "top-down predicted" (i.e. peptide sequences are generated based on the results of
the "top-down" search) "bottom-up" search.
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Figure 6.3: Flow chart of simple integration of independent "top-down" and "bottom-up"
searching algorithms.
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Figure 6.4: Integrated approach of PTMSearch Plus that is able to combine "top-down"
and "bottom-up" searching algorithms.
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Current "bottom-up" search engines (e.g. Sequest, DBDigger etc.) don't have the
possibility to limit the number of PTMs in a single peptide to a reasonable level that
could be considered acceptable from a chemical viewpoint [62, 118]. If a peptide has
nX=4 arginines, and arginines can have mono-, di- or tri-methylation (pX=3), then it
results in 256 peptide candidates each with different PTMs. Generally, peptides with 0, 1
or 2 PTMs could be found. For this reason, it seemed to be practical to let the user limit
the number of possible PTMs on a single peptide (m) in the software to reduce the
searching time. Using the example above, (nX=4, pX=3) the number of the different
peptide candidates is 13 or 67, using m=1 or m=2, respectively. This simple example
clearly demonstrates that the number of PTM peptide candidates, and the time necessary
to search them against the experimental "bottom-up" data, can be (drastically) reduced by
limiting the number of PTMs that a single peptide can have based on simple chemical
viewpoint and our experimental experience. The reduction in the number of peptide
candidates, by limiting the maximum PTM/peptide, is even more drastic when different
PTMs are assigned to different amino acids (e.g. methylations to arginine and lysines, βmethythiolation to aspartic acid, etc.). Bottom-up inputs are also available for Sequest
[62], DBDigger[118], and DTASelect[61] text files, however, the advantages of "topdown" predicted "bottom-up" search cannot be utilized in these cases.
Methods
All proteins, salts, and buffers were obtained from Sigma Chemical Co. (St.
Louis, MO). Sequencing grade trypsin was purchased from Promega (Madison, WI).
Formic acid was obtained from EM Science (affiliate of Merck KGaA, Darmstadt,
Germany). HPLC-grade acetonitrile and water were used for all LC-MS-MS analyses
144

(Burdick and Jackson, Muskegon, MI). Ultrapure 18 MΩ water used for sample buffers
was obtained from Millipore Milli-Q system (Bedford, MA). Fused silica capillary
tubing was purchased from Polymicro Technologies (Phoenix, AZ).
Preparation of Protein Standard Mixture and Rhodopseudomonas palustris Ribosomal
Proteins
In this study, all prepared samples were divided into two portions. One portion
was examined by 1D LC-MS-MS bottom-up mass spectrometry and the other portion of
the sample was examined using LC-FT-ICR-MS for top-down mass spectrometry. By
correlating the two data sets, using PTMSearch Plus with the same sample, it was
possible to identify the proteins, but also to characterize PTMs on the proteins.
Five proteins were used in a five protein mixture: ubiquitin (MW 8 kDa), chicken
lysozyme C (MW 14 kDa), bovine ribonuclease A (MW 13 kDa), bovine carbonic
anhydrase II (MW 29 kDa), and bovine beta lactoglobulin-B (MW 18 kDa). The proteins
were dissolved in HPLC grade water to give a final concentration of 1 mg/mL of each
protein, and diluted as required for the analysis. The PSM mixture was digested for
bottom-up analysis with sequencing grade trypsin added at 1:20 (wt/wt) of enzyme to
protein. The digestions were run with gentle shaking at 37 °C for 12 hours. Samples
were immediately desalted with an Omics 100 µl solid phase extraction pipette tip
(Phenomenex, Torrance, CA). All samples were frozen at -80°C until LC-MS/MS
analysis.
70S ribosomes from R. palustris were purified and fractionated using a high salt
sucrose cushion and sucrose density fractionation as previously described [119]. For
bottom-up analysis acid extracted [120] ribosomal proteins were denatured and reduced
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in 6M guanidine HCl, 50 mM Tris-HCl (pH 7.6), with 10 mM DTT at 60 °C for 45
minutes. Afterward, the proteins were digested with 1 µg trypsin overnight at 37 °C.
Remaining disulfides were reduced with 10 mM DTT at 60 °C for 45 minutes. To
perform top-down analysis the ribosomal samples were neither reduced nor digested.
Results and Discussion
Protein Standard Mixture
A five protein standard mixture consisting of ubiquitin, lysozyme, ribonuclease A,
β-lactoglobulin B, and carbonic anhydrase was evaluated with PTMSearch Plus. The
protein standard mixture served as a training set to evaluate the performance of the
program with an initial simple mixture. To begin the search of the five protein standard,
using PTMSearch Plus, a combined top-down and bottom-up search was selected using
both the built in simple bottom-up searching method, as well as the top-down and
external search option using the DBDigger program as described above [118]. Both
programs were used in order to validate the simple built in bottom-up searching method
with a known external bottom-up search algorithm to ensure both data sets corresponded.
A directory comprising text files from the top-down data obtained from scripting
methods by selecting data rich regions across the total ion chromatogram, as well as a
directory of the MS2 files generated from the raw bottom-up MS/MS data files, was input
for the five protein search. These data directories can be selected from browser tab at the
input sites within the software main screen. Once the appropriate data directories were
loaded, a list of PTMs to be searched was input. Within all searches of the protein
standard mixture, the only specified PTMs were disulfide bonds and methionine
truncation. These two PTMs were selected due to the intact proteins used containing
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these modifications. A feature of the PTM function within PTMSearch Plus is the ability
to perform certain smart PTM searches (Figure 6.3). For example, the program looks for
the number of cystines within a protein and will not allow for more disulfide bonds to be
formed than there are cystines to support.
All searching was performed with a database composed of the five proteins, as
well as common contaminants to give a total of 43 proteins within the database. Topdown specifications included a maximum mass difference of one dalton and a minimum
of three peaks within the isotopic package. Also used in the top-down search
specifications were all three FFT data sizes (128, 256, 1024K), and apodization both on
and off. For the bottom-up search parameters, a peptide can have a maximum of two
missed cleavages, a maximum of two PTMs on a peptide, a minimum of 5 amino acids
within a peptide, and a minimum mass of 400 Da and maximum mass of 6000 Da.
Of the five proteins searched for within the mixture, four could be identified both from
the intact protein data, as well as having supporting peptide data from both bottom-up
search types. The identified four proteins with corresponding top-down and bottom-up
data included ubiquitin, lysozyme, ribonuclease A, and β-lactoglobulin-B. Carbonic
anhydrase is a 29 kDA protein that is difficult to elute from the C4 reverse phase column
used in the top-down analysis. Therefore, carbonic anhydrase was identified in the
bottom-up searching but not in the top-down data.
Post translational modifications in the form of disulfide bonds were identified on
three of the proteins in the integrated search. These included lysozyme with two
disulfide bonds, β-lactoglobulin B with two disulfides, as well as ribonuclease A with
multiple isoforms and disulfide bonds. Also identified was ubiquitin with a methionine
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truncation. All of these modifications were expected due to the use of purchased protein
stocks with these known modifications. These modifications were previously known,
however, PTMSearch Plus was able to identify them without any prior inputs into the
software indicating their presence.
Rhodopseudomonas palustris Ribosomal Proteins
In a recent study by Strader et al. top-down and bottom-up characterization of the
ribosome from R. palustris was performed. In this study 53 of the 54 orthologs to the E.
coli ribosomal proteins were identified by bottom-up analysis, and 42 intact protein
identifications were obtained by the top-down approach [54]. Following top-down mass
measurement, the authors used a manually created intact protein look-up table that
contained intact molecular masses, methionine truncated molecular masses, and all
possible combinations of methionine truncation with single acetylation and multiple
methylations, up to 9, for the entire suit of 54 possible ribosomal proteins. After bottomup measurement, the authors used SEQUEST [62] to identify peptides with no
modifications. Next, numerous single searches of the data using SEQUEST with
individual possible PTMs was performed. Once the identifications from both the topdown and bottom-up approach were generated, they were then compared to one another
manually to provide conformation of both methods. This manually inspected data set
yielded a test set for PTMSearch Plus to test the program with a complex mixture. Since
PTMSearch Plus is able to take the top-down intact protein data and the bottom-up
MS/MS data and combine them into one single search, thereby eliminating the time
consuming manual search and conversion of data, the time to search both raw data sets
took only minutes as compared to months for the manual conversion.
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When performing the searches with PTMSearch Plus, a combined top-down and
bottom-up search was performed, using both the built in simple bottom-up searching, as
well as the top-down and external search option using the DBDigger program. Top-down
search specifications included a maximum mass difference of one dalton and a minimum
of three peaks within the isotopic package. Also used in the top-down search
specifications was all three FFT data sizes (128, 256, 1024K), and apodization both on
and off. For the bottom-up search parameters, a peptide can have a maximum of two
missed cleavages, a maximum of two PTMs on a peptide, a minimum of 5 amino acids
within a peptide, and a minimum mass of 400 Da and maximum mass of 6000 Da.
Within all searches of the complex ribosomal mixture, the only specified PTMs were
methylations, acetylations, and methionine truncation. These PTMs were selected due to
the initial study using these modifications, therefore, our search results could be directly
compared to the manual results published in the study.
Using PTMSearch Plus, we were able to identify all of the 53 identified by
bottom-up analysis, and 42 intact protein identified by the top-down approach within the
Strader et al. study [54]. PTMSearch Plus is able to output the proteins identified by
bottom-up only, top-down only, and a list of measured intact proteins, with or without
PTMs, that have confirming bottom-up data. The examine matches interactive output
selection, loads a graphical display showing the identified protein with its corresponding
identified peptide and PTMs. This function is able to filter the results with a number of
different options to show only the top-down matches that have confirmation with bottomup data, delete duplicate proteins with the same PTMs, and delete duplicate peptides that
confirm the protein plus PTM. Once the results have been filtered, the user is able to view
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the identified proteins with their associated PTMs and peptides. Within the results view,
the protein name is shown, sequence of the peptides, the PTMs on the protein and the
peptides, as well as the b and y ion labeled ms/ms spectra of the peptide. These results
interfaces allow for the quick and easy viewing of results. When looking at the proteins
that contain supporting peptide data we find a total of 41 R. palustris ribosomal proteins.
This is consistent with the individual top-down and bottom-up data due to there only
being 42 identified top-down peaks to match peptides. The one unidentified top-down
peak is L36 where bottom-up could not provide any supporting peptides. These results
are consistent with what was seen in the Strader et al. study [54]. Figure 6.4 shows the
top-down and bottom-up data for ribosomal protein L33 as out put by PTMSearch Plus.
The L33 protein was identified with a methylation of the peptide AK*AVTIKIK by
bottom-up analysis. The mass of L33 with a methionine truncation and a methylation was
identified in the top-down searching. When PTMSearch Plus output the proteins that
have confirming peptide data L33 was shown [Figure 6.5].
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(A)

(B)

Figure 6.5: Integrated top-down and bottom-up results for the R. palustris L33 protein.
(A) Shown are the results lists from PTMSearch Plus with the labeled confirming
MS/MS spectrum from the bottom-up analysis. The sequence of the peptide is given
with the methylation labeled as MET within the sequence. (B) Shown is the top-down
spectrum of the intact protein with the de-methionation and a methylation.
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Conclusions
PTMSearch Plus provides a novel software for the integration of top-down and
bottom-up protein and PTM identification. The software allows for the use of multiple
data and instrument platforms to be combined. This methodology provides an integrated
top-down and bottom-up searching algorithm that is not only fast but accurate. The
software was demonstrated with a protein standard mixture and complex ribosomal
protein mixture. All proteins from the protein standard mixture, which was used as a
training set, could be identified using PTMSearch Plus. The R. palustris complex
ribosomal mixture was previously examined in an integrated fashion by manual
comparison. Using PTMSearch Plus all of the identified ribosomal proteins identified in
the previous study were identified in a fraction of the time. Both of these test cases
showed the power of the integrated approach, as well as demonstrating the accuracy and
speed of PTMSearch Plus.

152

Chapter 7
Identification of PTMs and Isoforms from the Versatile Microbe
Rhodopseudomonas palustris Under Three Metabolic States
All of the data presented below are in preparation for submission Heather M. Connelly,
Dale A. Pelletier, Vilmos Kertesz, Melissa Thompson, W. Judson Hervey, Tse-Yuan Lu,
Patricia K. Lankford, Gregory B. Hurst, Frank W. Larimer, and Robert L. Hettich Topdown Characterization of the Versatile Rhodopseudomonas palustris Microbe Under
Three Growth Conditions to Identify PTMs and Isoforms. Journal of Proteome Research
(2006). Judson Hervey a graduate student in the genome science and technology
program provided signal peptide database. All MS sample preparation, experiments and
data analysis were performed by Heather M. Connelly.
Introduction
Rhodopseudomonas palustris belongs to the α-proteobacteria, and is a purple
nonsulfur anoxygenic phototrophic bacterium found in diverse environments from fresh
water to soil. One of the unique features of R. palustris is its ability to grow and function
under many metabolic states. These states include: photoheterotrophic where energy is
obtained from light and carbon from organic carbon sources, photoautotrophic where
energy is from light and the main source of carbon is from carbon dioxide,
chemoheterotrophic where carbon and energy are from organic compounds, and finally
chemoautotrophic where energy is from inorganic compounds and carbon from carbon
dioxide [10, 11, 12, 13] (Figure 7.1). R. palustris has the ability to be a biofuel producer
by producing hydrogen gas as a byproduct of nitrogen fixation, as well as a greenhouse
gas sink by converting carbon dioxide into cell mass. Since most of these metabolic
states can easily be attained in laboratory settings, R. palustris is an ideal model system
for the study of diverse metabolic modes and their control within a single organism.
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Figure 7.1: Graphical representation of the core metabolic states of Rhodopseudomonas
palustris interrogated in this study. The top figure illustrates the basic anaerobic state for
photoheterotrophic growth in light without oxygen. The bottom figure illustrates the basic
aerobic state for chemoheterotrophic growth in the dark with oxygen present. The circle
in the center of the cell represents central metabolism. This figure was adapted from
Larimer et al. Nat. Biotechnol.2004, 22, 55-60.
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Recently, R. palustris has been sequenced revealing a 5.4 Mb genome with 4836
potential protein encoding regions [13]. This sequencing and annotation effort other
along with proteome profiling, protein-protein interaction studies, global gene knockouts
[14], and transcriptome profiling [15], will provide a detailed systems biology
characterization of this microbe. A study of the baseline proteome of an R. palustris
wild-type strain under phototrophic and chemotrophic growth conditions, including
variants of each state, was recently completed providing a starting point for
understanding this microbe’s protein diversity [121].
The goal of this study was to provide the first comprehensive intact protein or
“top-down” characterization of R. palustris. Intact protein or Top-down mass
spectrometry can be used to provide intact protein identification as well as insight into
protein modification states, to ascertain the role individual proteins play in the complex
metabolism states of R. palustris. This powerful method can provide information on the
natural state of intact proteins, including details about post-translational modifications
(PTM’s), truncations, mutations, signal peptides, and isoforms due to top-down mass
spectrometry’s ability to measure the molecular weight of a protein very accurately and
detect any covalent modifications that alters the mass of a protein.
The more common peptide or “bottom-up” mass spectrometric approach involves
enzymatic digestion of intact proteins with a protease to generate a peptide mixture.
However, bottom-up methods provide a comprehensive list of proteins, vital information
about post translational modifications may be missed if the peptides containing the
particular modification escape detection. Furthermore, identifying peptides that come
from a complex protein mixture may not provide information on the presence of different
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isoforms (variations of a protein that may include different states of PTMs) that may exist
for a particular protein.
An integrated top-down and bottom-up approach allows for a more complete
characterization of proteins due to the unique strengths of each technique. In an
integrated approach, intact protein masses from the top-down analysis corresponding to a
particular PTM or isoform are compared to the comprehensive list of proteins provided
by the bottom-up analysis. This correlation between the two methods can provide
information on PTM location and identity, as well as verifying gene start sites within the
genome annotation with more certainty. The comprehensiveness of this technique has
been previously demonstrated in studies of the Shewanella oneidensis proteome as well
as the 70S ribosomal complex from Rhodopseudomonas palustris [54, 35]. Combing the
strengths of two important mass spectrometric techniques such as “top-down” and
“bottom-up”, proteomic strategies provides a powerful tool to examine proteins from
selected growth states of R. palustris.
Three growth states of R. palustris were interrogated with this integrated topdown and bottom-up approach. These three growth states consist of two categories:
aerobic growth in the dark (chemotrophic) and anaerobic growth in light (phototrophic).
The main growth state was the anaerobic photoheterotrophic growth mode, with light
providing the energy, organic carbon in the form of succinate providing the carbon source
for cell material, and ammonia serving as the nitrogen source. The second growth state
examined was a variant of the photoheterotrophic growth mode in which nitrogen
fixation is performed. In this state, nitrogen gas was substituted for ammonia as the
nitrogen source forcing the cells to fix nitrogen. The final growth state examined was the
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aerobic state or chemoheterotrophic growth state, in which cells were grown aerobically
in the dark, with succinate as both the carbon and energy source, and nitrogen serving as
the ammonia source. These three growth conditions provided an opportunity to examine
both intact proteins and how post translational modifications (PTMs) from R. palustris
play a role in the complex metabolic processes carried out by this organism.
This study provides the first large-scale characterization of these three growth
states of R. palustris by an integrated top-down and bottom-up approach. This global
measurement strategy can provide information on intact proteins, including PTMs,
isoforms, and signal peptides from a given growth state. This technological approach
provides information on the function and location of proteins, as well as providing
confirming peptide MS/MS data. This tool is especially powerful when determining what
modification states play a role in the switch between different growth conditions,
characterizing known and unknown proteins, and determining trends within protein
expression across the chosen metabolic states.
Material and Methods
Chemicals and Reagents
All salts, buffers, dithiothreitol (DTT), guanidine HCl, trifluoroacetic acid, phenyl methyl
sulfonyl fluoride (PMSF), were obtained from Sigma Chemical Co. (St. Louis, MO).
Sequencing-grade trypsin was purchased from Promega (Madison, WI). Formic acid was
obtained from EM Science (Affiliate of Merck KgaA, Darmstadt, Germany). HPLC
grade acetonitrile and water were used for all LC-MS analyses (Burdick & Jackson,
Muskegon, MI). Ultrapure 18 MΩ water used for sample buffers was obtained from a
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Millipore Milli-Q system (Bedford, MA). Fused silica capillary tubing was purchased
from Polymicro Technologies (Phoenix, AZ).
Cell Growth and Protein Fractionation
R. palustris strain CGA010, a hydrogen-utilizing derivative of the sequenced
strain (unpublished C. S. Harwood) and referred to here as the wild-type strain, was
grown under the three conditions outlined in the Introduction section. Wild type R.
palustris cells were grown anaerobically in light or aerobically in dark on defined mineral
medium at 30 °C to mid-log phase (OD 660 nm = 0.6). Carbon sources were added to a
final concentration of 10 mM succinate, 10 mM sodium bicarbonate. For the
photoheterotrophic N2 fixing cultures, ammonium sulfate was replaced by sodium sulfate
in the culture medium and N2 gas was supplied in the headspace. Chemoheterotrophic
cells were grown aerobically in the dark with shaking at 200 rpm; phototrophic cells were
grown anaerobically in the light with mixing with a stir bar. All anaerobic cultures were
illuminated with 40 or 60 W incandescent light bulbs from multiple directions. 4-5 liters
of cells were grown for all three states and pooled together for each state. The cell pellet,
obtained by centrifugation at 1000 X g for 10 minutes, from each growth state was
French Pressed to yield 60-120 mg of protein for each of the three growth states. Cell
extract was centrifuged at 10,000g for 35 minutes in a Sorvall centrifuge to remove all
unbroken cells. Protein extract was used for off-line anion exchange FPLC fractionation.
To perform off-line anion exchange chromatography 60 mg of protein was injected onto
a 5 ml HiTrap (HiTrap SP HP, Amersham Pharmacia) ion exchange column connected to
an AKTA (Amersham Pharmacia) FPLC system. After protein injection, a 30 minute
ammonium acetate gradient was run from 0.2 M to 2 M. Twenty fractions from each
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growth state (total of 60 from 3 growth states) were determined to have sufficient protein
concentrations (400 µg) by a Bradford protein assay. Each FPLC fraction obtained was
then divided into two equal protein concentration portions. One portion was examined by
1D LC-MS-MS bottom-up mass spectrometry and the other portion of the sample was
examined using LC-FTICR-MS for top-down mass spectrometry. All fractions were
analyzed with 1X coverage with top-down methods due to the proteins precipitating upon
freezing. Bottom-up analysis was performed with 2X coverage on all fractions.
Data Analysis
All resulting top-down and bottom-up data sets were analyzed with two methods.
In the first method, the SEQUEST algorithm was used to identify MS-MS spectra with
their counterparts predicted from a protein sequence database [62]. For all database
searches, an R. palustris proteome database was used, which contained 4,833 proteins
and 36 common contaminants. All resultant output files from SEQUEST were filtered by
DTASelect [61] at the 1-peptide, 2-peptides and 3-peptides level with the following
parameters: SEQUEST, delCN of at least 0.08 and cross-correlation scores (Xcorrs) of at
least 1.8 (+1), 2.5 (+2) and 3.5 (+3). Once filtered the results were analyzed by Contrast
[61] for comparison. In the second method, integrated top-down and bottom-up
searching was performed with the PTMSearch Plus software developed at Oak Ridge
National Laboratory. Output files containing bottom-up data from PTMsearch Plus were
filtered by DTASelect [61] at the 2-peptides level with the following parameters:
MASPIC [118], scores of at least 23 (+1), 28 (+2) and 43 (+3). The output files
containing top-down data were filtered with at least three peaks within the isotopic
package, a 3000 Da mass cutoff and a relative abundance of at least 10%. The
159

PTMSearch Plus program allows for the combined searching of both the top-down and
bottom-up data sets, as well as allowing for the searching of a defined set of PTMs. In
the integrated top-down and bottom-up data searches a standard set of PTMs were
searched for including: methylation, acetylation, de-methionation, and disulfide bonds
(restricted to top-down data). Less common PTMs such as uridylylation were searched
individually. All data outputs generated were manually inspected and then compared
using Microsoft Access (Microsoft Corp., Redmond, WA).
Results and Discussion
Approximately twenty fractions were obtained from the off line FPLC separation
of the protein lysate from each of the three anaerobic, nitrogen fixing, and aerobic growth
states. Off line FPLC was used to separate the large complex mixtures of proteins from
the three growth states for top-down analysis, due to its proven ability to reduce down the
complexity of the mixture. Therefore, by reducing the complexity of the protein mixture,
this method allowed for better separation from the on-line HPLC methods employed, as
well as more comprehensive protein identifications. Top-down methodologies are a
powerful tool, but some limitations do exist such as on-line chromatography of intact
proteins is difficult due to the wide range of protein sizes and hydrophobicities within the
complex mixtures used. This method of off line FPLC fractionation followed by on line
HPLC takes a large amount of protein starting material (in the milligram range),
although, this is not of great concern due to the ability to produce more than enough
material (~120 mg) from the 4 liters of culture from each growth state. Another area of
concern using this strategy is the loss of protein during the off line separation. This
problem is unavoidable, due to the need to have a prior separation of the complex protein
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mixture before the top-down analysis. By providing this initial separation step with
FPLC, we increase the overall ability to analyze and identify more proteins than with no
initial separation. We have found this technique of off line fractionation followed by on
line HPLC, to be highly reproducible and simple to implement for a large-scale study of
multiple samples [35].
Each data set generated with the integrated top-down bottom-up approach was
searched with PTMSearch Plus, which combined the top-down and bottom-up data set
searches to provide positive identifications of both proteins and their associated PTMs.
PTMSearch Plus is a new search algorithm developed at Oak Ridge National Laboratory
(ORNL), which provides the first integrated top-down and bottom-up searching
algorithm that allows the user to select the number and types of PTMs they wish to search
for. As well as the integrated searching approach, all bottom-up MS/MS data sets were
searched with SEQUEST [62], filtered with DTASelect [61], and compared with Contrast
[61]. Since SEQUEST is a proven search tool within the community; the search results
from SEQUEST were used to manually verify the outputs from PTMSearch Plus were
accurate. The results from the integrated top-down and bottom-up searches for all three
growth states allowing up to 10 methylations, 2 acetylations, N-terminal methionine
truncation, and disulfide bonds on the intact proteins are shown in Table 7.1. These
PTMs and amounts were used for searching due to biological constrains and to keep the
search space and results manageable. For example, only one N-terminal methionine
truncation can be present on a protein and the number of disulfide bonds is restricted to
the number of cysteines present within the protein sequence. Also shown in Table 7.1 are
the results for the SEQUEST searches of the bottom-up MS/MS data with no specified
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Table 7.1: Number of identified proteins from all three searching methods.
Growth Condition
Anaerobic
Nitrogen Fixing
Aerobic
a
b
c

PTMSearch Plus
TDBU PTM a
119
214
426

PTMSearch Plus
BU PTMs b
853
785
1373

Total Non-Redundant Proteins Identified
599
Top-down and bottom-up searching with PTMs performed with PTMSearch Plus

Bottom-up searching with PTMs performed with PTMSearch Plus
Bottom-up searching performed with SEQUEST and no PTMS
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1908

SEQUEST BU
no PTM c
465
295
512
713

PTMs and the PTMSearch Plus bottom-up results allowing for the PTMs listed above.
There were more proteins identified using the bottom-up searching containing PTMs. The
identification of more proteins with the PTMSearch Plus program is due to the ability to
confidently identify MS/MS spectra from a peptide containing PTMs. These MS/MS
spectrum would have been unidentified in the SEQUEST program. This is due to the
inability of SEQUEST to perform searches with multiple modifications specified.
Therefore, using PTMSearch Plus provides more comprehensive identifications for the
data set. One method used to ensure our searches were identifying proteins correctly was
to examine some of the common proteins that one would expect to find, such as
elongation factors, chaperonin GroES, and nitrogen regulatory proteins. Table 7.2
provides a list of these expected proteins found in both the top-down and bottom-up data
sets. The percent sequence coverage of the protein from the bottom-up data is provided
in Table 7.2 as well as the ppm error from the top-down data.
Both the top-down and bottom-up data sets were evaluated separately and in an
integrated approach within this study. Tthe bottom-up method provides a confident list
of proteins, using MS/MS data, but there are instances where bottom-up is unable to
provide identifications. These proteins missed with the bottom-up method are generally
very amenable to the top-down approach, due to the proteins being within a size range
that works well for top-down measurements (3-15 kDa). Generally, the unidentifiable
proteins from bottom-up are small in size or have very few tryptic sites. Small proteins
when digested form peptides that are too small to be seen within the mass spectrometer
(less than 400 Da).
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Table 7.2: Expected proteins and their percent sequence coverage and mass accuracy.
Gene
Number
RPA3053
RPA3672
RPA2513
RPA1141
RPA2165

Category
Transcription
Transcription
Translation
Cellular Processes
Cellular Processes

RPA2966

Signal Transduction

Product
Cold Shock Protein
Cold Shock Protein
Elongation Factor P
Chaperonin GroES1
Chaperonin GroES2
GlnB Nitrogen Regulatory Protein
PII
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%
Sequence
Coverage
73.1
52.4
41
49
58.7

Mass
Accuracy
1.2
12
28.1
11.1
1.7

51.8

-4.1

Also, proteins with few tryptic sites generate peptides that are to large to be measured
with the mass spectrometers employed in bottom-up. Table 7.3 provides examples of
some of these proteins, where the tryptic peptides used are outside the 400-6000 Da range
generally seen in the bottom-up method, but were identified by top-down. Also, within
this study, positive protein identifications from bottom-up searching require two unique
peptides. In the cases presented in Table 7.3, some of these proteins do not have the
required two unique peptides for a positive identification. Therefore, top-down methods
alone are able to add another level of information above the identification of PTMs and
isoforms generally considered. Contained within the top-down data sets are proteins with
good isotopic resolution and mass accuracy, but are unidentified. These unidentified
proteins may be from degradation and truncation products or the result of missed start
sites within the protein annotation process.
Due to the focus of this research being to confidently identify intact proteins and
their associated PTMs, all data we will focus our biological analysis on will be from the
integrated TDBU data obtained for the PTMSearch Plus program. From the integrated
Top-down and bottom-up searching, a total of 599 non-redundant proteins were identified
from all three growth states [Table 7.4]. Table 7.4 shows all 599 proteins identified,
organized by functional categories. These 599 proteins include both proteins identified
with and without PTMs and all have bottom-up MS/MS confirmation.
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Table 7.3: Proteins not identified by bottom-up analysis that were identified by topdown.
Protein
RPA0214

RPA1952

RPA1773

RPA1085

Intact Mass
Peptides
8651.6691 1-MALGEPQEVPNDPGPVTPPPEVPPSTPGTPTEPPLEQPPGN
PNPDIPPPEEPGAPPQPNELPGQMPAEVPMQSPGR-77

7593.1835

Mass Peptide
7929.859

78-SVPNPGVA-85

739.827

1-TAELNILGVFVPTILICAAAAFILTSLVSR-30

3117.788

31-LLVWLNFYHLVWHHTLFNLTIFVVIVFVALGLVSGWPQ-68

4493.411

11366.5634 1-MK-2

277.388

3-WLYLLIAIVAEVVGTSALK-21

2059.521

22-ASQGFTVLLPSVLVVVGYGAAFYFLSLTLSSISVGIAYA
WSGIGIVLISAVGWLWFGQALDTAAIIGIAFIIAGVGIINFFSNVSAH-109

9065.685

14242.7461 1-MK-2

277.388

3-YAGILAAFALGASVAGADAGSLVYTPTNPAFGGS
PLNGSWQMQQATAGNHFNR-55

5297.859

56-AAPTSGPQQLTQSQIFAQQLQSQLYASLANQVT
QAIFGANAQQSGTFSFQGTTISFAK-113

6108.735

114-VDGQTNITINDGSTVTQISLPTVTH-138

2611.847
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Table 7.4: All 599 proteins identified from the three growth states of R. palustris
Gene
Number

Aerobic

Anaerobic

Nitrogen
Fixing

RPA0008 10127.686a, S
RPA0010 18760.967, S

b

10086.001, Wd

RPA0036 17908.472, W
RPA0038
RPA0039

13314.382, Mc
7457.667, S

RPA0040 21979.05, S
RPA0052

16447.565, M

RPA0054
RPA0059

15894.144, W
43156.031, M

RPA0090 15149.266, W
RPA0092 10019.455, W
RPA0155

16656.413, M

RPA0158 13359.566, S
13359.564, M
RPA0159 9477.775, S
9463.792, S
22277.636, S

RPA0160
RPA0177 32018.782, W
RPA0179 19541.781, W
RPA0203 20990.138, M
RPA0207 13656.301, S

13699.846, M
RPA0222

19744.263, M

RPA0224 28876.763, S
RPA0233 31223.309, S
RPA0235 22365.940, M
22366.559, M
22366.103, S
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PTMs

BU
Protein Annotation
Seq.
Cov.e
1xDEM-3xMET 30 circadian clock protein
1xDEM
4xMET
transcriptional regulator,
probable glutamate
conserved unknown
protein
1xMET
70 ribosomal protein L20
1xDEM-3xMET 27 50S ribosomal protein
L35
4xMET
21 translation initiation
factor IF-3
1xDEM-4xMET
putative nitrogen
regulatory IIA
protein(enzyme
1xDEM-3xMET 12 putative small heat shock
protein
1xDEM-1xMET 51 L-carnitine
dehydratase/bile acidinducible
1xDEM
82 hypothetical protein
1xDEM-2xMET 50 conserved hypothetical
protein
6xMET
10 putative tolR/exbD
protein
1xDEM
42 putative ribosomal
protein L21
1xDEM
1xDEM-2xMET 40 ribosomal protein L27
1xDEM-1xMET
1xDEM-3xMET 9 possible
acetyltransferases.
6xMET
9 putative H+-transporting
ATP synthase gamma
2xMET
13 putative H+-transporting
ATP synthase delta
1xDEM-3xMET 78 heme exporter protein A
(heme ABC transporter
1xDEM-3xMET 28 unknown protein
1xDEM-6xMET
1xDEM-8xMET 61 Beta-Ig-H3/Fasciclin
domain
1xDIS-6xMET
9 similar to eukaryotic
molybdopterin
1xDEM-3xMET 73 putative Citrate lyase
beta chain (acyl lyase
15 3-isopropylmalate
3xMET
dehydratase small
3xMET
subunit
3xMET

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

RPA0241 14297.711, S 14297.834, S
RPA0244 12017.821, S

Nitrogen
Fixing

PTMs

14297.470, S
1xDEM
12017.633, S 1xDEM

Protein Annotation
BU
Seq.
Cov.e
32 50s ribosomal protein L19
14 ribosomal protein S16

RPA0246 13472.790, W
RPA0263 15891.873, M

14
1xDEM-4xMET 27

RPA0267 32750.676, M
RPA0272
12360.825, M

1xDEM-5xMET

RPA0274

12367.542, M 1xURY

4
17
13

RPA0276 12559.245, S

2-4xMET

17

RPA0282 16018.135, W

1xDEM

8

RPA0283 24983.847, S

1xDEM

9

RPA0285 23538.857, W

1xDIS-9xMET

6

RPA0292 30801.005, W

1xDEM-1xDIS- 6
3xMET
1xDEM-6xMET 17
1xDEM-1xDIS- 5
4xMET
1xDIS-3xMET
8
1xDIS-3xMET
8xMET
7

RPA0298 30818.180, W
RPA0301 25755.166, W
RPA0311 23669.290, W
23669.449, M
RPA0323 14372.435, M
RPA0326 13489.857, W
RPA0329 26017.808, S
RPA0331 22173.571, M
RPA0335 22366.393, M
RPA0350 16176.801, S
16176.339, S
RPA0354 11347.234, S

1xDEM-9xMET
13490.434, M 1xDEM-9xMET
2xDIS-3xMET
1xDEM-7xMET
22305.627, M 7xMET
1xDEM-8xMET
22366.586, M 1xDEM-8xMET
9xMET
9xMET
16119.958, M 5xMET
1xDEM-5xMET

RPA0356 15924.889, M
RPA0359 26896.572, S
26866.940, W
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12
4
15
9
13

22

3xMET

9

5xMET
3xMET

5

PilT protein, N-terminal
Protein of unknown
function UPF0047
possible thioredoxin
GlnK, nitrogen regulatory
protein P-II
GlnK, nitrogen regulatory
protein P-II
PAP/25A core
domain:DNA polymerase,
beta-like
possible transcriptional
regulator
putative two-component
response regulator
Protein of unknown
function UPF0001
chromosome partitioning
protein, ParA
DUF299
putative DNA polymerase
III epsilon chain
imidazoleglycerolphosphate synthase,
Protein of unknown
function UPF0102
DUF24, predicted
transcriptional regulator,
ribonuclease PH
possible heat shock
protein
putative phospholipid Nmethyltransferase
putative patch repair
protein
putative pts system
phosphocarrier protein
HPr
conserved hypothetical
protein
conserved unknown
protein

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

RPA0366 12741.565, S

Nitrogen
Fixing

PTMs

Protein Annotation
BU
Seq.
Cov.e
11 unknown protein

RPA0377 30252.460, W

1xDEM-34xMET
2xDIS-8xMET
16027.527, W 2xDIS-8xMET
1xDIS-7xMET

RPA0384 20438.524, W

1xDIS-8xMET

8

RPA0395 21641.686, M

1xDIS-2xMET

10

RPA0403 14135.043, W

9xMET

9

RPA0373 16027.073, W

RPA0414

13

thioredoxin

4

conserved unknown
protein
conserved unknown
protein
Metal dependent
phosphohydrolase, HD
region
conserved hypothetical
protein
DUF167

11855.153, M

4xMET
16
11870.371, M 5xMET
RPA0433 10011.569, S
28
1xDEM
10011.231, M
1xDEM
10011.035, M 1xDEM
RPA0435
15379.549, S 1xDEM-2xMET 12
RPA0443 15004.785, W

1xDEM-3xMET 10

RPA0450 16585.565, M
RPA0453

1xDEM-1xDIS 20
16644.153, S 1xDEM-4xMET
20348.108, M 4xMET
57

RPA0489
RPA0490

12526.718, M 1xDIS-1xMET
9
8068.031, M 1xDEM-9xMET 25

RPA0493 10848.394, S
RPA0501 9422.580, S
RPA0511

1xDEM
28
10876.330, S 1xDEM-2xMET
1xDEM
13
33493.706, W
10xMET
8

RPA0517 17835.864, W

1xDEM-8xMET 15

RPA0526
RPA0532
RPA0543 18434.769, S
RPA0571 20007.852, S

25590.320, M

1xDIS-9xMET

13

1xDEM-1xDIS- 13
6xMET
1xDEM
49
20105.929, S 1xDEM-7xMET
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ribosomal protein S15

putative ribosome-binding
factor A
possible transcriptional
regulator
ferric uptake regulation
protein
possible NifU-like
domain (residues 119187)
ferredoxin II
conserved hypothetical
protein
50S ribosomal protein
L28
BolA-like protein
PpiC-type peptidyl-prolyl
cis-trans isomerase
putative transcriptional
regulator (Fur family)
50S ribosomal protein
L32
beta-ketothiolase,
acetoacetyl-CoA
reductase
unknown protein
two-component, response
regulator

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

Nitrogen
Fixing

RPA0578 9423.369, S
RPA0594 14966.448, S
RPA0598 9622.031, W
RPA0600

18099.337, S

RPA0607 30498.225, S
RPA0609

29001.611, S

RPA0616 11188.397, S 11188.089, M 11188.397, M
RPA0617
21259.868, S
RPA0618 14793.278, S
RPA0626
29733.197, W
RPA0629

31499.295, W

RPA0633

12907.673, M

RPA0643 13969.928, W
RPA0646 9413.638, M
RPA0650 27433.140, S
RPA0653 28669.548, S
RPA0662

8848.975, S

RPA0663 17079.605, S
RPA0673 25777.576, S
RPA0687 23830.531, M
RPA0688 20543.116, M
RPA0702
RPA0703

43081.468, S
25979.575, S

RPA0704 35909.585, W
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Protein Annotation
BU
Seq.
Cov.e
1xDIS-1xMET
17 unknown protein
1xDEM-1xDIS- 17 putative mutator protein
7xMET
mutT
1xDEM-1xDIS 22 putative glutaredoxin
1xDEM-7xMET 16 conserved hypothetical
protein
1xDEM-2xDIS- 7 putative
3xMET
protoporphyrinogen
oxidase, hemK
1xDEM-3xMET 4 conserved hypothetical
protein
22 Uncharacterized BCR
7xMET
9 putative recombination
protein recR
1xDIS-4xMET
10 unknown protein
6 2,3,4,5tetrahydropyridine-2carboxylate
1xMET
5 putative acetylglutamate
kinase
2xMET
7 probable ribonuclease p
protein component
1xDEM-3xMET 13 conserved hypothetical
protein
1xDEM-4xMET 39 conserved hypothetical
protein
2xDIS-4xMET
8 cyclohex-1-ene-1carboxyl-CoA hydratase
2xDIS-7xMET
30 2ketocyclohexanecarboxylCoA hydrolase
1xDEM-4xDIS- 19 ferredoxin
3xMET
1xMET
60 transcriptional regulator
1xDEM-9xMET 50 transcriptional activator
6xMET
40 conserved hypothetical
protein
5xMET
60 ATP-binding component,
PhnN protein, possible
3xMET
30 possible phosphonate
ABC transporter,
permease
1xDIS-4xMET
30 conserved hypothetical
protein
7xMET
40 conserved unknown
protein
PTMs

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

RPA0707

Nitrogen
Fixing

PTMs

11958.916, M 7xMET

RPA0714 18760.967, S

1xDEM-9xMET

RPA0717

23441.430, S 9xMET

RPA0729 20656.598, M

4xMET
2xMET
2xDIS-4xMET
1xDEM-3xMET

20627.654, S
RPA0739 21203.439, S
RPA0767 34867.931, W
RPA0771 10002.695, M
9926.698, M
RPA0775 19030.859, M
RPA0791 30019.876, W

4xMET
1xDEM-2xDIS7xMET
1xDEM-8xMET

RPA0795 22822.941, S
RPA0830

4xMET
1xDEM-8xMET

23441.430, S 5xMET

RPA0843 17712.212, M

9xMET

RPA0844 19203.863, M

1xMET

RPA0855
39499.553, M
RPA0866 14264.828, W

1xDEM-1xMET
1xDEM-6xMET

RPA0868 6011.702, S
RPA0885

1xDEM-5xMET
10254.021, W 1xDEM-4xMET

RPA0893 15051.893, W

8xMET
14893.115, S 1xDEM-6xMET
4xMET

RPA0903 20630.974, S
RPA0907 13450.536, M
RPA0917

8xMET
18515.305, M 1xDEM-6xMET

RPA0918 8566.680, M
RPA0920 17135.907, S
RPA0927

5xMET
7731.168, W 1xDEM-1xDIS4xMET
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Protein Annotation
BU
Seq.
Cov.e
11 putative periplasmic
divalent cation resistance
70 bifunctional cobinamide
kinase, cobinamide
80 putative cob(I)alamin
adenosyltransferase
40 conserved hypothetical
protein
12 putative cytochrome c
40 PAS
domain:GGDEF:PAC
motif
13 possible protein
commonly found in
insertion
80 hypothetical protein
60 similar to Staphylococcus
nuclease (SNase-like)
70 possible SOS-response
transcriptional repressor
47 conserved unknown
protein
98 putative Fo ATP synthase
B chain
12 putative FoF1 ATP
synthase, subunit B'
37 Beta-lactamase-like
12 putative nucleoside
diphosphate kinase
regulator
33 hypothetical protein
10 conserved hypothetical
protein
53 conserved hypothetical
protein
35 putative transcriptional
regulator
18 possible response
regulator receiver domain
12 Transcriptional Regulator,
AraC Family
20 possible 50S ribosomal
protein L31
11 GCN5-related Nacetyltransferase
28 probable transcriptional
regulator

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

Nitrogen
Fixing

RPA0930 21414.056, M
RPA0932 19542.010, S
RPA0941 11384.043, W
RPA0942 10806.326, W
RPA0953 9142.316, S
9286.551, W
RPA0956
RPA0973 12572.113, S
RPA0977

17064.368, W

41253.600, S

RPA0993 20540.812, W
RPA0999

22495.358, M

RPA1000 14479.792, M
RPA1017
RPA1019

13746.840, M
12257.701, S

RPA1025

13455.728, M

RPA1030 26939.380, S
RPA1061 31284.422, S
RPA1064

18078.781, S

RPA1066 10119.106, W
RPA1088
RPA1090 23792.666, S

12590.446, M

RPA1097 26941.767, S
RPA1100 21697.417, S
RPA1106

18345.992, W
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Protein Annotation
BU
Seq.
Cov.e
1xDEM-1xDIS- 45 possible 3-octaprenyl-45xMET
hydroxybenzoate
1xDEM-3xMET 13 conserved unknown
protein
1xDEM-4xMET 21 conserved hypothetical
protein
9xMET
11 conserved hypothetical
protein
1xDEM
26 possible
exodeoxyribonuclease
1xMET
small subunit
1xDIS-7xMET
44 hypothetical protein
2xDIS-3xMET
17 hydrogenase
formation/expression
protein hypA
7xMET
32 hydrogenase
expression/formation
protein hypD
1xDEM-4xMET 13 possible alpha-ribazole5`-phosphate phosphatase
9xMET
54 conserved hypothetical
protein
1xDIS-3xMET
11 Nitrogenase-associated
protein:Arsenate
1xDEM-1xDIS- 78 Nitrogen fixation-related
8xMET
protein
1xDEM-1xDIS- 11 possible transcriptional
5xMET
activator HlyU
1xDIS-9xMET
74 possible
Ectothiorhodospira
Vacuolata
15 possible CoA transferase,
subunit B
2xMET
46 possible polyketide
synthesis protein
60 conserved hypothetical
protein
6xMET
22 hypothetical protein
1xDEM-8xMET 14 hypothetical protein
1xDEM-1xMET 15 possible nitrogen
regulator
52 DUF28
5xMET
73 RuvA; Holliday branch
migration protein
1xDEM-6xMET 11 conserved hypothetical
protein
PTMs

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

RPA1107

Nitrogen
Fixing
19521.468, S

RPA1108 14415.533, W
RPA1111 9426.774, W
RPA1141 10493.013, S
10492.701, S
10493.154, S
RPA1152
RPA1157

18166.729, M
9553.862, S

RPA1160 12698.756, W
RPA1168 17026.930, W
17027.435, M
RPA1173 9369.198, S
RPA1175 14420.772, W
RPA1191 17028.760, S
RPA1228

19751.976, S

RPA1263
RPA1271 16026.872, M

10369.363, M

RPA1278 16179.437, M
16135.775, W
RPA1279
RPA1289 12010.505, M
RPA1291 11431.413, W

10911.295, M

RPA1302
RPA1333 22674.886, M

12590.586, M

RPA1342
RPA1344 17028.852, S
RPA1361
RPA1366 12350.218, S

9999.405, M
7132.965, M

RPA1390 24811.042, M
RPA1392 19630.240, M
RPA1414 31284.422, S
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Protein Annotation
BU
Seq.
Cov.e
1xDEM-6xMET 90 possible transcriptional
regulator
1xDEM-1xDIS- 17 Myb DNA-binding
4xMET
domain:DGPF domain
1xDIS-7xMET
12 hypothetical protein
1xDEM
40 chaperonin GroES1,
cpn10
1xDEM
1xDEM
4xMET
23 hypothetical protein
8xMET
73 conserved unknown
protein
5xMET
11 conserved unknown
protein
1xDEM-2xMET 15 molybdopterin converting
factor, subunit 2
1xDEM-2xMET
5xMET
13 possible cold shock
protein
1xDEM-8xMET 24 chemotaxis protein
CheY4
7xMET
73 putative RNA
methyltransferase
1xDEM-9xMET 59 putative 2-oxoglutarate
ferredoxin
6xMET
27 putative II.1 protein
8xMET
63 conserved hypothetical
protein
1xDEM-6xMET 18 GatB/Yqey
1xDEM-3xMET
1xDEM-7xMET 79 hypothetical protein
1xDEM-6xMET 11 hypothetical protein
8xMET
32 putative proteic killer
suppression protein
1xDEM-2xMET 90 unknown protein
73 conserved hypothetical
protein
1xDEM-4xMET 21 hypothetical protein
6xMET
14 hypothetical protein
9xMET
24 hypothetical protein
8xMET
20 putative sulfur oxidation
protein
2xDIS-5xMET
69 conserved hypothetical
protein
1xDEM
77 nitroreductase family
proteins
9xMET
11 MaoC-like dehydratase
PTMs

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

Nitrogen
Fixing

RPA1416 25863.037, S
RPA1441 28744.987, M
28829.754, S
RPA1442 28899.592, M
28885.179, S
9368.408, W
16811.588, S

RPA1454
RPA1455
RPA1475 8778.512, W
RPA1500 21499.481, M
RPA1535 14599.861, W

14514.801, M
RPA1551

11037.662, W
11084.940, W

RPA1578 28900.136, S
RPA1586 27968.897, S
RPA1587 9927.322, M
RPA1589
RPA1591

23442.195, S
13697.058, M

RPA1593 18006.889, S
RPA1600 8272.686, S
8273.949, S
8301.483, S
RPA1606

14218.167, M
14245.615, M

RPA1615 28867.609, M
RPA1617
RPA1620
RPA1629

21315.981, M
11417.855, M
13456.672, M

RPA1634 16381.157, M
RPA1645 8065.034, W
RPA1659
RPA1661
RPA1682 22620.915, W

22884.739, S
10306.118, W

RPA1693 22557.316, W
RPA1697 19054.936, S
RPA1717

14245.615, S
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Protein Annotation
BU
Seq.
Cov.e
1xDIS-9xMET
54 putative branched-chain
amino acid transport
2xMET
77 possible uridylate kinase
8xMET
7xMET
85 possible uridine
monophosphate kinase
6xMET
1xDEM-4xMET 22 hypothetical protein
1xDIS-5xMET
40 nitric-oxide reductase
subunit C
9xMET
17 hypothetical protein
1xDIS-4xMET
11 unknown protein
1xDEM-7xMET 80 cytochrome c2
1xDEM-1xMET
1xDEM-8xMET 18 hypothetical protein
2xMET
8xMET
97 ferredoxin--NADP+
reductase
1xDEM-1xDIS- 85 putative short-chain
1xMET
dehydrogenase/reductase
3xMET
22 hypothetical protein
1xDEM-1xMET 12 30S ribosomal protein S4
3xMET
15 conserved unknown
protein
1xDEM-7xMET 50 Thioesterase superfamily
1xDEM-1xMET 30 BolA-like protein
1xDEM-1xMET
1xDEM-3xMET
8xMET
79 conserved unknown
protein
10xMET
1xDEM-4xMET 61 putative methyltransferase
8xMET
52 ErfK/YbiS/YcfS/YnhG
1xDEM-1xMET 25 unknown protein
1xDEM-6xMET 58 chemotaxis response
regulator
4xMET
12 conserved unknown
protein
4xMET
33 unknown protein
1xDEM
25 conserved unknown
protein
1xDIS-3xMET
24 DUF156
6xMET
72 putative two component
response regulator
3xMET
86 superoxide dismutase
1xDEM-6xMET 84 Competence-damaged
protein
1xDEM-7xMET 17 hypothetical protein
PTMs

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

Nitrogen
Fixing

RPA1719 11861.782, W
RPA1726 35298.166, S
RPA1757

26980.102, M

RPA1777 15295.070, M
RPA1788 15964.473, M
15894.144, M
RPA1812

24467.277, W

RPA1824 17461.560, M
RPA1825 9003.751, M
RPA1827 9668.191, M
RPA1831 9577.858, S
RPA1839 13292.780, W
RPA1842 12496.787, M
RPA1855 22351.107, M
RPA1870

18515.305, M

RPA1872 11267.049, M
RPA1896
19940.857, M
RPA1900

10669.437, M
10697.929, S

RPA1905

31763.171, M

RPA1908 16820.322, M
RPA1909
17137.601, M
RPA1915 24984.711, M
RPA1928 33099.112, M
RPA1964
RPA1978

19754.608, M
37839.176, S

175

Protein Annotation
BU
Seq.
Cov.e
5xDIS-3xMET
23 Protein of unknown
function UPF0153
1xDEM-1xDIS- 56 putative oxidoreductase
6xMET
1xDEM-1xDIS- 31 possible oxoacyl carrier
7xMET
protein reductase
1xDEM-2xMET 11 DUF35
1xDIS-8xMET
23 possible 4hydroxybenzoyl-CoA
1xDIS-3xMET
thioesterase
1xDEM-9xMET 66 conserved hypothetical
protein
1xDEM-1xMET 32 unknown protein
6xMET
11 conserved hypothetical
protein
1xDEM-3xMET 19 hypothetical protein
1xDIS-2xMET
20 conserved hypothetical
protein
6xMET
25 putative dihydroneopterin
aldolase
1xDEM-4xMET 14 conserved unknown
protein
1xDIS-5xMET
74 conserved hypothetical
protein
1xDEM-7xMET 82 possible transcriptional
regulator (MarR/EmrR
7xMET
11 Rhodocoxin
7xMET
38 homologue of
Rhodobacter capsulatus
gene
6xMET
95 homologue of
Rhodobacter capsulatus
8xMET
gene
1xDEM-2xDIS- 50 homologue of
3xMET
Rhodobacter capsulatus
gene
4xMET
77 hypothetical protein
1xMET
11 putative transcriptional
regulator, MarR family
1xDEM-9xMET 58 FeuP two-component
system, regulatory protein
2xDIS-6xMET
76 ferredoxin-like protein
[2Fe-2S]
1xDEM-4xMET 14 hypothetical protein
1xDEM-1xDIS- 29 molybdenum biosynthetic
8xMET
protein A
PTMs

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

RPA1982 20026.946, S

Nitrogen
Fixing

PTMs

RPA1985 12722.134, M

8xMET
19882.199, W 1xDEM-7xMET
1xDEM-3xMET

RPA1992 15165.192, M
RPA1993 9832.024, M

2xMET
1xDEM-3xMET

RPA1996
RPA2004 22567.353, W

10698.920, M 2xDIS-6xMET
1xDIS-8xMET

RPA2006 26621.810, S

1xDEM-8xMET

RPA2012 11188.935, S

1xDEM-5xMET
1xDEM

11118.798179,
M
RPA2028 21793.511, S

Protein Annotation
BU
Seq.
Cov.e
15 conserved unknown
protein
12 probable diacylglycerol
kinase
88 possible NtrR protein
14 possible virulenceassociated protein
16 hypothetical protein
95 conserved hypothetical
protein
74 putative
phosphatidylserine
decarboxylase
36 conserved unknown
protein

1xDEM-4xMET 73

RPA2032 19942.040, M

89

RPA2036 26939.380, S

1xDIS-2xMET

41

RPA2040 22362.657, M

4xMET

74

RPA2044 27086.658, M

1xDIS-7xMET

55

RPA2045
RPA2057 12463.311, W
RPA2066
RPA2068 10674.355, M

36322.528, S

1xDEM-3xDIS1xMET
1xDEM-4xMET
35090.978, M 1xDEM-4xMET
1xMET

51
19
60
14

11

hypothetical protein
putative nosX
conserved unknown
protein
putative uroporphyrin III
methylase
precorrin 3 or 4 methylase
cobalamin biosynthesis
protein G; CbiG
conserved unknown
protein
possible cytochrome C
precursor
putative enoyl-CoA
hydratase/isomerase
hypothetical protein

13

hypothetical protein

RPA2082 25774.205, W

1xDEM-6xMET 22

RPA2084 27462.806, M
RPA2085 12941.148, W

1xDEM
2xMET

13
14

RPA2125

12587.776, M

RPA2136 11243.957, M

1xDIS-1xMET
18
11115.419, W 1xDEM-1xMET
1xDIS-6xMET
54

RPA2145 28029.307, S
RPA2158 11824.846, S

24

1xDEM-2xDIS3xMET
1xDIS-3xMET

RPA2159 11346.894, W

176

conserved hypothetical
protein
acetolactate synthase
(small subunit)
possible transcriptional
regulator (GntR family)
possible choline ABC
transporter ATP-binding
conserved unknown
protein
biotin synthetase

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

Nitrogen
Fixing

PTMs

RPA2165 11164.094, S 11163.802, S

11164.046, S

RPA2179

20109.335, M

RPA2188
RPA2196

11659.550, M 1xDIS-6xMET
25015.256, M

RPA2197
25380.431, M
RPA2205 13441.281,M
RPA2239 22823.257, M
RPA2241
17775.413, M

1xDEM-9xMET

RPA2243 9127.186, M

5xMET

RPA2264 17948.706, S

6xMET

RPA2265

1xDEM-3xMET
1xDEM-3xMET

35913.907, W

RPA2338
17752.529
RPA2359 30819.670, W

1xDEM-1xDIS2xMET
9xMET
1xDEM-4xMET
1xDEM-7xMET
5xMET
1xDEM-1xDIS6xMET
1xDEM
1xDEM
NATIVE, 14xMET
NATIVE, 14xMET
NATIVE,
1xMET
NATIVE,
1xMET
1xDEM
4xMET

RPA2368 8395.593, S

2xMET

RPA2274 13462.515, W
RPA2283 10475.250, S
10517.445, W
RPA2313
RPA2314
RPA2334

19275.381, M
15152.212, M
11959.120, M
11959.120, M

RPA2335

11442.593, S
11442.593, S

RPA2336

10908.894,S
10921.606, M

RPA2401 12335.292, S

Protein Annotation
BU
Seq.
Cov.e
27 chaperonin GroES2,
cpn10
87 xanthine-guanine
phosphoribosyltransferase
11 hypothetical protein
89 conserved hypothetical
protein
47 cell division protein FtsJ
11 hypothetical protein
10 putative partition protein
11 conserved hypothetical
protein
16 putative transcriptional
regulator
85 conserved hypothetical
protein
33 conserved hypothetical
protein
11 hypothetical protein
14 putative proteic killer
suppression protein
11 unknown protein
13 cytochrome c556
unknown protein
76

unknown protein

47

unknown protein

52
52

unknown protein
putative periplasmic
protein
possible transcriptional
regulatory protein
conserved unknown
protein
hypothetical protein
possible AmiR
antitermination protein
NADH:ubiquinone
oxidoreductase 17.2 k

17
19

RPA2407 12113.494, W
RPA2409
24359.957, S

1xDEM-3xMET 12
1xDIS-6xMET
32

RPA2421 15886.364, M

4xMET

177

16

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

Nitrogen
Fixing

PTMs

RPA2433 16394.228, W

4xMET

RPA2437 15964.473, M

1xDEM-1xDIS6xMET
1xDIS-5xMET

RPA2442 27754.376, M
RPA2443

25651.912, W

1xDEM-3xMET

RPA2446
RPA2453

43113.781, S
35496.288, S

4xMET
1xDEM-9xMET

RPA2456 23830.531, S
RPA2465 27433.140, S

2xMET

RPA2470 13365.283, M
RPA2492

22366.559, M

RPA2513 20843.685, S
20843.911, M
RPA2520
RPA2521
RPA2522
RPA2523

20568.489, M
7939.293, S
9477.775, S
17028.379, S
17028.555, S

RPA2528
RPA2531
RPA2533
RPA2540

19053.121, S
10302.373, W
15410.303, M
31329.289, S

RPA2546 15869.205, M
15966.401, W
16217.439, M

RPA2549

1xDEM-1xDIS2xMET
9xMET
9xMET
2xMET
1xDEM-8xMET
3xMET
1xDEM-1xDIS
1xDEM-1xDIS
2xDIS-1xMET
7xMET
1xDEM-6xMET
1xDEM-3xDIS4xMET
3xMET
10xMET
1xDIS-6xMET

Protein Annotation
BU
Seq.
Cov.e
12 possible two-component
response regulator
12 3-dehydroquinate
dehydratase type 2
78 putative outer membrane
protein
24 probable antioxidant
protein
33 putative aminotransferase
37 translation peptide
releasing factor RF-2
31 possible bacterioferritin
co-migratory protein
56 sufC, related to ABC
transporter ATP-binding
13 Protein of unknown
function,
HesB/YadR/YfhF
79 Conserved hypothetical
protein
41 elongation factor P
32
21
22
81
71
10
11
43
15
10

RPA2552 11779.037, S
RPA2556
30215.805, M

8xMET
15
1xDEM-4xMET 36

RPA2589 21640.620, M

1xDIS-2xMET

78
83

RPA2603 16010.780, M

1xMET
7xMET
2xMET

88

RPA2604 16795.230, M

1xDEM

11

RPA2601 17688.403, M
17771.338, S

178

hypothetical protein
hypothetical protein
hypothetical protein
putative
lactoylglutathione lyase
hypothetical protein
hypothetical protein
unknown protein
3-hydroxy-3methylglutaryl-CoA lyase
FKBP-type peptidylprolyl cis-trans isomerase
conserved hypothetical
protein
unknown protein
PA-phosphatase related
phosphoesterase
possible competencedamaged protein
phosphopantetheine
adenylyltransferase
conserved hypothetical
protein
peptidyl prolyl cis-trans
isomerase

Table 7.4: Continued
Protein Annotation
BU
Seq.
Cov.e
RPA2639 17915.266, M
2xMET
13 probable L-2-aminothiazoline-4-carboxylic
acid
RPA2640
25979.119, S 5xMET
71 Isochorismatase hydrolase
family
RPA2648 27758.256, M
1xDEM-5xMET 39 unknown protein
RPA2649 12888.806, M
1xDEM-7xMET 15 conserved unknown
protein
RPA2652
7178.843, W
unknown protein
RPA2667 26252.611, W
1xDEM-1xDIS- 81 conserved unknown
7xMET
protein
RPA2687
17032.969, S 2xMET
82 large-conductance
mechanosensitive channel
RPA2688 18258.432, M 18114.023, M
8xMET
83 small protein B
1xDEM-7xMET
RPA2690
24467.277, W
1xDEM-3xDIS- 40 possible uracil-DNA
5xMET
glycosylase
RPA2692
14368.256, M
20 RNA polymerase omega
subunit
RPA2695 15655.277, M
1xDEM
15 acyl carrier protein
synthase
15813.404, W 2xMET
RPA2702 18944.166, M
8xMET
94 DUF24, predicted
transcriptional regulator,
RPA2715 19653.464, M
16 possible transcriptional
regulator, MarR family
RPA2717 7852.327, M
1xDEM-6xMET 29 conserved hypothetical
protein
RPA2718 21067.252, M
1xDEM-5xMET 14 hypothetical protein
RPA2721 9921.998, M
2xDIS-3xMET
22 hypothetical protein
RPA2728
17040.698, W
1xDEM-6xMET 56 riboflavin synthase, beta
chain
17026.731, M 1xDEM-5xMET
RPA2729 19691.488, M
5xMET
86 putative N-utilization
substance protein B
RPA2732 8397.260, W
1xDEM
48 conserved hypothetical
protein
8397.280, M 1xDEM
RPA2734 32102.932, S
4xMET
31 possible epoxide
hydrolase-related protein
RPA2742 12862.989, M
2xMET
22 integration host factor
alpha subunit
12904.490, M 5xMET
RPA2744
7862.194, S
1xDEM-2xMET 95 hypothetical protein
RPA2748 34871.554, W
3xDIS-3xMET
53 possible short-chain
dehydrogenase
RPA2755
18260.081, M 1xMET
13 possible DNA-binding
stress protein
RPA2766 15132.167, W
1xDEM-4xMET 85 Phenylacetic acid
degradation-related
RPA2783 21797.403, M
1xDIS-8xMET
11 hypothetical protein
Gene
Number

Aerobic

Anaerobic

Nitrogen
Fixing

179

PTMs

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

RPA2795

Nitrogen
Fixing
28838.153, M

RPA2801 15572.265, M
15571.851, M
RPA2814 17696.443, S
17696.403, S
RPA2823 10207.451, M
RPA2848 17799.324, M
RPA2852
35915.053, W
RPA2856 11421.239, W
RPA2868 11896.347, W
RPA2869

20102.175, S

RPA2892 18214.481, M
RPA2896 8985.992, W
8986.770, W
8986.950, M
RPA2899 18139.023, M
18139.454, W
RPA2919 20660.667, M
20660.757, M
RPA2932
RPA2933 9923.460, M

14258.256, S
9923.086, M

RPA2934 14212.615, W
RPA2940

11024.113, W

RPA2942 18761.236, M
18685.995,W
RPA2953 11116.797, S
RPA2966
RPA2973
RPA2982 10002.695, M

11145.405, S
12335.167, M 12335.891, M
20173.446, M

180

Protein Annotation
BU
Seq.
Cov.e
1xDIS-7xMET
10 Protein of unknown
function UPF0001
1xDIS-1xMET
33 Collagen triple helix
repeat
1xDIS-1xMET
1xDEM
46 single-strand DNAbinding protein
1xDEM
45 conserved hypothetical
protein
1xDEM-5xMET 13 possible sec-independent
protein secretion
1xDEM-5xMET 32 putative sugar hydrolase
1xDEM-1xDIS- 83 Protein of unknown
5xMET
function,
HesB/YadR/YfhF
2xMET
14 Septum formation
initiator
1xDEM-1xDIS- 92 possible flavin-dependent
6xMET
oxidoreductase
3xMET
57 molybdenum cofactor
biosynthesis protein C
1xDEM-1xDIS- 13 hypothetical protein
8xMET
1xDEM-1xDIS8xMET
1xDEM-1xDIS8xMET
3xMET
99 conserved hypothetical
protein
3xMET
1xDEM-2xMET 22 ribosome releasing factor
1xDEM-2xMET
2xDIS-1xMET
11 hypothetical protein
1xDEM
22 conserved hypothetical
protein
1xDEM
1xDEM-1xMET 13 conserved unknown
protein
1xDEM-8xMET 12 NADH-ubiquinone
dehydrogenase chain K
8xMET
86 NADH-ubiquinone
dehydrogenase chain I
3xDIS-3xMET
1xDEM-2xMET 33 possible DNA-binding
protein hu-alpha (NS2)
1xDEM-4xMET
98 nitrogen regulatory
protein P-II
1xDEM
12 hypothetical protein
4xMET
13 possible insertion element
ISR1 hypothetical 10
PTMs

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

RPA2985

Nitrogen
Fixing
24851.053, M

RPA2998 32018.782, W
RPA3005 10219.565, M
RPA3021 21125.201, M
21139.221, M
RPA3024
RPA3034

14141.632, W
9212.003, M
9212.352, M

RPA3035 15363.893, M
15307.924, M
21369.003, S

RPA3037
RPA3053 7525.886, S 7526.470, S
RPA3056 15289.620, W
15289.332, M

15289.489,M
8567.662, S

RPA3073
RPA3074

25406.064, M

RPA3077 17932.594, M

17932.615, M

RPA3078 9046.970, S
RPA3080

21178.830, S

RPA3086 9397.898, S
RPA3101 17232.381, W
RPA3103 7088.891, W
7088.003, W
RPA3109

10697.310, M

RPA3113

17140.300, M

RPA3123 11112.651, W
11056.853, S
RPA3126 15994.192, M
RPA3129 6249.313, S
6249.333, S
6249.462, S
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Protein Annotation
BU
Seq.
Cov.e
1xDEM-5xMET 93 conserved unknownl
protein
7xMET
49 putative
dihydrodipicolinate
synthase
4xMET
19 hypothetical protein
3xMET
24 transcriptional regulator
4xMET
1xDEM-1xDIS- 17 unknown protein
6xMET
unknown protein
1xDEM-2xMET
1xDEM-2xMET
5xMET
87 hypothetical protein
1xMET
7xMET
63 conserved unknown
protein
65 cold shock protein
5xMET
33 nucleoside-diphosphatekinase
5xMET
5xMET
1xDEM-9xMET 16 constitutive acyl carrier
protein
4xMET
57 3-oxoacyl-acyl carrier
protein reductase fabG
18 possible 30S ribosomal
protein S6
1xDEM-6xMET 13 30S ribosomal protein
S18
31 putative 50S ribosomal
protein L9, cultivar
3xMET
17 hypothetical protein
1xDEM-7xMET 88 conserved unknown
protein
8xMET
13 hypothetical protein
8xMET
9xMET
64 conserved hypothetical
protein
4xMET
10 conserved hypothetical
protein
1xDEM-8xMET 83 hypothetical protein
1xDEM-4xMET
5xMET
10 conserved hypothetical
protein
1xDEM-1xMET 30 50S ribosomal protein
L33
1xDEM-1xMET
PTMs

1xDEM-1xMET

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

Nitrogen
Fixing

RPA3130 14169.554, S
RPA3134 10997.690, S
10998.578, M
10997.732, S
14709.646, W
25980.423, S

RPA3148
RPA3152
RPA3162 13284.110, M
13312.971, W
RPA3168 8804.559, S
RPA3180 11166.904, S
11139.519, S
RPA3212 15955.683, M
RPA3213
8030.265, S
RPA3215 25048.560, S
RPA3223
RPA3225 15717.489, S

35934.629, S
15717.933, S

RPA3227 13761.002, M
13761.158, M
13761.287, M
RPA3228 14357.764, M
14357.709, M
RPA3231 16837.254, S 16836.541, S

14384.163, M
16836.630, S

RPA3232 7093.155, S
7092.929, S
7092.861, S
12905.679, S

RPA3234
RPA3235 19273.207, S
19273.083, S

19273.221, S
RPA3236 14576.761, S
14576.574, S
RPA3238 21122.037, M
RPA3239 11012.697, S
11012.444, S
11012.821, S
RPA3240 13489.094, M 13488.674, M 13489.187, M
RPA3242 7849.937, S
7849.874, S
7849.864, S

182

Protein Annotation
BU
Seq.
Cov.e
1xDEM-3xMET 79 Helix-turn-helix motif
9xMET
16 conserved unknown
protein
9xMET
9xMET
1xDEM-7xMET 69 DUF174
1xDIS-3xMET
57 hypothetical protein
7xMET
16 possible helix-turn-helix
9xMET
1xDEM-7xMET 21 possible flgaellar switch
protein FliN
9xMET
11 hypothetical protein
7xMET
7xMET
14 unknown protein
1xDEM-6xMET 18 hypothetical protein
1xDEM-5xMET 80 putative nitroreductase
1xDEM-7xMET 68 putative alginate lyase
3xMET
21 50S ribosomal protein
L17
3xMET
1xDEM-1xMET 22 30S ribosomal protein
S11
1xDEM-1xMET
1xDEM-1xMET
1xDEM-3xMET 79 30S ribosomal protein
S13
1xDEM-3xMET
1xDEM-5xMET
87 50S ribosomal protein
L15
1xDEM
20 ribosomal protein L30
1xDEM
1xDEM
1xDEM
26 50S ribosomal protein
L18
1xDEM
41 50S ribosomal protein L6
1xDEM
1xDEM
1xDEM-7xMET 27 30S ribosomal protein S8
1xDEM-7xMET
6xMET
12 50S ribosomal protein L5
1xDEM-1xMET 21 50S ribosomal protein
L24
1xDEM-1xMET
1xDEM-1xMET
22 50S ribosomal protein
L14
1xDEM
24 50S ribosomal protein
L29
1xDEM
1xDEM
PTMs

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

Nitrogen
Fixing

RPA3243 15296.048, S
15296.084, S
RPA3244 26178.851, W
RPA3246 10088.469, S
10088.391, S
RPA3248 10908.765, S 10908.483, S

10088.778, S
10908.697, S

RPA3251 11668.941, S 11668.783, S

11668.568, S

RPA3254
RPA3261 15004.785, W

17556.347, M
14902.234, M

RPA3269 12754.760, S
12754.702, S
12754.772, S
RPA3270 19054.936, M
RPA3272 23878.783, S
RPA3274 20026.946, S
20026.860, S
RPA3275

9402.074, M

RPA3290 23849.470, S
RPA3300 27834.970, S
RPA3319 15533.356, W
15560.493, S
15532.882, S
RPA3327 10062.561, W
RPA3328

15602.023, W

RPA3373 10271.970, M
RPA3390 16873.403, M
16789.906, M
16672.650, M
RPA3394

17200.646, S

RPA3397
16658.898, M
RPA3402 15218.140, W

183

Protein Annotation
BU
Seq.
Cov.e
1xMET
23 50S ribosomal protein
L16
1xMET
1xDEM-1xDIS- 60 30S ribosomal protein S3
3xMET
1xDEM
27 30S ribosomal protein
S19
1xDEM
1xDEM
31 50S ribosomal protein
L23
40 30S ribosomal protein
S10
1xDEM
27 30S ribosomal protein S7
1xDIS-1xMET
91 transcriptional regulator
1xDEM-1xDIS3xMET
1xDEM-3xMET 47 50S ribosomal protein
L7/L12
1xDEM-3xMET
1xDEM-3xMET
1xDEM-1xMET 28 50S ribosomal protein
L10
1xDEM
12 50S ribosomal protein L1
9xMET
39 transcription
antitermination protein
9xMET
5xMET
84 preprotein translocase,
SecE subunit
1xDEM-1xDIS- 32 possible transcriptional
3xMET
regulator, TetR family
2xMET
73 possible transcriptional
regulator, TetR family
7xMET
58 hypothetical protein
9xMET
7xMET
1xDEM-4xMET 16 hypothetical protein
5xMET
13 conserved hypothetical
protein
7xMET
27 hypothetical protein
1xDIS-8xMET- 16 phosphoribosyl c-AMP
cyclohydrolase
1xDIS-2xMET
1xDEM-1xDIS3xMET
1xDEM-1xDIS- 93 DUF37
3xMET
6xMET
11 hypothetical protein
1xDEM-2xDIS- 15 conserved hypothetical
5xMET
protein
PTMs

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

Nitrogen
Fixing

RPA3434 22791.311, M
RPA3436 18900.382, M
RPA3446 29567.345, M
29595.953, M
7429.588, S

RPA3457
RPA3476 28083.780, S
RPA3481 9215.385, S
RPA3501 10149.437, W
10163.493, W
RPA3518 11231.845, W
RPA3524

36319.974, S

RPA3537 14096.695, M
RPA3555 18816.879, S
RPA3561
13124.930, S
RPA3574 6883.790, M
6897.073, M
RPA3579 10002.695, W
10030.489, W
RPA3583 12099.680, W

12127.793, M

RPA3589 RPA3589
RPA3602
RPA3606 10500.755, W
RPA3626

9716.998, W
9293.434, M

RPA3652

13698.826, S

RPA3653

9296.464, W

RPA3662 11279.887, W
RPA3663 10999.640, S
10998.597, S
RPA3671 10459.920, S
10460.115, S
10459.441, S
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Protein Annotation
BU
Seq.
Cov.e
1xDIS-6xMET
47 Universal stress protein
(Usp)
1xDEM-2xMET 13 GCN5-related Nacetyltransferase
1xDIS-2xMET
51 3-hydroxyisobutyrate
dehydrogenase
1xDIS-4xMET
1xDEM-5xMET 20 Biotin/lipoyl
attachment:Biotinrequiring
1xDEM-2xMET 84 possible energy
transducer TonB
7xMET
23 hypothetical protein
1xDEM-7xMET 67 conserved unknown
protein
1xDEM-8xMET
4xMET
95 Excinuclease ABC, C
subunit, N-terminal
1xDEM-6xMET 43 putative cell division
protein FtsQ
1xMET
11 conserved hypothetical
protein
1xDEM-2xMET 92 arsenate reductase
1xDIS-8xMET
14 possible arsenate
reduction regulatory
protein
1xDEM-4xMET 32 putative thiamin
biosynthesis ThiG
1xDEM-5xMET
4xMET
13 possible insertion element
ISR1 hypothetical 10
6xMET
1xDEM-5xMET 22 conserved hypothetical
protein
1xDEM-7xMET
conserved hypothetical
protein
1xDIS-4xMET
25 unknown protein
1xDIS-1xMET
13 hypothetical protein
1xDEM
27 conserved unknown
protein
1xDEM-2xMET 69 conserved hypothetical
protein
4xMET
26 Protein of unknown
function UPF0033
6xMET
14 urease beta subunit
1xDEM-3xMET 20 urease gamma subunit
1xDEM-3xMET
1xDEM-1xMET 59 translation initiation
factor if-1 (infA)
1xDEM-1xMET
1xDEM-1xMET
PTMs

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

Nitrogen
Fixing

RPA3672 8970.250, S
8969.587, M
9012.829, M
RPA3673 22674.886, M
RPA3676

18594.783, M

RPA3719 28867.609, S
RPA3721

30808.822, W

RPA3726 18517.400, M
RPA3745 17028.339, S
RPA3759

14695.257, M

RPA3770 17958.517, M
RPA3786 9335.393, S 9335.064, S
RPA3790 28964.617, M
RPA3794 11869.466, S
RPA3798 24649.796, M
RPA3799 11347.234, S
11347.449, M
RPA3803 17136.725, S
RPA3804 16026.165, S

16083.263, M

RPA3820 8418.840, M

8419.307, M

RPA3822 12010.648, W
RPA3824 12572.842, M
RPA3826

13316.091, M

RPA3827

11761.786, M

RPA3828
RPA3837 10002.695, W

7145.348, M
10030.489, W

RPA3852 20592.106, M
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Protein Annotation
BU
Seq.
Cov.e
1xDEM-2xMET 47 cold shock protein
1xDEM-2xMET
1xDEM-5xMET
8xMET
82 conserved unknown
protein
1xDEM-1xDIS- 35 putative type IV prepilin
1xMET
peptidase, cpaA
1xDEM-6xMET 64 putative high-affinity
branched-chain amino
acid
1xDEM-7xMET 45 possible ABC transporter,
permease protein
6xMET
90 conserved unknown
protein
5xMET
90 unknown protein
1xDEM-7xMET 31 putative 5carboxymethyl-2hydroxymuconate
1xDEM-3xMET 13 conserved unknown
protein
57 unknown protein
1xDIS-9xMET
56 putative efflux protein
4xDIS-4xMET
17 conserved hypothetical
protein
34 conserved unknown
protein
1xDIS-4xMET
16 DUF182
1xDIS-4xMET
1xDEM-1xDIS- 50 carbon-monoxide
8xMET
dehydrogenase small
subunit
PTM:1xDIS
35 conserved unknown
protein
1xDIS-4xMET
29 Protein of unknown
function UPF0062
5xMET
13 conserved unknown
protein
1xDEM
13 conserved hypothetical
protein
9xMET
12 conserved hypothetical
protein
3xMET
11 conserved hypothetical
protein
1xDEM-2xMET 25 Helix-turn-helix motif
4xMET
13 possible insertion element
ISR1
6xMET
1xDEM-8xMET 86 hypothetical protein
PTMs

Table 7.4: Continued
Gene
Number

Aerobic

RPA3878 17694.943, S

BU
Seq.
Cov.e
19
2xMET
68
26980.102, S 1xDIS-8xMET
29
76
1xDEM
1xDEM
9961.140, M 1xDEM
1xDEM-5xMET 74

RPA3886

10475.058, W 5xMET

12

RPA3887 15471.115, M

5xMET

78

RPA3895 28030.834, M

6xMET

59

RPA3864 9463.912, S
RPA3865
RPA3871
RPA3875 9961.592, M

Anaerobic
9463.471, S
19743.894, S

9961.076, M

RPA3896
RPA3898 18030.359, M

Nitrogen
Fixing

PTMs

15002.200, W 1xDEM-3xMET 10
3xMET
11

RPA3907 16930.802, M

9xMET

14

RPA3908 14169.336, S

8xMET

88

RPA3910 12130.745, S
12130.782, M
RPA3913 13458.449, S

20
1xMET
1xMET
12186.408, W 5xMET
1xDEM-7xMET 74

RPA3914 14420.772, M
RPA3923
34837.447, W

1xDEM-1xMET 12
1xDEM-2xDIS- 56
3xMET

RPA3924 24964.302, S

1xDEM-5xMET 87

RPA3939 19601.710, S

1xDIS-7xMET

RPA3956 11442.106, S

1xDEM-6xMET
11442.720, S 1xDEM-6xMET
RPA3957
12561.372, M
2xMET
RPA3970 23794.943, S
1xDEM-1xMET
RPA3988 19992.661, S
1xDEM-3xMET
RPA4005 10845.866, S
1xMET
RPA4006
RPA4010

17769.328, S
14013.813, M

97
30
84
69
95
12

1xDEM-5xMET 12
3xMET
13

RPA4030 13980.157, W

4xMET
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13

Protein Annotation
unknown protein
Thioesterase superfamily
Nuclear protein SET
conserved unknown
protein
conserved unknown
protein
Flagellar hook-basal body
complex protein FliE
flagellar basal-body rod
protein flgC
conserved hypothetical
protein
hypothetical protein
Flagellar basal bodyassociated protein FliL
DnaK suppressor protein
DksA
conserved unknown
protein
conserved hypothetical
protein
conserved hypothetical
protein
putative flbT protein
putative acetoin
dehydrogenase (TPPdependent)
conserved hypothetical
protein
conserved unknown
protein
ferredoxin
Hpt domain
putative
putative phosphatase
possible ribosomal protein
S21
hypothetical protein
putative response
regulator
hypothetical protein

Table 7.4: Continued
Gene
Number

Aerobic

RPA4047

Anaerobic

Nitrogen
Fixing

25162.285, W

RPA4050 29896.503, S
29896.082, S
RPA4067 11526.438, S
RPA4070 21755.278, M
RPA4072 17029.108, S
17029.156, S
17029.160, S
RPA4074 17903.487, S
17987.102, M
RPA4076 34867.931, W
RPA4077 23944.810, M
RPA4093
RPA4102 17031.513, M

9159.405, M

17086.813, S
RPA4104 22887.971, M
RPA4109
11913.973, S
11913.701, M
RPA4122 9250.851, M
RPA4129 12832.671, S
12832.592, S
12832.545, S
RPA4135

18385.213, S

RPA4137

13892.225, S

RPA4138 13905.092, S
RPA4151

31499.295, W

RPA4171 12340.401, W
12341.050, M
12326.933, W
RPA4176 10077.843, M
RPA4179
13333.444, S
RPA4191 11212.504, S
RPA4206 27433.140, S
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Protein Annotation
BU
Seq.
Cov.e
2xDIS-6xMET
59 Haloacid dehalogenaselike hydrolase
1xDEM-3xMET 25 unknown protein
1xDEM-3xMET
1xDEM-3xMET 13 hypothetical protein
1xDEM-3xMET 50 possible peptide
methionine sulfoxide
reductase
1xDEM
61 transcriptional elongation
factor greA
1xDEM
1xDEM
69 putative leucine regulon
1xDIS-3xMET
transcriptional
1xDIS-9xMET
4xMET
49 putative transcriptional
regulator, lysR family
1xDEM-1xDIS- 76 ATPase, ParA type
7xMET
1xDEM-3xMET 14 hypothetical protein
1xDEM-1xMET 12 putative transcriptional
regulator
1xDEM-5xMET
7xMET
66 hypothetical protein
7xMET
67 conserved hypothetical
protein
7xMET
5xMET
12 Conjugal transfer protein
TrbD
30 putative transcriptional
9xMET
regulator
9xMET
9xMET
5xMET
14 GCN5-related Nacetyltransferase
1xDEM
20 conserved unknown
protein
1xDEM-1xMET 28 conserved unknown
protein
2xDIS-2xMET
34 possible transcriptional
regulator of NADH
19 conserved unknown
3xMET
protein
3xMET
2xMET
1xMET
12 ribosomal protein S21
1xDEM-5xMET 57 conserved unknown
protein
1xDEM-7xMET 28 conserved unknown
protein
1xDEM-2xMET 77 D-beta-hydroxybutyrate
dehydrogenase
PTMs

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

Nitrogen
Fixing

RPA4210
RPA4214 10761.067, M

9267.744, W

RPA4217

7991.877, S

RPA4224 10459.824, S
RPA4227 22384.074, S

PTMs
4xMET
4xMET

6xMET
1xDIS-4xMET

RPA4228 12550.962, W
RPA4230 10046.148, S
RPA4241
15050.666, S
RPA4257 19545.573, M

1xDEM-4xMET
1xDEM-1xMET
10073.371, M 1xDEM-3xMET
1xDEM-6xMET
2xDIS-4xMET

RPA4272

25979.575, S 1xDEM

Protein Annotation
BU
Seq.
Cov.e
20 hypothetical protein
14 conserved hypothetical
protein
35 conserved unknown
protein
35 unknown protein
67 urease accessory protein
UreG
15 hypothetical protein
13 conserved unknown
protein
70 CBS domain
46 NADH-ubiquinone
dehydrogenase chain I
15 conserved unknown
protein
48 conserved hypothetical
protein
70 possible activator of
photopigment and puc
60 putative aldose reductase

RPA4277 23149.083, S

1xDEM-3xMET

RPA4282 18029.260, W

6xMET

RPA4297 30057.486, W
RPA4298 22791.264, S

1xDEM-1xDIS5xMET
2xMET

RPA4305 12110.554, M
RPA4319 5806.499, W
RPA4330 17933.468, S

1xDEM-5xMET 10
4xMET
25
2xMET
13

RPA4331

44426.051, S

RPA4344 8492.921, M
RPA4348

16278.313, M

RPA4349 18866.714, S

68

46
1xDEM-6xMET 22
1xDEM-5xMET 70

RPA4357 10095.787, M

1xDEM-1xMET 20
18851.297, M 1xDEM-1xDIS
1xDEM-1xMET 11

RPA4365

15801.209, M 1xDEM-1xDIS

13

RPA4372 15491.980, M

4xMET

10

RPA4381 16826.447, M

1xDIS-6xMET

59

RPA4383 18847.915, M
18804.927, M
RPA4393

7991.020, M
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1xDEM-6xMET
1xDEM-3xMET
4xMET
20

ATP/GTP-binding site
motif A (P-loop)
hypothetical protein
hypothetical protein
conserved unknown
protein
aspartate
aminotransferase A
hypothetical protein
conserved hypothetical
protein
conserved unknown
protein
conserved unknown
protein
GCN5-related Nacetyltransferase
Class I peptide chain
release factor domain
conserved unknown
protein
conserved unknown
protein
unknown protein

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

RPA4418

Nitrogen
Fixing
7110.894, W

RPA4457 13639.667, M
RPA4458 17466.002, W
RPA4466 12125.648, M
12125.666, M
RPA4467 16177.138, M
RPA4470 16387.876, W
RPA4473 11040.704, S
RPA4474 14375.557, S
14316.966, W
RPA4478 10792.071, S
RPA4483

10805.846, M
43079.763, S

RPA4500 7526.018, S
RPA4501
RPA4503 9513.824, M

7962.293, M

RPA4505
26141.064, M
RPA4518 11898.625, M
RPA4529 17419.338, M
RPA4541 19273.064, S
RPA4542
RPA4543 15054.561, W

11244.156, M

RPA4544 21753.512, M
RPA4548
RPA4573

12793.518, W
16639.503, M

RPA4574
RPA4600 16584.872, M

9800.818, S

RPA4602

10657.886, S

RPA4605

30483.750, S

RPA4610 10830.525, S

189

Protein Annotation
BU
Seq.
Cov.e
1xDEM-9xMET 22 conserved unknown
protein
1xDEM
20 putative sulfide
dehydrogenase
5xMET
51 hypothetical protein
1xDEM
15 putative sulfur oxidation
protein soxZ
1xDEM
1xDEM-2xMET 98 putative sulfur oxidation
protein soxY
1xDEM-3xMET 12 DUF336
4xMET
27 conserved hypothetical
protein
7xMET
12 possible transcriptional
activator
1xDIS-3xMET
1xMET
13 conserved hypothetical
protein
2xMET
1xDEM-1xDIS- 29 possible signal transducer
7xMET
1xDEM-1xDIS- 32 hypothetical protein
5xMET
2xMET
20 phnA-like protein
1xDIS-7xMET
14 conserved hypothetical
protein
1xMET
56 TPR repeat
2xMET
20 hypothetical protein
1xDEM-5xMET 10 putative arsenate
reductase
1xDEM-2xMET 73 DNA invertase gene rlgA
1xDEM-4xMET 18 unknown protein
8xMET
12 conserved hypothetical
protein
1xDEM-4xMET 61 conserved unknown
protein
6xMET
52 hypothetical protein
1xDIS-6xMET
12 conserved unknown
protein
1xDEM-5xMET 26 hypothetical protein
1xDEM-2xDIS- 15 conserved unknown
5xMET
protein
1xDEM-2xDIS- 11 ferredoxin like protein,
4xMET
fixX
1xDEM-1xDIS- 46 electron trnasfer
8xMET
flavoprotein beta chain
fixA
1xDEM-6xMET 18 Protein of unknown
function,
HesB/YadR/YfhF
PTMs

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

Nitrogen
Fixing

PTMs

RPA4612

11212.001, S

RPA4615

14719.802, S 7xMET

Protein Annotation
BU
Seq.
Cov.e
16 ferredoxin 2[4Fe-4S] III,
fdxB
25 nitrogenase molybdenumiron protein nifX
28 hypothetical protein
51 carbon-monoxide
dehydrogenase small
subunit
55 putative transcriptional
regulator

RPA4634
30215.805, M
RPA4666 16786.288, S
16786.506, M

1xDEM-6xMET
1xDIS-4xMET
1xDIS-4xMET

RPA4676 18896.116, S

1xDEM-1xDIS7xMET
4xMET
1xDEM-8xMET 13

RPA4678

18987.873, S
22847.204, S

RPA4686 28332.691, W
RPA4689

1xDEM-9xMET 68
16547.471, M

1xDEM-1xDIS- 40
4xMET
1xDEM-4xMET 13

RPA4701 14599.861, W
RPA4703

35090.978, M 2xDIS-6xMET

RPA4705 14571.402, M

94

RPA4707 23061.022, M

1xDEM-7xMET 13
1xDEM-4xMET
4xMET
76

RPA4724 19977.214, S

1xDEM-3xMET 75

RPA4738 13453.223, S
RPA4740

1xDEM-7xMET 18
13467.290, M 1xDEM-8xMET
14258.256, S 1xDIS-8xMET
11

RPA4744

24159.019, W 7xMET

53

5xMET

38
14
39

28138.352, M
RPA4770 14601.733, M
RPA4774
23446.932, W

1xDEM
3xMET
3xMET
1xDEM-3xMET
1xDIS-5xMET

13
10

RPA4775

2xMET

6

14530.074, M

RPA4748

31898.837, S

RPA4760 18312.327, S
RPA4768 28138.586, S

26963.040, W
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possible outer membrane
protein OprF (AF117972)
possible ABC transporter,
periplasmic amino
conserved hypothetical
protein
Protocatechuate 4,5dioxygenase, alpha chain
4-carboxy-2hydroxymuconate-6semialdehyde
phosphoribosyl-AMP
cyclohydrolase /
conserved hypothetical
protein
putative uridine 5monophosphate synthase
possible two-component
system reponse regulator
putative 4carboxymuconolactone
decarboxylase
possible thioredoxin-like
protein
3-hydroxybutyryl-CoA
dehydrogenase
unknown protein
conserved hypothetical
protein
DUF525
conserved unknown
protein
phosphate regulatory
protein, PhoB

Table 7.4: Continued
Gene
Number

Aerobic

Anaerobic

Nitrogen
Fixing

RPA4777 30253.206, M
RPA4804 10400.837, M
RPA4818 12907.825, M
RPA4825 13087.366, W
RPA4827 8356.579, M
8355.656, M
RPA4836 9578.187, S
a

Average molecular weight (Da)
S = Significant signal within the mass spectrum
c
M = Moderate signal within the mass spectrum
d
W = Weal signal within the mass spectrum
e
Percent bottom-up sequence coverage
DEM = N-terminal methionine truncation
ACE = acetylation
MET = Methylation
DIS = Disulfide Bond
URY = Uridylylation
b
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Protein Annotation
BU
Seq.
Cov.e
1xDIS-1xMET
13 phosphate ABC
transporter ATP-binding
protein,
5xMET
20 conserved hypothetical
protein
3xMET
80 conserved hypothetical
protein
2xMET
11 putative transcriptional
regulator, MerR family
1xDIS-4xMET
20 conserved hypothetical
protein
1xDIS-4xMET
1xDEM
19 30S ribosomal protein
S20
PTMs

Functional Categories
The use of protein identifications that have only top-down and bottom-up
identification limits the results to only the overlapping regions of the two data sets. For
example, the top-down analysis will be able to see proteins ≤ 40-60 kDa in size due to the
limitation of on line C4 reverse phase chromatography employed and the ability to elute
larger proteins off the column. In the bottom-up analysis smaller proteins will be missed,
because when the tryptic digest is performed smaller proteins will generate small peptides
that are not seen within the mass spectrometer. Therefore, we have a subset of 599
proteins containing both top-down and bottom-up confirmations.
These 599 proteins range in functional categories they belong to. The functional
categories for the identified proteins are shown in Table 7.5 (these functional categories
are based on the ORNL annotation scheme for bacteria
(http://genome.ornl.gov/microbial/). Table 7.5 depicts proteins identified from each
category, the total number of proteins predicted in each category from the genome, and
the percent of the predicted genome identified from each category. A total of 599 proteins
were confidently identified representing 12.44% of the genome predictions. Most of the
identified proteins fall into the unknowns and unclassified functional category in Table
7.5. This category contains two sub-groups that includes hypothetical and conserved
hypothetical proteins, as well as unknown and conserved unknown. Most of the
identified proteins were hypothetical and conserved hypothetical proteins, 141 in total
being followed by 100 proteins in the unknown function category.
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Table 7.5: Functional categories of identified proteins.
Category

Proteins

Unknowns and Unclassified
Replication Repair
Energy Metabolism
Carbon and Carbohydrate metabolism
Lipid Metabolism
Transcription
Translation
Cellular Processes
Amino Acid Metabolism
General Function Prediction
Metabolism of Cofactors and Vitamins
Transport
Signal Transduction
Purine and Pyrimidine Metabolism
Total

241
17
35
6
9
54
56
59
17
44
16
17
21
7
599
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Genome Prediction
% Identified
1407
17.13
126
13.49
306
11.44
107
5.61
158
5.70
283
19.08
168
33.33
524
11.26
181
9.39
420
10.48
150
10.67
699
2.43
231
9.09
56
12.50
4816
12.44

In our classification scheme, protein names are changed from hypothetical and conserved
hypothetical to unknown and conserved unknown when they are confidently identified
with at least two unique peptides [121]. Another category with numerous identifications
includes proteins involved in cellular processes such as chaperones, flagellar proteins,
stress proteins, and proteases. This category contained 59 proteins. The R. palustris
genome contains two separate copies of GroEL (RPA1140 and RPA2164) and GroES
(RPA1141 and RPA2165). We identified each of the two predicted GroES proteins
encoded by the RPA1141 and RPA2165 genes at high confidence. The two GroEL
proteins were not found due to the larger size of these proteins at 57626 Da for GroEL-1
and 57796 Da for GroEL-2. These larger molecular masses will prevent them from being
identified in the top-down analysis and therefore excluded from our combined top-down
and bottom-up data set.
The categories of transcription and translation make up two of the largest
percentages of proteins identified based on genome predictions and were identified in all
three growth states. This is to be expected since many of the proteins in these categories
are necessary under all metabolic modes. The large number of ribosomal proteins
provides most of the identifications in the translation functional category. In a previous
study of the purified 70S ribosome from R. palustris, we identified 53 of the 54 predicted
ribosomal proteins [54]. In the present study, we identified 45 of the 54 predicted
ribosomal proteins without prior purification. The missed ribosomal proteins are all small
and rich in lysine residues, which suggest that they were digested into peptides too small
for confident bottom-up identification. The larger ribosomal proteins were likely missed
by the top-down analysis due to the inability to elute them from the reverse phase C4
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column. This problem was also encountered in the previous study by Strader et al [54].
The transcription functional category mainly consisted of transcriptional regulators with a
total of 24 of these proteins comprising the 54 total identified proteins.
Proteins from the functional categories of, replication and repair, energy
metabolism, and purine and pyrimidine metabolism comprise some of the larger
percentages of the genome predictions based on the integrated top-down and bottom-up
data set. The category of replication and repair was detected with 17 proteins. In a
previous study baseline proteomics study performed in our laboratory, replication and
repair was found to be the category with the lowest abundance at 17% and 22 identified
proteins [121]. Howerver, in this study using the integrated top-down and bottom-up
method, the category of replication and repair was one of the higher percentage
categories with 17 proteins identified. This total is within the same range as identified in
the baseline bottom-up proteomics study. The identification of 17 proteins from this
category may be due to the size and ability of these proteins to be eluted from the C4
reverse phase column to be identified by top-down analysis well. In the category of
energy metabolism 35 proteins were identified. Most of these identifications include
proteins involved in photosynthesis and oxidative phosphorylation. One set of proteins
identified of particular interest are the NADH-ubiquinone dehydrogenase complexes.
Within this complex two operons (RPA2937-RPA2952 and RPA4252-RPA4264) are
each predicted to encode complete NADH-ubiquinone dehydrogenase proteins. It has
been theorized, the structure of each operon and the degree of divergence of the
individual proteins within these operons have different evolutionary lineages, possibly
from lateral transfer instead of duplication and divergence within the genome [13, 121].
195

A total of 3 proteins were identified from the first operon and 1 protein from the second
operon. These proteins were found across all metabolic states indicating expression under
all metabolic states. Isoforms of this protein were also identified which will be discussed
in greater detail later.
The categories of general function, metabolism of cofactors and vitamins, signal
transduction, amino acid metabolism, carbon and carbohydrate metabolism, and lipid
metabolism were identified with some of the smallest numbers of proteins predicted by
the genome sequence. From the signal transduction category 21 proteins were identified
with some of these identifications coming from nitrogen regulation proteins such as the
GlnK proteins and GlnB (RPA0272, RPA0274, and RPA2966) as well as the chemotaxis
proteins. Proteins from the categories of metabolism of cofactors and vitamins, amino
acid metabolism, carbon and carbohydrate metabolism, and lipid metabolism contained
proteins expected in metabolism of the individual products from the associated pathways
and in most cases represented across all growth states.
The transport category was identified with 17 proteins. This category should be
fairly abundant within the proteome. Originally, this was the case in the baseline study of
R. palustris; the integrated top-down and bottom-up method employed here provides a
low percentage of these proteins [121]. This is again due to the large size of the proteins
within this category at 30-50 kDa which would prevent the elution during the LC-FT-ICR
experiments off the C4 reverse phase column.
Comparison of Growth States
One goal of this study was to identify protein differences between the three growth
conditions (aerobic, anaerobic, and nitrogen fixing) employed for R. palustris. This
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comparison was first done by binary comparisons of related metabolic states as illustrated
in Figure 7.1. Proteins identified as showing expression differences between metabolic
states were then compared across all metabolic states to determine global trends in
protein expression. These differences were based on the presence or absence of the
protein in one state as compared to the closest metabolic state. For example, the
chemoheterotropic growth state (aerobic) was compared to the photoheterotrophic growth
state (anaerobic) as a baseline comparison. Also compared were the photoheterotrophic
growth state (anaerobic) and the photoheterotrophic nitrogen fixing growth state. It
should be noted that this technique is only useful in determining proteins presence or
absence between growth states and generating hypotheses about these proteins for future
testing.
Chemoheterotrophic Growth State Compared to the Photoheterotrophic Growth State
The chemoheterotrophic and photoheterotrophic states are the base states for this
study, as shown in Figure 7.1. The initial expectation is that the protein profiles of cells
grown under these two conditions would be quite different due to the cells obtaining
energy from the oxidation of succinate during chemoheterotrophic growth and energy
from light during photoheterotrophic growth. Most importantly, chemoheterotrophic cells
were grown aerobically whereas photoheterotrophic cells were grown anaerobically.
Succinate was the source of carbon for both growth modes. Interestingly, the hallmark R.
palustris phenotype of photosynthesis, the red coloring of the cell membranes, was
observed for every metabolic state, though the red coloring was much more prominent
under anaerobic states. This is due to R. palustris inability to turn off its photosynthetic
machinery completely, no matter what growth condition it is in. Therefore, certain
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photosystem proteins would be expected throughout all growth conditions. The
photosystem proteins are generally large in size and not amenable to the liquid
chromatography separations used in the top-down measurements and therefore, not listed
in the total 599 proteins identified. However, certain photosystem proteins, such as
RPA1548 which encodes for the H subunit of the photosynthetic reaction center, were
identified in the bottom-up analysis across all three growth states. Nonetheless,
differences were found at the protein level between these two growth states. The BolAlike protein (RPA0501) and chemotaxis protein CheY4 proteins (R1175) showed strong
correlation with the aerobic states with no expression under any of the anaerobic states.
In contrast, the anaerobic proteins unknown proteins RPA1495, RPA1620, RPA2333,
RPA2334, RPA2335, RPA2336, and RPA2338 all showed strong correlation with the
anaerobic states and no expression under the aerobic state. The operon of genes encoding
unknown proteins, from RPA2333 to RPA2338, is a unique operon that was previously
identified in a baseline proteomics study performed on R. palustris [121]. As in the
previous study, this entire operon, except RPA2337, was found to show relatively strong
expression under anaerobic states but no expression in the aerobic state. In the case of
RPA2337 it was not detected, even though it does not have any predicted transmembrane
domains which should make it detectable in both the peptide and protein form [121].
Photoheterotrophic Growth State Compared to Nitrogen-Fixing Growth State
In this study the evaluation of protein differences between with nitrogen fixation
in the photoheterotrophic state was a logical step in testing our methodology, due to
many of the proteins expressed during nitrogen fixation should be present when this
process is undertaken by the cell [121, 122]. As expected, a number of proteins expressed
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only under nitrogen fixing conditions were identified. Some of the proteins thought to be
involved in nitrogen fixation were found only under nitrogen-fixing conditions and not
detected to under any of the other growth conditions. These include RPA4209, glutamine
synthetase; and certain proteins within the nif regulon (RPA4602-4632) including
RPA4605, electron trnasfer flavoprotein beta chain fixA; RPA4612, the ferredoxin
2[4Fe-4S] III, fdxB; as well as RPA4615 nitrogenase molybdenum-iron protein nifX.
The protein RPA4209, glutamine synthetase, is involved in nitrogen fixation in concert
with the GlnK and GlnB proteins, which are regulated by a unique PTM under nitrogen
fixing conditions.
Post Translational Modifications
Of the 599 proteins identified by top-down and bottom-up most of these were identified
with some varying degree of PTMs; whether it is an N-terminal methionine truncation,
methylation, or acetylation. Nearly all proteins undergo some form of post translational
modification [1]. These post translational modifications are important to provide protein
heterogeneity; thereby allowing the protein to exists in multiple isoforms. Within this
study, the common PTMs of methylation, acetylation, N-terminal methionine truncation,
and disulfide bonds were examined. By far the most common PTM identified was Nterminal methionine truncation. Of the 599 proteins identified in this study 267 have a
methionine truncation. The truncation of the N-terminal methionine depends on the
charge and size of the amino acid side chain occupying the next position from the Nterminal methionine. According to the “N-end rule”, residues bearing small uncharged
side chains (stabilizing), such as alanine, allow docking of methionine peptidases that
cleave the N-terminal methionine. Within the 267 N-terminal truncated proteins
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identified, 184 have a stabilizing amino acid according to the “N-end rule”. Shown in
Table 7.6 are all of the N-terminal methionine truncated proteins identified and the
amino. acid occupying the second position. The proteins that do not follow the “N-end
rule” would make good candidates for further study. Also the proteins that do not adhere
to the rule may be the result of annotation errors and bear further analysis of the gene
start site calls.
Phosphorylation is a common PTM, although, most of the phosphorylation in R.
palustris is performed by a histidine kinase, which provides a very fleeting interaction as
well as being acid labile that posses problems during mass spectrometry analysis. Due to
these reasons, phosphorylation was not searched for within this study. Other specialized
PTMs such as uridylylation were searched for and identified within the top-down and
bottom-up data sets.
A number of proteins were identified with PTMs from the anaerobic growth state.
Of the 119 proteins identified by the integrated top-down and bottom-up analysis 90 of
these proteins from the anaerobic growth were identified with a form of a PTM. The most
abundant of the PTMs seen on the 90 proteins are N-terminal methionine truncation,
followed by proteins containing combinations of methylations. Of particular interest
were the unknown and hypothetical proteins that contain PTMs, due to the possible
information about function and location this can provide [Table 7.7]. The unique
hypothetical operon (RPA2333-RPA2338) was of interest because it was located in one
operon that was previously unknown. It has also been demonstrated that none of the
proteins in this operon have been found to have strong similarity to any genes in
sequenced microbial genomes to date except RPA2333, which is similar to segments of a
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Table 7.6: N-Terminal Methionine Truncations
Gene
RPA0008
RPA0038
RPA0159
RPA0335
RPA0366
RPA0526
RPA0662
RPA0673
RPA0927
RPA0953
RPA1088
RPA1090
RPA1141
RPA1175
RPA1717
RPA1777
RPA2012
RPA2197
RPA2334
RPA2437
RPA2556
RPA2604
RPA2728
RPA2768
RPA2814
RPA2852
RPA2869
RPA2953
RPA3078
RPA3129
RPA3227
RPA3228
RPA3232
RPA3237
RPA3238
RPA3239
RPA3255
RPA3270
RPA3272
RPA3273
RPA3436
RPA3457
RPA3583
RPA3671
RPA3803
RPA3875
RPA3956
RPA4067
RPA4102
RPA4137
RPA4344
RPA4574
RPA4612
RPA4738
RPA4836
RPA1697
RPA2649

Second AA
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
C
C

Function
circadian clock protein
ribosomal protein L20
ribosomal protein L27
putative phospholipid N-methyltransferase
unknown protein
50S ribosomal protein L32
ferredoxin
transcriptional activator
probable transcriptional regulator
possible exodeoxyribonuclease small subunit
hypothetical protein
possible nitrogen regulator
chaperonin GroES1, cpn10
chemotaxis protein CheY4
hypothetical protein
DUF35
conserved unknown protein
cell division protein FtsJ
unknown protein
3-dehydroquinate dehydratase type 2
PA-phosphatase related phosphoesterase
peptidyl prolyl cis-trans isomerase
riboflavin synthase, beta chain
ribosomal protein S9
single-strand DNA-binding protein
putative sugar hydrolase
possible flavin-dependent oxidoreductase
possible DNA-binding protein hu-alpha (NS2)
30S ribosomal protein S18
50S ribosomal protein L33
30S ribosomal protein S11
30S ribosomal protein S13
ribosomal protein L30
30S ribosomal protein S14
50S ribosomal protein L5
50S ribosomal protein L24
30S ribosomal protein S12
50S ribosomal protein L10
50S ribosomal protein L1
50S ribosomal protein L11
GCN5-related N-acetyltransferase
Biotin/lipoyl attachment:Biotin-requiring
conserved hypothetical protein
translation initiation factor if-1 (infA)
carbon-monoxide dehydrogenase small subunit
conserved unknown protein
ferredoxin
hypothetical protein
putative transcriptional regulator
conserved unknown protein
hypothetical protein
hypothetical protein
ferredoxin 2[4Fe-4S] III, fdxB
possible two-component system reponse regulator
30S ribosomal protein S20
Competence-damaged protein
conserved unknown protein
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Table 7.6: Continued
Gene
RPA1279
RPA1615
RPA1812
RPA1824
RPA1842
RPA2241
RPA3130
RPA3524
RPA3721
RPA4138
RPA4191
RPA4297
RPA2533
RPA4179
RPA0207
RPA0501
RPA0517
RPA2648
RPA3244
RPA3672
RPA3924
RPA4418
RPA0855
RPA3123
RPA4605
RPA0233
RPA0600
RPA0646
RPA0866
RPA1064
RPA1108
RPA1454
RPA2239
RPA2283
RPA3589
RPA3676
RPA3828
RPA3878
RPA4070
RPA4542
RPA4610
RPA0885
RPA1019
RPA1107
RPA2057
RPA2314
RPA2522
RPA2667
RPA3223
RPA3501
RPA4544
RPA4676
RPA0160
RPA0298
RPA1017
RPA1278
RPA1905

Second AA
D
D
D
D
D
D
D
D
D
D
D
D
E
F
G
G
G
G
G
G
G
G
H
H
H
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
K
K
K
K
K
K
K
K
K
K
K
L
L
L
L
L

Function
hypothetical protein
putative methyltransferase
conserved hypothetical protein
unknown protein
conserved unknown protein
conserved hypothetical protein
Helix-turn-helix motif
putative cell division protein FtsQ
possible ABC transporter, permease protein
conserved unknown protein
conserved unknown protein
putative aldose reductase
unknown protein
conserved unknown protein
unknown protein
BolA-like protein
putative transcriptional regulator (Fur family)
unknown protein
30S ribosomal protein S3
cold shock protein
conserved hypothetical protein
conserved unknown protein
Beta-lactamase-like
hypothetical protein
electron transfer flavoprotein beta chain fixA
putative Citrate lyase beta chain (acyl lyase
conserved hypothetical protein
conserved hypothetical protein
putative nucleoside diphosphate kinase regulator
conserved hypothetical protein
Myb DNA-binding domain:DGPF domain
hypothetical protein
putative partition protein
putative proteic killer suppression protein
conserved hypothetical protein
putative type IV prepilin peptidase, cpaA
Helix-turn-helix motif
conserved unknown protein
possible peptide methionine sulfoxide reductase
unknown protein
Protein of unknown function, HesB/YadR/YfhF
conserved hypothetical protein
possible transcriptional activator HlyU
possible transcriptional regulator
hypothetical protein
cytochrome c556
hypothetical protein
conserved unknown protein
putative alginate lyase
conserved unknown protein
conserved unknown protein
putative transcriptional regulator
possible acetyltransferases.
DUF299
Nitrogen fixation-related protein
GatB/Yqey
homologue of Rhodobacter capsulatus gene
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Table 7.6: Continued
Gene
RPA1985
RPA2028
RPA2603
RPA2934
RPA3101
RPA3148
RPA3327
RPA4470
RPA0331
RPA1025
RPA2718
RPA2899
RPA3719
RPA4529
RPA4634
RPA0571
RPA0594
RPA2045
RPA2165
RPA3663
RPA4050
RPA4077
RPA0039
RPA0283
RPA0598
RPA1302
RPA1342
RPA1600
RPA1620
RPA2456
RPA2690
RPA3168
RPA3213
RPA3246
RPA3254
RPA3759
RPA4176
RPA4228
RPA4600
RPA4686
RPA4701
RPA0090
RPA0263
RPA0653
RPA1586
RPA1827
RPA2006
RPA2453
RPA2717
RPA3215
RPA3319
RPA0092
RPA0203
RPA0301
RPA0543
RPA0767
RPA0868

Second AA
L
L
L
L
L
L
L
L
M
M
M
M
M
M
M
N
N
N
N
N
N
N
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
Q
Q
Q
Q
Q
Q
Q
Q
Q
Q
R
R
R
R
R
R

Function
probable diacylglycerol kinase
conserved hypothetical protein
conserved hypothetical protein
conserved unknown protein
conserved unknown protein
DUF174
hypothetical protein
DUF336
possible heat shock protein (HSP-70 COFACTOR),
possible Ectothiorhodospira Vacuolata
hypothetical protein
conserved hypothetical protein
putative high-affinity branched-chain amino acid
putative arsenate reductase
hypothetical protein
two-component, response regulator
putative mutator protein mutT
biotin synthetase
chaperonin GroES2, cpn10
urease gamma subunit
unknown protein
ATPase, ParA type
50S ribosomal protein L35
putative two-component response regulator
putative glutaredoxin
unknown protein
hypothetical protein
BolA-like protein
unknown protein
possible bacterioferritin co-migratory protein
possible uracil-DNA glycosylase
possible flgaellar switch protein FliN
hypothetical protein
30S ribosomal protein S19
30S ribosomal protein S7
putative 5-carboxymethyl-2-hydroxymuconate
ribosomal protein S21
hypothetical protein
conserved unknown protein
possible ABC transporter, periplasmic amino
Protocatechuate 4,5-dioxygenase, alpha chain
hypothetical protein
Protein of unknown function UPF0047
2-ketocyclohexanecarboxyl-CoA hydrolase
putative short-chain dehydrogenase/reductase
hypothetical protein
putative phosphatidylserine decarboxylase
translation peptide releasing factor RF-2
conserved hypothetical protein
putative nitroreductase
hypothetical protein
conserved hypothetical protein
heme exporter protein A (heme ABC transporter
putative DNA polymerase III epsilon chain
unknown protein
PAS domain:GGDEF:PAC motif
hypothetical protein
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Table 7.6: Continued
Gene
RPA1289
RPA1915
RPA2523
RPA3024
RPA4277
RPA4349
RPA4689
RPA0054
RPA0282
RPA0433
RPA0435
RPA0443
RPA0450
RPA0493
RPA0607
RPA0609
RPA0714
RPA0917
RPA0930
RPA0932
RPA0993
RPA1106
RPA1228
RPA1659
RPA1726
RPA1757
RPA1964
RPA2066
RPA2082
RPA2732
RPA2744
RPA3073
RPA3235
RPA3236
RPA3269
RPA3290
RPA3394
RPA3476
RPA3555
RPA3852
RPA3896
RPA3913
RPA4272
RPA4383
RPA4501
RPA4724
RPA0052
RPA0059
RPA0222
RPA0267
RPA0292
RPA0326
RPA0354
RPA0643
RPA1168
RPA1589
RPA1593

Second AA
R
R
R
R
R
R
R
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
T
T
T
T
T
T
T
T
T
T
T

Function
hypothetical protein
FeuP two-component system, regulatory protein
putative lactoylglutathione lyase
unknown protein
conserved hypothetical protein
conserved unknown protein
conserved hypothetical protein
putative small heat shock protein
possible transcriptional regulator
ribosomal protein S15
putative ribosome-binding factor A
possible transcriptional regulator
ferric uptake regulation protein
50S ribosomal protein L28
putative protoporphyrinogen oxidase, hemK
conserved hypothetical protein
bifunctional cobinamide kinase, cobinamide
Transcriptional Regulator, AraC Family
possible 3-octaprenyl-4-hydroxybenzoate
conserved unknown protein
possible alpha-ribazole-5`-phosphate phosphatase
conserved hypothetical protein
putative 2-oxoglutarate ferredoxin
conserved unknown protein
putative oxidoreductase
possible oxoacyl carrier protein reductase
hypothetical protein
putative nosX
putative uroporphyrin III methylase
conserved hypothetical protein
hypothetical protein
constitutive acyl carrier protein
50S ribosomal protein L6
30S ribosomal protein S8
50S ribosomal protein L7/L12
possible transcriptional regulator, TetR family
DUF37
possible energy transducer TonB
arsenate reductase
hypothetical protein
hypothetical protein
conserved hypothetical protein
conserved unknown protein
conserved unknown protein
phnA-like protein
putative uridine 5-monophosphate synthase
putative nitrogen regulatory IIA protein(enzyme
L-carnitine dehydratase/bile acid-inducible
Beta-Ig-H3/Fasciclin domain
possible thioredoxin
chromosome partitioning protein, ParA
DUF24, predicted transcriptional regulator,
putative pts system phosphocarrier protein HPr
conserved hypothetical protein
molybdopterin converting factor, subunit 2
30S ribosomal protein S4
Thioesterase superfamily
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Table 7.6: Continued
Gene
RPA1870
RPA1978
RPA1993
RPA2032
RPA2084
RPA2158
RPA2338
RPA2520
RPA2540
RPA2766
RPA2856
RPA2973
RPA2985
RPA3626
RPA3770
RPA3970
RPA3988
RPA4010
RPA4206
RPA4241
RPA4348
RPA4357
RPA4457
RPA4500
RPA4541
RPA4602
RPA4666
RPA4678
RPA4760
RPA0490
RPA1535
RPA2265
RPA2848
RPA2933
RPA3824
RPA4072
RPA4467
RPA4483
RPA4770

Second AA
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
V
V
V
V
V
V
V
V
V
Y

Function
possible transcriptional regulator (MarR/EmrR
molybdenum biosynthetic protein A
possible virulence-associated protein
acetolactate synthase (small subunit)
precorrin 3 or 4 methylase
hypothetical protein
unknown protein
hypothetical protein
3-hydroxy-3-methylglutaryl-CoA lyase
Phenylacetic acid degradation-related
Protein of unknown function, HesB/YadR/YfhF
hypothetical protein
conserved unknownl protein
conserved unknown protein
conserved unknown protein
putative
putative phosphatase
putative response regulator
D-beta-hydroxybutyrate dehydrogenase
CBS domain
conserved hypothetical protein
conserved unknown protein
putative sulfide dehydrogenase
hypothetical protein
DNA invertase gene rlgA
ferredoxin like protein, fixX
carbon-monoxide dehydrogenase small subunit
possible outer membrane protein OprF (AF117972)
unknown protein
conserved hypothetical protein
cytochrome c2
conserved hypothetical protein
possible sec-independent protein secretion
conserved hypothetical protein
conserved hypothetical protein
transcriptional elongation factor greA
putative sulfur oxidation protein soxY
possible signal transducer
DUF525
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Table 7.7: Identification of unknown proteins with PTMs from the anaerobic growth
state.
Protein
RPA2334
RPA2335
RPA2336
RPA2338
RPA1495
RPA1620

Putative PTM
Methionine Truncation
1, 2, 4 Methylations
1 Methylation
Methionine Truncation
Methionine Truncation
Methionine , 1 Methylation

Function
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
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putative cation transport ATPase but does not have the predicted transmembrane domains
generally associated with such a transport ATPase.
When this operon was examined with top-down methods a series of PTMs
including methylations and N-terminal methionine truncations were identified [Table
7.7]. The proteins RPA2334 and RPA2338 were identified with an N-terminal
methionine truncation. Interesting though, RPA2335 was identified with a series of 1-4
methylations as well as in its native form and RPA2336 was identified with 1
methylation, as seen in Figure 7.2. This unique hypothetical operon with its series of
PTMs may provide a target for future functional studies such as gene knockouts and
protein interaction studies through tagging protocols or other biochemical enrichment
techniques. Also identified within the anaerobic growth state were the unknown proteins
RPA1495 with an N-terminal methionine truncation and RPA1620 with an N-terminal
methionine truncation as well as 1 methylation. Protein RPA1495 is found within an
operon with light harvesting proteins which may provide a possible associated function
for this protein. Methylation is a common PTM found on lysine and arginine mainly.
These two residues have very polar side chains that are positively charged. When these
residues are blocked by a methylation or acetylation the basic nature of that site within
the protein can be changed, thereby making it more or less accessible to other targets.
Within the aerobic growth state a number of proteins were identified with PTMs. Of the
426 proteins identified 394 of these possessed some form of a PTM. Included in the list
of proteins that contain PTM unknown as well as common proteins such as ribosomes
were identified. Two unknown proteins were of particular interest due to multiple
isoforms being present.
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2-methylations

(A)

4-methylations
1-methylation

3-methylations
Native form

Native form

(B)

1-methylation

Figure 7.2: Mass spectra of RPA2335 and RPA2336. (A) Mass spectrum of RPA2335
from a unique anaerobic unknown operon showing the native, 1 methylation, 2
methylations, and 3 methylations isoforms. (B) Mass spectrum of RPA2336 from a
unique anaerobic unknown operon showing the native protein and isoform with 1
methylation.
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The unknown protein RPA4610 (17% sequence coverage) was found to have an
N-terminal methionine truncation with a combination of 4-8 methylations [Figure 7.3].
The protein was only identified in this highly modified state making it an interesting
candidate for further functional studies. Another unknown protein identified with
multiple isoforms was RPA4330 which has a native form as well as a methylated version.
Protein RPA0501 that was identified only in this growth state was shown to have an Nterminal methionine truncation. Two ribosomal proteins L30 and L23 also were
identified with a native or an N-terminal methionine truncation and containing one
methylation.
The nitrogen fixing growth state has 214 identified proteins; of these 192 have a
PTM. Several of the unknown and hypothetical proteins within the nitrogen fixing
growth state contain PTMs and multiple isoforms. Of particular interest are three of these
conserved hypothetical proteins including, RPA2732 identified with an N-terminal
methionine truncation form as well as an isoform with 2 acetylations and 1 methylation.
A set of hypothetical proteins were identified within one mass spectrum from the LCFTICR-MS data, as seen in Figure 7.4. Within this mass spectrum the first pair of
proteins is RPA 1286 containing a unmodified form and a methylated isoform; the
second pair are RPA2979 with an N-terminal methionine truncation plus 2 methylations
and an isoform with an N-terminal methionine truncation plus 3 methylations.
A specialized PTM of interest associated with the nitrogen fixing growth state
was uridylylation found on the GlnK and GlnB proteins. The GlnK and GlnB proteins
are members of the pII signal transduction protein family. In R. palustris there are three
annotated forms of pII proteins; GlnK1, GlnK2, and GlnB.
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1 DEM + 6 methylations
1 DEM + 5 methylations
1 DEM + 4 methylations

1 DEM + 7 methylations

1 DEM + 8 methylations

Figure 7.3: Mass spectrum of unknown protein RPA4610. The unknown protein
RPA4610 with an N-terminal methionine truncation and a combination of 4-8
methylations from the aerobic growth state. DEM represent N-terminal methionine
truncation within the figure.
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RPA1286
1 methylation

RPA2979

1 DEM + 3 methylations

Native
1 DEM + 2 methylations

Figure 7.4: A set of hypothetical proteins identified within one mass spectrum from the
LC-FTIC-MS data. Within the mass spectra the first pair of proteins is RPA1286
containing a native form and a methylated isoform; the second pair is RPA2979 with an
N-terminal methionine truncation plus 2 methylations and an isoform with an N-terminal
methionine truncation plus 3 methylations.
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Two of these proteins were found to undergo uridylylation under ammonium starvation
conditions (nitrogen fixing), presumably to regulate the AmtB ammonium transporter as
well as glutamine synthetase [102]. Under nitrogen fixing growth conditions the GlnK2
(RPA0274) and GlnB (RPA2966) proteins were identified in both the unmodified and
modified states [123]. The GlnK2 protein was identified in the nitrogen fixing growth
state along with GlnB, while GlnK1 was identified in the anaerobic growth states. These
are the states the proteins should be found in according to previous research (Chapter 5).
Signal Peptides
Top-down mass spectrometry can provide information on the function and
location of proteins. This is especially true when proteins containing signal peptides are
considered. Most cell types and organisms employ several ways of targeting proteins to
the extracellular environment or subcellular locations. Most of the proteins targeted for
the extracellular space or subcellular locations carry specific sequence motifs (signal
peptides) characterizing the type of secretion/targeting it undergoes. To identify potential
amino-terminal signal peptides, primary sequence analysis of the predicted R. palustris
proteome was performed by the SignalP NN [124], SignalP HMM [124], PrediSi [125],
and PSORTb [126] algorithms. A subdatabase containing R. palustris proteins with
predicted signal peptides by all three signal peptide prediction algorithms was created by
Judson Hervey, a graduate student in the Genome Science and Technology program.
Amino-terminal signal peptides were removed from each protein in the subdatabase
based upon the predicted cleavage site by the SignalP NN(2) algorithm. Within the three
growth states of R. palustris examined, 22 proteins with predicted signal peptides were
identified using the database of predicted proteins containing signal peptides [Table 7.8].
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Table 7.8: Identified proteins with signal peptides.
Protein

Unprocessed
MW

Processed
MW

Measured
Mass

RPA0088

7665.972

5687.447

5687.404

RPA0090

15280.276

8049.5894

8048.786

RPA0091

11250.928

7572.476

7572.525

Sequence
Coverage

Function
Unknown Protein

7.5

Hypothetical Protein
Hypothetical Protein
Putative High Potential
Iron Sulfur Protein

RPA0744

9858.252

6185.924

6186.192

RPA1023

11434.053

8706.657

8706.918

RPA1088

12609.711

8223.414

8223.715

13.5

Hypothetical Protein

RPA1428

27812.97

25962.713

25962.602

19.8

Possible Lipoprotein

RPA1454

9442.541

6067.368

6067.362

21.6

RPA1824

17579.16

12571.359

12571.258

8.2

RPA1847

9430.428

7119.5864

7120.332

RPA1874

7297.609

5526.5815

5526.812

RPA2544

8676.271

5865.847

5865.694

RPA2546

15826.283

12707.527

12707.453

RPA3025

11292.242

7926.262

7926.935

RPA3034

9315.853

6270.1743

RPA3101

17265.908

RPA3362

10279.998

RPA3373

Hypothetical Protein

Hypothetical Protein
Unknown Protein
Conserved Hypothetical
Protein

34.9

Hypothetical Protein
Conserved Hypothetical
Protein
FKBP-type Peptidyl-prolyl
cis-trans Isomerase

6270.788

19.8

Unknown Protein

13337.184

13337.205

8.8

Unknown Protein

7755.001

7754.766

10172.86

8148.3096

8149.009

RPA3957

12532.322

6725.5767

6725.496

RPA4329

15828.192

13645.581

13645.413

Hypothetical Protein

Unknown Protein
15.5
9

RPA4467

16279.965

12802.759

12802.356

9.8

RPA4573

16557.592

15352.109

15351.637

27.8
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Hypothetical Protein
Hpt Domain
Unknown Protein
SoxY2 Putative Sulfur
Oxidation Protein
Unknown Protein

Twelve of the 22 identified proteins have some bottom-up sequence coverage. However,
the signal peptide is not able to be identified by bottom-up methods the rest of the protein
can provide peptide information for identification. The remaining 10 proteins identified
that do not have bottom-up sequence coverage are generally too small to be detected, in
bottom-up, after truncation In the case of signal peptide searching the union of top-down
and bottom-up identifications are shown, as well as proteins identified with only topdown searching [Table 7.8].
Seventeen of the proteins identified were unknown or hypothetical proteins. The
identification of signal peptides from these proteins provides a basis for starting to
determine the function and location of these proteins. The putative high potential ironsulfur protein (RPA0744), FKBP-type peptidyl-prolyl cis-trans isomerase (RPA2546),
and soxY2 putative sulfur oxidation protein (RPA4467) were all proteins that were
identified with known functions. These three proteins have functions that a signal peptide
would expect to been seen for. For example, the putative high potential iron-sulfur
proteins are a specific class of high-redox potential 4Fe-4S ferrodoxins that function in
anaerobic electron transport and which occurs in photosynthetic bacteria. Also, this
protein has been shown to have predicted signal peptides in other bacteria. In R. palustris
the putative high potential iron-sulfur protein (RPA0744) was identified in the anaerobic
nitrogen fixing growth state, which correlates with its function in electron transport
during anaerobic growth. The integrated top-down and bottom-up approach provided for
the identification of 22 signal peptides in R. palustris, which gives an additional level of
information about this organism.
Conclusions
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In this study, we have characterized the R. palustris proteome by integrated topdown and bottom-up analysis under three major metabolic states. We confidently
identified 599 proteins by an integrated top-down and bottom-up approach. In total, 241
proteins classified as unknown and conserved unknown proteins were identified,
representing 17.3% of the identified proteins. Over 500 proteins were identified
containing some form of a PTM. The proteome analysis of a number of metabolic states
with their associated PTMs and isoforms is necessary to begin to understand how
microbes change their proteome to adapt to the resources present. The conserved
unknown and unknown proteins that were identified as containing multiple isoforms
under the metabolic states examined here are excellent targets for future studies, because
they may have important functions under those states. The detection of PTMs on an
unknown operon of five proteins found to be expressed only under the phototrophic
(anaerobic illuminated) states, with no evidence of expression under chemotrophic
(aerobic dark) states, was an excellent example of the discovery capabilities of this
general method to provide further information of function and location for these proteins.
Our data indicates that it is possible to identify large numbers of intact proteins
with and with out PTMs and correlate this information to bottom-up ms/ms data. By
creating a list of common PTMs one can begin the process of imparting information
about the natural state of the protein and how it may be functioning within the cell. This
is the first study of this magnitude to offer such a comprehensive list of intact identified
proteins with their associated PTMs. This employed technique should provide a starting
point of future work with protein complexes and functional studies within this as well as
other microbial systems.
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Chapter 8
Conclusions and Impact of Integrated and Computational Platform for the Analysis
of Intact Proteins and PTMs of Microbial Systems by Top-down Mass Spectrometry
The overall goal of this dissertation research was to develop an integrated
computational and experimental platform for characterizing protein isoforms and PTMs
in microbial systems by top-down FT-ICR mass spectrometry. We first evaluated the
methodologies of microbial growth, intact protein and protein complex extractions,
followed by sample preparation and then progressed to identification of the
instrumentation needed to integrate the two methodologies used in these studies.
Emphasis was placed on the development of integrated top-down and bottom-up
informatics and the challenges faced in the integration of these two large data sets and
extraction of relevant biological data. We then illustrated how these technologies can be
applied to the analysis of complex protein mixtures, protein complexes and microbial
proteomes. Great progress has been made through these studies, but much work is still
needed in the areas of intact protein separations, data data-dependent MS/MS on intact
proteins within liquid chromatography time scales, and further analysis of PTMs once
tentatively identified. Some avenues of research performed in this dissertation to combat
these issues are discussed below.
During this dissertation work, an essential need for fundamental advancements in
the analysis of proteins and peptides was addressed. Two areas of particular interest
included better methods of determination of charge states for large proteins and advanced
protein fragmentation methods with the FTICR-MS. Each of these areas was addresses in
this dissertation work. Due to the difficulties encountered with LC-FTICR-MS
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measurements and charge state determination, an automated method for determining
charge states from high-resolution mass spectra was developed. Fourier transforms of
isotope packets from high-resolution mass spectra are compared to Fourier transforms of
modeled isotopic peak packets for a range of charge states. The charge state for the
experimental ion packet is determined by the model isotope packet that yields the best
match in the comparison of the Fourier transforms. Existing charge state assignment
algorithms for FTICR-MS data appear to require centroiding before charge
determination, and errors in this process can lead to errors in assessed charges. Use of
Fast Fourier transforms (FFT) for charge determination does not require centroiding and
appears to achieve superior sensitivity and noise suppression than algorithms of this type,
especially for LC-FTICR-MS measurements. This advancement can be applied to data
analysis in order to ensure the most accurate protein identifications during searching
against a protein database. The second area targeted for FTICR-MS development was the
evaluation of proteins and peptide fragmentation methods within the FTICR-MS. This
work demonstrated the use of MSAD as a replacement for more commonly applied
fragmentation methods, such as SORI-CAD, within the FTICR as a feasible option for
simple peptides solutions, tryptic digest and simple mixtures. MSAD provides a
fragmentation method that can fragment all peptides in the sample in one step eliminating
the isolation step needed for SORI-CAD, which provides a more operationally simple
and time saving method. MSAD saves time during the experimentation process,
although, the data analysis is in-depth and time consuming due to the complexity of the
fragmentation spectra. Therefore, at this time we are not employing MSAD for intact
protein analysis. These two fundamental studies provided better methods for protein
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charge state determination under liquid chromatography conditions. Also, these studies
provided alternative fragmentation methods of proteins and peptides within the FTICRMS, thereby advancing the field of top-down mass spectrometry.
The combination of the top-down and bottom-up MS methodologies for the
characterization of individual proteins, protein complexes and whole proteomes were the
major focus of this dissertation work. While many proteomics groups are focusing on
either top-down or bottom-up techniques, very few have tried to integrate the two
technologies. Through the work of this dissertation we have pushed the forefront of this
technology. Our initial effort was to analyze complex ribosomal protein mixtures from R.
palustris and antibiotic resistant E. coli strains; this effort showed great promise for this
integrated technology to obtain a detailed level of information not possible by either
technique alone. This includes the determination of the position and number of posttranslational modifications on the intact protein product, as well as the determination of
the number and position of amino acid changes (mutations) within intact proteins for
most potential substations (Ile-Leu can’t be resolved because they are isobaric). The
integrated top-down and bottom-up analysis of component proteins of the 70S ribosome
from R. palustris enhanced several aspects of the analysis. For this study, the bottom-up
approach was expanded to the use of 1D and 2D LC-MS/MS methodologies for the
analysis of the enzymatically digested ribosomal protein complex. For the experiments on
R. palustris ribosomal complexes, we performed LC-ES-FT-ICR for intact protein
measurements. Not only was this method useful in the analysis of R. palustris ribosomes;
the use of integrated top-down and bottom-up mass spectrometry approaches provided
insight into the role of ribosomal proteins in streptomycin resistance in E. coli. In this
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study, we employ an integrated top-down and bottom-up approach to characterize the
ribosomal proteins from wild type K12 and two streptomycin resistant strains of E. coli.
Using this method, a complement of ribosomal proteins with unique PTM series,
isoforms, and point mutations were identified from all three strains. For the first time,
this method allowed for the interrogation of differential post translational modifications
in the “compensation” process for E. coli, as well as further conformation of point
mutations thought to confer antibiotic resistance.
The analysis of key regulation sites within protein complexes was the next step in
the development of the integrated top-down and bottom-up platform. To perform this
analysis, affinity purifications of the R. palustris pII family of proteins consisting of
GlnK1, GlnK2 and GlnB were analyzed. In bacteria, the pII family generally plays a
pivotal role in nitrogen metabolism regulation due to its ability to sense internal cellular
ammonium concentrations. The uridylylation of these proteins regulate ammonia
transporters as well as glutamine synthetase. Affinity purifications in conjunction with
top-down and bottom-up mass spectrometry permitted the isolation and characterization
of the functional state and isoforms for these proteins as a function of nitrogen
availability. From this work, it was determined that under nitrogen fixing conditions, all
of these pII proteins are uridylylated, all on the Tyr-51 positions. Thus, pII protein
uridylylation appears to be tightly coordinated with nitrogen availability. By using a
combined technique of protein affinity purifications and mass spectrometry, it was
determined, for the first time, that GlnK2, GlnK1 and GlnB proteins possess an
uridylylation under nitrogen fixing growth conditions in R. palustris. This information
allowed for a previously un-afforded glimpse into the modifications and isoforms of the
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proteins that regulate the AmtB transporter and glutamine synthetase in R. palustris. Not
only did this method provide a glimpse into a key regulation site for a protein complex it
also expanded the capabilities of this approach for future systems.
At the outset of this dissertation a primary limitation of top-down analysis was
bioinformatics tools for querying protein databases. The isotopic packets of intact
proteins and the MS/MS spectra of intact proteins are both much more complicated than
those derived from peptide measurements thereby enhancing this problem. This
dissertation work provided the first informatics tools for combining top-down and
bottom-up datasets to search for PTMs, amino acid substitutions, and N-terminal
truncations. At the start of this dissertation, the ProSight PTM and PROCLAIM
algorithms had been available for the analysis of intact protein and their MS/MS spectra
against protein databases as well as PTM prediction. Even with these programs, no major
effort had been made to integrate top-down analysis with traditional enzymatic bottom-up
analysis for protein identification and PTM analysis. Our ORNL developed algorithm
PTMSearchPlus is the first software providing a comprehensive search method that
allows for the integration of top-down protein identification with the bottom-up peptide
data to identify proteins and their associated PTMs. The software is built around multiple
instrumentation platforms and data inputs. These multiple instrumentation and data
platforms include bottom-up ion trap data, as well as top-down high resolution data such
as FTICR data. The software can accomplish independent top-down or bottom-up
searches, as well as these two parts of the program being able to interact in a combined
search. By combining these two search capabilities, the results from the top-down search
can limit the number of the proteins that are used to generate the database used for the
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bottom-up search (search time decrease) and in return, the results of the bottom-up search
can be used as a confirmation for the proteins with associated PTMs found in the topdown search. This integration reduces the search time dramatically, allowing the user to
search for more PTMs on proteins and peptides during a reasonable time frame. The
software was demonstrated with a protein standard mixture and complex ribosomal
protein mixture. All proteins from the protein standard mixture, which was used as a
training set, were identified using PTMSearchPlus. The R. palustris complex ribosomal
mixture was previously examined in an integrated fashion by manual comparison. Using
PTMSearchPlus all of the identified ribosomal proteins identified in the previous study
were identified in a fraction of the time. Both of these test cases showed the power of the
integrated approach as well as demonstrating the accuracy and speed of PTMSearchPlus.
The final goal of this dissertation was to apply the developed integrated
computational and experimental platforms developed to intact proteomes of microbial
systems under different growth conditions. This is the first study of this magnitude to
offer such a comprehensive list of intact identified proteins with their associated PTMs.
Within this study, the first large-scale characterization of three growth states of R.
palustris by an integrated top-down and bottom-up approach was performed. This global
measurement strategy was able to provide information on intact proteins, including
PTMs, isoforms, and signal peptides from a given growth state. The technological
approaches developed in this dissertation provided information on the function and
location of proteins, as well as providing confirming peptide MS/MS data. These tools
were shown to be especially powerful when determining what modification states play a
role in the switch between different growth conditions, characterizing known and
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unknown proteins, and determining trends within protein expression across the chosen
metabolic states. Our data indicates that it is possible to identify large numbers of intact
proteins with and without PTMs and correlate this information to bottom-up MS/MS
data. This technique should provide a starting point of future work with protein
complexes and functional studies within this, as well as other microbial systems.
This dissertation provided the first comprehensive platform for integrated topdown and bottom-up analysis of proteins, but many areas of work remain. Four of the
most important areas of work include intact protein separations, data-dependent MS/MS
on intact proteins within liquid chromatography time scales, intact protein bioinformatics,
and further analysis of PTMs once tentatively identified. Top-down technology in its
current form has difficulties with the complex mixtures found in whole proteome
analysis. Potential 2D separations of intact proteins such as the off-line FPLC followed
by on-line HPLC employed in this dissertation may overcome some of these limitations
by providing less complex protein fractions to analyze. However, the loss of protein is
always a concern when employing multiple protein purification and separation steps, this
is necessary to reduce the protein complexity from a proteome into more manageable
fractions for the mass spectrometer. The main area of concern, though, is the inability to
separate some protein sizes and types with the commonly employed C4 reverse phase
chromatography, such as proteins larger than 40- 50 kDa. This limitation exists due to online chromatography of intact proteins is often difficult; because of the wide range of
protein sizes and hydrophobicities within the complex proteome mixtures. Parts of this
problem can be addressed by employing shorter carbon chain reverse phase columns,
such as a C2 column. Another option is to use different stationary phases for intact
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protein separation. One example of an alternative is hydrophilic interaction
chromatography (HILIC). HILIC is a variant of normal phase chromatography, where the
stationary phase must be extremely polar. The elution order with HILIC is least to most
polar, the opposite of that in reverse phase liquid chromatography. This method provides
promise, although, there are still issues with protein precipitation that need to be worked
out. One other option is buffer additives, such as hexafluroisoporponal (HFIP), which
acts as a chaotrope to help provide better separations. These three solutions do provide
some benefit, but in the future better separation methods for intact proteins are needed.
One of the primary technological advances needed for this combined technology
includes methods for data-dependent MS/MS on intact proteins on liquid chromatography
time scales. Currently, the methods of IRMPD and ECD are employed for intact protein
MS/MS. These methods, while powerful, still leave room for improvement in the ability
to perform them on a liquid chromatography time scale and accomplish extensive
fragmentation of the protein. New instrumentation, such as the use of resolving
quadrupoles within the FT-ICR may help. Using the resolving quadrupole in the front of
the FT-ICR the proteins can be targeted for dissociation more readily. Also the use of
IRMPD in tandem with ECD provides two distinct forms of fragmentation and provides a
wider range of fragmentation for proteins of varying sizes. Hopefully the continuation of
fundamental instrumentation research will provide some of the answers to this limitation.
Work in this dissertation moved the field of top-down bioinformatics forward, by
using an integrated top-down and bottom-up search method found in PTMSearch Plus.
This program provides a great advance in integrated top-down and bottom-up searching,
but more work is need in the areas of addressing point mutation, signal peptides, and
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truncations. Amino Acid point mutations in proteins are one of the most difficult areas to
include in a protein identification algorithm, due to the enormous combination of
possibilities for all of the 20 amino acids within the protein sequence. Another area of
future work is the automated prediction and identification of signal peptides. Signal
sequences play an important role in protein processing and identification can sometimes
be crucial to determining a protein’s function and possible location within the cell (i. e. if
located within the periplasm). Hopefully, future work will advance the area of intact
protein analysis by providing quick and automated ways of identifying these PTMs.
The integrated top-down and bottom-up technology has already allowed for the
characterization of hundreds of conserved unknown and unknown proteins and their
associated PTMs as well as PTMs on known proteins. One of the clearest challenges is
the integration of the field of PTM analysis in proteomics with rapid structural analysis,
functional assays and genetic methods to develop rapid integrated methods to determine
not only the identity of conserved unknown and unknown proteins, but also their function
and the role the PTMs on them play. Another challenge is to determine what role
identified PTMs play in the regulation of known proteins. For top-down proteomics to
become truly useful at gaining insight into the function and regulation of the many
proteins present in any microbial species, this must be accomplished
The final major challenge is the application of this technology to microbial
growth states for rapid and routine analysis. While small important steps were taken in
the course of this dissertation, much work is still needed. The complexity of PTMs on
proteins is truly daunting but unless initial steps are taken to attack this important aspect
no progress will be made. Hopefully, the work presented in this dissertation brings us one
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step closer to the ultimate goal of an integrated computational and experimental platform
for characterizing protein isoforms and PTMs in microbial systems by top-down FT-ICR
mass spectrometry.
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